0001564590-20-054189.txt : 20201116 0001564590-20-054189.hdr.sgml : 20201116 20201116162134 ACCESSION NUMBER: 0001564590-20-054189 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 65 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201116 DATE AS OF CHANGE: 20201116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LM FUNDING AMERICA, INC. CENTRAL INDEX KEY: 0001640384 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37605 FILM NUMBER: 201317273 BUSINESS ADDRESS: STREET 1: 1200 WEST PLATT STREET STREET 2: SUITE 100 CITY: TAMPA STATE: FL ZIP: 33606 BUSINESS PHONE: 813-222-8996 MAIL ADDRESS: STREET 1: 1200 WEST PLATT STREET STREET 2: SUITE 100 CITY: TAMPA STATE: FL ZIP: 33606 10-Q 1 lmfa-10q_20200930.htm 10-Q - SEPT 2020 lmfa-10q_20200930.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

Commission file number 001-37605

 

LM FUNDING AMERICA, INC.

(Exact name of Registrant as specified in its charter)

 

 

Delaware

47-3844457

(State or other jurisdiction of

incorporation or organization)

(I.R.S. employer

identification no.)

 

 

1200 West Platt Street

Suite 100

Tampa, FL

33606

(Address of principal executive offices)

(Zip code)

Registrant’s telephone number, including area code: 813-222-8996

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

Trading symbol

Name of each exchange on which registered

Common Stock par value $0.001 per share

LMFA

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.:

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

The registrant had 15.4 million shares of Common Stock, par value $0.001 per share, outstanding as of November 16, 2020.

 

 

 

 


LM FUNDING AMERICA, INC.

TABLE OF CONTENTS

 

 

 

Page

 

 

 

PART I.

FINANCIAL INFORMATION

3

 

 

 

Item 1.

Financial Statements

3

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Balance Sheets
September 30, 2020 (unaudited) and December 31, 2019

3

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Operations
Three and Nine Months Ended September 30, 2020 and 2019 (unaudited)

4

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2020 and 2019 (unaudited)

5

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Equity
for the Three and Nine Months Ended September 30, 2020 and 2019 (unaudited)

6

 

Notes to Unaudited Condensed Consolidated Financial Statements

7

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

26

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

35

 

 

 

Item 4.

Controls and Procedures

35

 

 

 

PART II.

OTHER INFORMATION

36

 

 

 

Item 1.

Legal Proceedings

36

 

 

 

Item 1A.

Risk Factors

36

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

37

 

 

 

Item 3.

Defaults Upon Senior Securities

37

 

 

 

Item 4.

Mine Safety Disclosures

37

 

 

 

Item 5.

Other Information

37

 

 

 

Item 6.

Exhibits

38

 

 

SIGNATURES

39

 

2


PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Balance Sheets

 

 

 

September 30, 2020

 

 

December 31,

2019

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Cash

 

$

12,234,506

 

 

$

822,909

 

Finance receivables:

 

 

 

 

 

 

 

 

Original product - net (Note 3)

 

 

169,594

 

 

 

273,711

 

Special product - New Neighbor Guaranty program, net of allowance for credit losses of (Note 4)

 

 

95,944

 

 

 

129,272

 

Prepaid expenses and other assets

 

 

217,084

 

 

 

145,267

 

Due from related party (Note 5)

 

 

-

 

 

 

125,045

 

Discontinued operations - current assets (Note 10)

 

 

-

 

 

 

276,953

 

Current assets

 

 

12,717,128

 

 

 

1,773,157

 

Fixed assets, net (Note 1)

 

 

8,378

 

 

 

8,288

 

Real estate assets owned  (Note 1)

 

 

20,281

 

 

 

21,084

 

Operating lease - right of use assets (Note 8)

 

 

185,370

 

 

 

260,260

 

Other investments - related party (Note 1)

 

 

-

 

 

 

1,500,000

 

Goodwill (Note 2)

 

 

-

 

 

 

4,039,586

 

Other Assets

 

 

11,122

 

 

 

11,021

 

Discontinued operations - long-term assets, net (Note 10)

 

 

-

 

 

 

27,245

 

Long-term assets

 

 

225,151

 

 

 

5,867,484

 

Total assets

 

$

12,942,279

 

 

$

7,640,641

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Note payable (Note 6)

 

 

-

 

 

 

69,540

 

Related party convertible note payable

 

 

-

 

 

 

3,461,782

 

Accounts payable and accrued expenses

 

 

383,058

 

 

 

210,870

 

Due to related party (Note 5)

 

 

264,412

 

 

 

-

 

Current portion of lease liability (Note 8)

 

 

98,846

 

 

 

94,235

 

Discontinued operations - current liabilities (Note 10)

 

 

-

 

 

 

280,057

 

Total current liabilities

 

 

746,316

 

 

 

4,116,484

 

 

 

 

 

 

 

 

 

 

Lease liability - long-term (Note 8)

 

 

97,368

 

 

 

171,648

 

Note payable - long-term (Note 6)

 

 

339,797

 

 

 

-

 

Discontinued operations - long-term liabilities (Note 10)

 

 

-

 

 

 

517,584

 

Long-term liabilities

 

 

437,165

 

 

 

689,232

 

Total liabilities

 

 

1,183,481

 

 

 

4,805,716

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock, par value $.001; 30,000,000 shares authorized; 15,418,799  and 3,134,261 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively

 

 

15,419

 

 

 

3,134

 

Additional paid-in capital

 

 

29,978,962

 

 

 

17,326,553

 

Accumulated deficit

 

 

(18,235,583

)

 

 

(14,494,762

)

Total stockholders’ equity

 

 

11,758,798

 

 

 

2,834,925

 

Total liabilities and stockholders’ equity

 

$

12,942,279

 

 

$

7,640,641

 

 

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

 


3


LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (unaudited)

 

 

 

For the Three Months

Ended September 30,

 

 

For the Nine Months

Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest on delinquent association fees

 

$

105,592

 

 

$

348,451

 

 

$

495,280

 

 

$

1,226,464

 

Administrative and late fees

 

 

19,929

 

 

 

33,690

 

 

 

78,397

 

 

 

116,497

 

Recoveries in excess of cost - special product

 

 

37,127

 

 

 

30,927

 

 

 

122,117

 

 

 

57,199

 

Underwriting and other revenues

 

 

27,651

 

 

 

49,242

 

 

 

96,815

 

 

 

164,757

 

Rental revenue

 

 

62,185

 

 

 

90,353

 

 

 

143,609

 

 

 

310,307

 

Total revenues

 

 

252,484

 

 

 

552,663

 

 

 

936,218

 

 

 

1,875,224

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Staff costs and payroll

 

 

2,522,481

 

 

 

318,823

 

 

 

3,151,033

 

 

 

924,154

 

Professional fees

 

 

385,705

 

 

 

380,307

 

 

 

1,372,281

 

 

 

1,334,380

 

Settlement costs with associations

 

 

17,934

 

 

 

8,825

 

 

 

29,854

 

 

 

49,003

 

Selling, general and administrative

 

 

96,483

 

 

 

102,027

 

 

 

251,434

 

 

 

285,430

 

Recovery of cost from related party receivable

 

 

(100,000

)

 

 

-

 

 

 

(300,000

)

 

 

-

 

Provision for credit losses

 

 

30,000

 

 

 

7,641

 

 

 

30,000

 

 

 

266

 

Real estate management and disposal

 

 

53,432

 

 

 

84,362

 

 

 

152,882

 

 

 

381,796

 

Depreciation and amortization

 

 

(3,383

)

 

 

18,122

 

 

 

10,383

 

 

 

55,513

 

Collection costs

 

 

771

 

 

 

(3,974

)

 

 

(28,484

)

 

 

(17,275

)

Other operating expenses

 

 

3,120

 

 

 

3,009

 

 

 

13,758

 

 

 

18,265

 

Total operating expenses

 

 

3,006,543

 

 

 

919,142

 

 

 

4,683,141

 

 

 

3,031,532

 

Operating loss from continuing operations

 

 

(2,754,059

)

 

 

(366,479

)

 

 

(3,746,923

)

 

 

(1,156,308

)

Gain on disposal of assets

 

 

-

 

 

 

(6,421

)

 

 

-

 

 

 

(6,421

)

Interest expense

 

 

(2,300

)

 

 

23,150

 

 

 

10,326

 

 

 

76,913

 

Loss from continuing operations before income taxes

 

 

(2,751,759

)

 

 

(383,208

)

 

 

(3,757,249

)

 

 

(1,226,800

)

Income tax benefit

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss from continuing operations

 

 

(2,751,759

)

 

 

(383,208

)

 

 

(3,757,249

)

 

 

(1,226,800

)

Gain on disposal of discontinued operations

 

 

-

 

 

 

-

 

 

 

16,428

 

 

 

-

 

Gain from operations of discontinued operations

 

 

-

 

 

 

103,561

 

 

 

-

 

 

 

39,632

 

Net gain/(loss) from discontinued operations

 

 

-

 

 

 

103,561

 

 

 

16,428

 

 

 

39,632

 

Net loss

 

$

(2,751,759

)

 

$

(279,647

)

 

$

(3,740,821

)

 

$

(1,187,168

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings/(loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per common share - continuing operations

 

$

(0.28

)

 

$

(0.12

)

 

$

(0.66

)

 

$

(0.39

)

Basic earnings/(loss) per common share - discontinued operations

 

$

-

 

 

$

0.03

 

 

$

0.00

 

 

$

0.01

 

Basic loss per common share - net loss

 

$

(0.28

)

 

$

(0.09

)

 

$

(0.66

)

 

$

(0.38

)

Diluted loss per common share - continuing operations

 

$

(0.28

)

 

$

(0.12

)

 

$

(0.66

)

 

$

(0.39

)

Diluted earnings/(loss) per common share - discontinued operations

 

$

-

 

 

$

0.03

 

 

$

0.00

 

 

$

0.01

 

Diluted loss per common share - net loss

 

$

(0.28

)

 

$

(0.09

)

 

$

(0.66

)

 

$

(0.38

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

9,790,538

 

 

 

3,134,160

 

 

 

5,662,035

 

 

 

3,133,495

 

Diluted

 

 

9,790,538

 

 

 

3,134,160

 

 

 

5,662,035

 

 

 

3,133,495

 

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

 

4


LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows

(unaudited)

 

 

 

For the Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net loss

 

$

(3,740,821

)

 

$

(1,187,168

)

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net loss to cash used in operating activities

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

5,919

 

 

 

51,990

 

Right to use asset depreciation

 

 

74,890

 

 

 

27,133

 

Stock compensation

 

 

135,679

 

 

 

10,366

 

Recovery of uncollectible related party receivables

 

 

(300,000

)

 

 

-

 

Gain on termination of operating lease

 

 

-

 

 

 

(1,421

)

Gain on sale of fixed assets

 

 

-

 

 

 

(5,000

)

Gain on disposal of discontinued operations

 

 

(16,428

)

 

 

-

 

Reserve for accounts

 

 

30,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Change in assets and liabilities

 

 

 

 

 

 

 

 

Prepaid expenses and other assets

 

 

120,598

 

 

 

79,996

 

Accounts payable and accrued expenses

 

 

272,976

 

 

 

91,929

 

Advances (repayments) from related party

 

 

689,457

 

 

 

(1,174

)

Other liabilities

 

 

-

 

 

 

62,580

 

Lease liability payments

 

 

(69,669

)

 

 

(23,466

)

Deferred taxes

 

 

-

 

 

 

(14,200

)

Net cash used in operating activities

 

 

(2,797,399

)

 

 

(908,435

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Net collections of finance receivables - original product

 

 

74,117

 

 

 

115,769

 

Net collections of finance receivables - special product

 

 

33,328

 

 

 

88,046

 

(Payments)/proceeds for real estate assets owned

 

 

(3,920

)

 

 

80,076

 

Purchase of fixed assets

 

 

(1,286

)

 

 

(13,299

)

Proceeds from sale of fixed assets

 

 

-

 

 

 

5,000

 

Cash received from investment in note receivable - related party

 

 

1,500,000

 

 

 

-

 

Net cash received from business acquisition

 

 

(246,914

)

 

 

51,327

 

Net cash provided by investing activities

 

 

1,355,325

 

 

 

326,919

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Borrowings

 

 

185,785

 

 

 

-

 

Principal repayments

 

 

(108,043

)

 

 

(135,149

)

Exercise of warrants

 

 

3,081,480

 

 

 

22,320

 

Proceeds from stock subscription

 

 

9,447,535

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

 

12,606,757

 

 

 

(112,829

)

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH

 

 

11,164,683

 

 

 

(694,345

)

 

 

 

 

 

 

 

 

 

CASH - BEGINNING OF YEAR

 

 

1,069,823

 

 

 

3,520,753

 

CASH - END OF YEAR

 

$

12,234,506

 

 

$

2,826,408

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

10,326

 

 

$

31,936

 

Income taxes

 

$

-

 

 

$

-

 

SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION

 

 

 

 

 

 

 

 

Financing loan for purchase of fixed assets

 

$

-

 

 

$

12,892

 

Insurance financing

 

$

192,514

 

 

$

127,490

 

ROU asset obligation recognized

 

$

-

 

 

$

331,477

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5


LM Funding America, Inc. and Subsidiaries Consolidated Statements of Changes in Stockholders’ Equity (unaudited)

For the Three and Nine Months Ended September 30, 2020 and 2019

 

 

Common Stock

 

 

Additional paid-

 

 

Accumulated

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

in capital

 

 

Deficit

 

 

Total Equity

 

Balance - December 31, 2018

 

 

3,124,961

 

 

$

3,125

 

 

$

17,295,408

 

 

$

(11,489,884

)

 

$

5,808,649

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercised for cash

 

 

9,300

 

 

 

9

 

 

 

22,311

 

 

 

-

 

 

 

22,320

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,500

 

 

 

-

 

 

 

3,500

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(457,018

)

 

 

(457,018

)

Balance - March 31, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,321,219

 

 

$

(11,946,902

)

 

$

5,377,451

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,431

 

 

 

-

 

 

 

3,431

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(450,503

)

 

 

(450,503

)

Balance - June 30, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,324,650

 

 

$

(12,397,405

)

 

$

4,930,379

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,435

 

 

 

-

 

 

 

3,435

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(279,647

)

 

 

(279,647

)

Balance - September 30, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,328,085

 

 

$

(12,677,052

)

 

$

4,654,167

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - December 31, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,326,553

 

 

$

(14,494,762

)

 

$

2,834,925

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

 

186,000

 

 

 

186

 

 

 

128,661

 

 

 

-

 

 

 

128,847

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(551,094

)

 

 

(551,094

)

Balance - March 31, 2020

 

 

3,320,261

 

 

$

3,320

 

 

$

17,455,214

 

 

$

(15,045,856

)

 

$

2,412,678

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for cash

 

 

520,838

 

 

 

521

 

 

 

1,249,479

 

 

 

 

 

 

 

1,250,000

 

Warrants exercised for cash

 

 

1,227,700

 

 

 

1,228

 

 

 

2,945,252

 

 

 

 

 

 

 

2,946,480

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,397

 

 

 

-

 

 

 

3,397

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(437,968

)

 

 

(437,968

)

Balance - June 30, 2020

 

 

5,068,799

 

 

 

5,069

 

 

 

21,653,342

 

 

 

(15,483,824

)

 

 

6,174,587

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for cash

 

 

8,500,000

 

 

 

8,500

 

 

 

8,172,035

 

 

 

 

 

 

 

8,180,535

 

Warrants exercised for cash

 

 

1,700,000

 

 

 

1,700

 

 

 

15,300

 

 

 

 

 

 

 

17,000

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,435

 

 

 

-

 

 

 

3,435

 

Warrants exercised for cash

 

 

150,000

 

 

 

150

 

 

 

134,850

 

 

 

 

 

 

 

135,000

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,751,759

)

 

 

(2,751,759

)

Balance - September 30, 2020

 

 

15,418,799

 

 

$

15,419

 

 

$

29,978,962

 

 

$

(18,235,583

)

 

$

11,758,798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6


LM FUNDING AMERICA, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

LM Funding America, Inc. (“LMFA” or the “Company”) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the “Predecessor”). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.

LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January 8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering.

The Company acquired IIU, Inc. on January 16, 2019 (“IIU”), which provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and

7


severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note

8


 

was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

Specialty Health Insurance

Our former subsidiary IIU Inc. (“IIU”) through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad

 

Non United States citizens or residents who travel to the United States

These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered included:

 

HealthCare Abroad - Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.

 

HealthCare Global – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.  There is an age limit of 70 years old.

 

HealthCare America – up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old.

 

HealthCare International – International medical insurance & assistance for persons living outside their home country.  There is an age limit of 70 years old.

 

HealthCare War – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.  There is an age limit of 70 years old.

 

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the nine months ended September 30, 2020.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

9


On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  

In addition, on October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect to his beneficial ownership of shares of common stock of the Company.  In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company’s Board of Directors.  Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.  Furthermore, the Company was informed by Hanfor prior to such termination that Hanfor would be unable to provide audited financial statements for Hanfor for the foreseeable future because of ongoing legal issues in China.  As a result, the Company believes that the purported appointment of Mr. Han to the Company’s Board of Directors is invalid.   

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

 

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

 

On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of Nasdaq stating that the Company was not in compliance with the Minimum Bid Price Rule. The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  

 

If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company’s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company’s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement. 

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors. However, a reverse stock split was not effected pursuant to such approval.

Registered Public Offering

On August 18, 2020, in connection with an underwritten public offering, we raised approximately $8.2 million in net proceeds by issuing 10.2 million shares of common stock, the exercise of 1.7 million pre-funded warrants and 11.2 million warrants to purchase shares of common stock. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.

10


 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary, Wallach & Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of September 30, 2020 and for the three and nine months ended September 30, 2020 and September 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.

 

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s New Neighbor Guaranty program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.

We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

 

Revenue Recognition

Accounting Standards Codification (“ASC”) 606 of the Financial Accounting Standards Board (“FASB”) states an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the “accounts”). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social factors affecting the real estate environment in general. The Company’s contracts with its customers have very specific performance obligations.  The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.  The Company determined rental income from leasing arrangements is specifically excluded from the standard.  The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.

Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:

11


Finance Receivables—Original Product: Under the Company’s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company’s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3)) and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.

Finance Receivables—Special Product (New Neighbor Guaranty program): During 2012, the Company began offering associations an alternative product under the New Neighbor Guaranty program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i) a negotiated amount or (ii) on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company’s funded or principal amount, then a loss is recognized.

Net Commission Revenue: The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.  If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.

Cash

The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation’s (“FDIC”) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.

Finance Receivables

Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company’s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at September 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $142,027 and $112,027.

Under the New Neighbor Guaranty program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area. The Company estimated an allowance for credit losses for this program of $6,564 as of September 30, 2020 and $20,016 at December 31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.

The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company’s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

During the nine months ended September 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $51,080, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

12


Real Estate Assets Owned

In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.

Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens. In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10, Fair Value Measurements. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.

The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.  These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.  These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.  Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.  As of September 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $20,281 and $21,084, respectively.  

During the three and nine month period ended September 30, 2020 and 2019, depreciation expense was $(4,990) and $4,723 for 2020 and $5,385 and $17,354 for 2019, respectively.

If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.

If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.

Fixed Assets

The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company’s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of September 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and nine month period ended September 30, 2020 and 2019 was $nil and $nil for 2020 and $5,814 and $17,444 for 2019, respectively. 

Right to Use Assets

The Company capitalizes all leased assets pursuant to ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.  As of September 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $185,370 and $260,260, respectively. Amortization expense for right to use assets for the three and nine month period ended September 30, 2020 and 2019 was $23,661 and $74,890 for 2020 and was $22,281 and $27,133 for 2019, respectively while the payments totaled $69,669 for the nine months ended September 30, 2020. 

Other Investments – Note Receivable - Related Party

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended

13


the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.   The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven’s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

Goodwill

Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.

During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the 2019 annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.  This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of September 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively. 

 Debt Issue Costs

The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. The Company did not have any unamortized debt issue costs at September 30, 2020 and at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (“ASU”) 2015-03 (see below). The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under ASU 2015-03 (ASC 835-30-45-3).    

Settlement Costs with Associations

Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and nine months ended September 30, 2020 and 2019 were approximately $18,000  and $30,000 for 2020 and $9,000  and $49,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.  

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Under ASC 740-10-30-5, Income Taxes, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.

Loss Per Share

14


Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.  

The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.

On October 15, 2018, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.  The Reverse Stock Split became effective on October 16, 2018 and the Company’s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.

The Company has restated all share amounts to reflect the Reverse Stock Split.

Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.  

The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

 

As of September 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

14,790,059

 

2,879,287

Convertible Note

 

-

 

1,436,424

 

As part of its initial public offering, on October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of September 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was $0 and $0, respectively. These warrants will expire on October 31, 2020.

 

On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,875,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.  During the twelve months ended December 31, 2019, warrants for 9,300 shares were exercised for $22,320. During the nine months ended September 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480. There are 1,638,000 warrants remaining. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.67 per share.

 

As part of its underwriting agreement dated, October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.90 per share.

 

On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018 and August 18, 2020, these warrants now have the right to purchase 777,059 shares at an exercise price of $0.34 per share. These warrants expire in the year 2023.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was approximately $249,000.

 

A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares. On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (“IIU”), for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. LMFA originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.  

 

15


As part of its underwritten public offering on August 18, 2020 the Company issued 11,200,000 warrants that allowed for the right to purchase 11,200,000 shares of common stock at an average exercise price of $0.90 per share. These warrants have a weighted average remaining life of 4.88 years as of September 30, 2020. These warrants expire in the year 2025.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was $0. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.

 

Stock-Based Compensation

The Company records all equity-based incentive grants to employees and non-employee members of the Company’s Board of Directors in operating expenses in the Company’s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards.

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters.     

Fair Value of Financial Instruments

FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables.

Risks and Uncertainties

Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.  

In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.

Non-cash Financing and Investing Activities

During the nine months ended September 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.  Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.  The fair value of these properties was first applied to recover the Company’s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.

During the nine months ended September 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.  

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.  The guidance is effective January 1, 2020 with a one-year early adoption permitted.  We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.

Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

16


Subsequent Events

The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued. 

 

Note 2. Goodwill and Acquisition

On November 2, 2018, the Company invested cash by purchasing stock under a Securities Purchase Agreement (the “IIU SPA”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House N.A. (whose ownership excluding unexercised warrants is approximately 20% of the Company’s outstanding stock as of the date of acquisition), pursuant to which IIU issued to the Company a Senior Convertible Promissory Note (“IIU Note”) in the original principal amount of $1,500,000 in exchange for a purchase price of $1,500,000.  The maturity date of the Note is 360 dates after the date of issuance (subject to acceleration upon an event of default).  The Note carries a 3.0% interest rate, with accrued but unpaid interest being payable on the Note’s maturity date.  

The IIU Note allows the Company the right on or after the maturity date to convert any unpaid principal and accrued and unpaid interest of the IIU Note into shares of IIU based on a conversion amount which is the fair value of the common shares of IIU at the time. The conversion price will be reset if IIU issues or sells common shares, convertibles securities or options at a price per share that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale of such dilutive issuance.

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven House North America, LLC (“Craven”) to purchase all of the outstanding shares of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings. IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies are fully underwritten with no claim risk remaining with IIU.

The Board of Directors of LMFA approved the purchase of IIU. LMFA purchased 100% of the outstanding stock of IIU for $5,089,357.  LMFA paid the Purchase Price at closing as follows:

 

 

Cancellation by LMFA of all principal and accrued interest of IIU’s Promissory Note dated November 3, 2018 and issued to LMFA for principal indebtedness and accrued interest of $1,507,375.

 

LMFA issued to Craven a $3,581,982 Senior Convertible Promissory Note (“Craven Convertible Note”) for the balance of the Purchase Price.  At the option of Craven, the Convertible Note may be paid in restricted common shares of LMFA or cash.  The Craven Convertible Note shall bear simple interest at 3% per annum.  The Craven Convertible Note shall be due and payable 360 days from the Closing Date. If repaid by LMFA in restricted common stock, the outstanding principal and interest of the Craven Convertible Note shall be paid by LMFA by issuing to Seller a number of restricted common shares equal to the adjusted principal and accrued interest owing on the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42. The note principal was subsequently reduced by $120,200 arising from lower than expected Closing Cash and Net Working Capital. Craven had verbally agreed to extend repayment of this Craven Convertible Note 12 months from April 15, 2019.

 

Net cash received in the business acquisition was $51,327.As such, the $1.5 million note receivable was cancelled as of January 16, 2019.

 

The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:

 

 

January 16, 2019

 

 

Total adjusted purchase price

$

4,969,200

 

 

Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:

 

 

 

 

Cash

 

51,300

 

 

Prepaid and other current assets

 

5,200

 

 

Profit on purchased policies

 

14,600

 

 

Property, plant and equipment

 

17,100

 

 

Accounts payable

 

(5,100

)

 

Accrued expenses and other liabilities

 

(62,686

)

 

Income taxes

 

(28,500

)

 

Deferred revenue

 

(9,300

)

 

Debt

 

(703,000

)

 

Preliminary estimate of the fair value of assets and liabilities assumed

 

(720,386

)

 

 

 

 

 

 

Goodwill

$

5,689,586

 

 

17


 

We performed an assessment effective as of December 31, 2019 in light of the Company’s sale of IIU on January 8, 2020 which resulted in a $1.65 million goodwill impairment.  On January 8, 2020, the Company entered into a SPA with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Convertible Promissory Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. See Note 10 Discontinued Operations.

 

Note 3. Finance Receivables – Original Product

The Company’s original funding product provides financing to community associations only up to the secured or “Super Lien Amount” as discussed in Note 1.  Finance receivables for the original product as of September 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Funded during the current year

 

$

16,000

 

 

$

40,000

 

1-2 years outstanding

 

 

14,000

 

 

 

15,000

 

2-3 years outstanding

 

 

9,000

 

 

 

20,000

 

3-4 years outstanding

 

 

17,000

 

 

 

11,000

 

Greater than 4 years outstanding

 

 

256,000

 

 

 

300,000

 

 

 

 

312,000

 

 

 

386,000

 

Reserve for credit losses

 

 

(142,000

)

 

 

(112,000

)

 

 

$

170,000

 

 

$

274,000

 

Number of active units with delinquent assessments

 

 

489

 

 

 

598

 

Amount of outstanding interest and late fees on active units

 

$

8,682,000

 

 

$

9,167,000

 

The Company reserved $30,000 on financing receivables during the three month period ended September 30, 2020.

Note 4. Finance Receivables – Special Product (New Neighbor Guaranty program)

The Company typically funds amounts equal to or less than the “Super Lien Amount”.  During 2012 the Company began offering Associations an alternative product under the New Neighbor Guaranty program where the Company funds amounts in excess of the “Super Lien Amount”.  

Under this special product, the Company purchases substantially all of the outstanding past due assessments due from delinquent property owners, in addition to all interest, late fees and other charges in exchange for the Company’s commitment to pay monthly assessments on a going forward basis up to 48 months.  

As of September 30, 2020, maximum future contingent payments under these arrangements was approximately $34,000.  

Delinquent assessments and accrued charges under these arrangements as of September 30, 2020 and December 31, 2019, are as follows:

 

 

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Finance receivables, net

 

$

96,000

 

 

$

129,000

 

Delinquent assessments

 

 

205,000

 

 

 

374,000

 

Accrued interest and late fees

 

 

91,000

 

 

 

235,000

 

Number of active units with delinquent assessments

 

 

20

 

 

 

31

 

 

Allowance for credit losses are recorded for losses that are considered “probable” and can be “reasonably estimated” in accordance with ASC 450-20.  Recoverability of the Company’s Original Product is generally assured because of the protection of the Super Lien under Florida statute and as such no allowance is recorded.    

Credit losses on the NNG product were estimated by the Company based on analyzing the investment in each unit and comparing that balance to the average payout for completed units for the past 12 months. The allowance for losses based on these analyses, had a remaining balance of $7,000 and $20,000 as of September 30, 2020 and December 31, 2019, respectively.

 

Note 5. Due to Related Party

Legal services for the Company associated with the collection of delinquent assessments from property owners are performed by a law firm, Business Law Group (“BLG”), which was owned solely by Bruce M. Rodgers, the Chief Executive Officer of LMFA until and

18


through the date of the initial public offering. Following the offering, Mr. Rodgers transferred his interest in BLG to other attorneys at the firm through a redemption of his interest in the firm, and BLG is now under control of those lawyers. The law firm has historically performed collection work primarily on a deferred billing basis wherein the law firm receives payment for services rendered upon collection from the property owners or at amounts ultimately subject to negotiations with the Company.

During 2016, the Company experienced a decline in collection events that affected revenues both to the Company and BLG.  That resulted in an increase in the related party receivable and reflects the decision by the Company to advance funds to BLG based on the amount of their unpaid legal fees due from property owners.  Effective January 1, 2017, the Company entered into a new services agreement with BLG which partially alters the traditional deferred billing arrangement noted above.  

 

Under the new agreement, the Company pays BLG a fixed monthly fee of $82,000 for services rendered.  The Company will continue to pay BLG a minimum per unit fee of $700 in any case where there is a collection event and BLG receives no payment from the property owner.  This provision has been expanded to also include any unit where the Company has taken title to the unit or where the association has terminated its contract with either BLG or the Company.    

Amounts expensed by the Company to BLG for the three and nine months ended September 30, 2020 and 2019, respectively were approximately $247,000 and $756,000 for 2020 and $262,000 and $799,000 for 2019, respectively.  As of September 30, 2020 and December 31, 2019, receivables from property owners for charges ultimately payable to BLG approximate $1,542,000 and $1,883,000, respectively.

Under the related party agreement with BLG in effect during 2020 and 2019, the Company pays all costs (lien filing fees, process and serve costs) incurred in connection with the collection of amounts due from property owners.  Any recovery of these collection costs is accounted for as a reduction in expense incurred.  The Company incurred expenses related to these types of costs for the three and nine months ended September 30, 2020 and 2019 were $28,000 and $95,000 for 2020 and $49,000 and $158,000 for 2019, respectively. Recoveries during the three and nine months ended September 30, 2020 and 2019, related to those costs were approximately $28,000 and $124,000 for 2020 and $53,000 and $175,000 for 2019, respectively.  

The Company also shares office space and related common expenses with BLG.  All shared expenses, including rent, are charged to the legal firm based on an estimate of actual usage.  Any expenses of BLG paid by the Company that have not been reimbursed or settled against other amounts are reflected as due from related parties in the accompanying consolidated balance sheet. BLG was charged approximately $45,000 for the office sub-lease.

Amounts (payable) receivable from BLG as of September 30, 2020 and December 31, 2019 were approximately ($264,400) and $152,800, respectively. In the first nine months of September 30, 2020, the Company subsequently recouped $300,000 of previously write-off amounts to BLG.

On December 20, 2019, the Company loaned $1.5 million to Craven in the form of a secured promissory note (the “Craven Secured

Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly.

The Company subsequently extended the due date of the Craven Secured Promissory Note and the monthly interest payments to August 1, 2021. The Craven Secured Promissory Note is secured by, among other things, stock pledge of Craven’s 640,000 common stock of the Company and the assignment of the assets of Craven in favor of the Company.  This loan and the accrued interest was repaid on June 29, 2020.

19


Note 6. Debt and Other Financing Arrangements

 

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $20,746 was required upfront and equal installment payments of $19,251 to be made over a 10 month period. The note matures May 1, 2021. Annualized interest is 5.95%

 

$

154,012

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

339,797

 

 

$

4,149,578

 

 


20


As of September 30, 2020, minimum annual principal payments are as follows:

 

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

57,755

 

2021

 

 

96,257

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

339,797

 

On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan. These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers.

 

The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the fourth quarter of 2020.

 

 

Note 7. Going Concern

 The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company has experienced significant operating losses over the past 4 years (2016 through September 30, 2020) with cumulative losses of approximately $18,236,000 and negative cashflows from operations. These losses resulted in the usage of all cash proceeds from the Company’s initial public offering in 2015. For the year ended December 31, 2019, the Company disclosed the substantial doubt about the Company’s ability to continue as a going concern

The Company received a total of approximately $14.0 million during the nine months ended September 30, 2020 due to a number of factors including:

 

Holders of our warrants exercised such warrants for 1.2 million shares in June 2020 which resulted in the Company receiving approximately $2.9 million.

 

The Company was repaid approximately $1.5 million on a related party receivable.

 

The Company received $1.25 million for the issuance of 520,838 common shares.

 

The Company received $8.3 million for the issuance of 10,200,000 common shares.

 

Holders of our warrants exrcised such warrants for 150 thousand in August 2020 which resulted in the Company receiving approximately $0.1 million.

 

As such, we have $12.2 million of cash as of September 30, 2020 which will be enough to satisfy our estimated liquidity needs for the 12 months from the issuance of these financial statements. These factors mitigated the substantial doubt about the Company’s ability to continue as a going concern as defined by ASU 2014-15.

  

Note 8. Commitments and Contingencies

Leases

The Company leases certain office space, construction and office equipment, vehicles and temporary housing generally under non-cancelable operating leases. Leases with an initial term of one year or less are not recorded on the balance sheet, and the Company generally recognizes lease expense for these leases on a straight-line basis over the lease term. As of September 30, 2020, the Company’s operating leases have remaining lease terms ranging from less than one year to 3 years, some of which include options to

21


renew the leases. The exercise of lease renewal options is generally at the Company’s sole discretion. The Company’s leases do not contain any material residual value guarantees or material restrictive covenants.

The Company determines if an arrangement is a lease at inception. Operating lease ROU assets and current and long-term operating lease liabilities are separately stated on the Consolidated Balance Sheet as of September 30, 2020. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The present value of future lease payments are discounted using either the implicit rate in the lease, if known, or the Company’s incremental borrowing rate for the specific lease as of the lease commencement date. The rate was determined as a fair value of the lease over a 37 month period using a 6.5% interest rate for the present value calculation. The ROU asset is also adjusted for any prepayments made or incentives received. The lease terms include options to extend or terminate the lease only to the extent it is reasonably certain any of those options will be exercised. Lease expense is recognized on a straight-line basis over the lease term. The Company accounts for lease components (e.g., fixed payments) separate from the non-lease components (e.g., common-area maintenance costs). The Company does not have any material financing leases.

The Company leased its office under an operating lease beginning March 1, 2014 and ending July 31, 2019. The Company’s new office lease began July 15, 2019 and ends July 31, 2022. It also had a month to month lease for its IIU operations in 2019. A related party has a sub-lease for approximately $4,900 per month plus operating expenses.

 

The Company shares this space and the related costs associated with this operating lease with a related party (see Note 5) that also performs legal services associated with the collection of delinquent assessments.  Net rent expense recognized for the three and nine months ended September 30, 2020 and 2019 were approximately $26,000 and $76,000 for 2020 and $50,000 and $148,000 for 2019, respectively.

 

The following table presents components of lease expense excluding discontinued operations for the three and nine months ended September 30, 2020 and 2019:

 

 

Three Months

Ended

September 30,

2020

 

Nine Months

Ended

September 30,

2020

Three Months

Ended

September 30,

2019

Nine Months

Ended

September 30,

2019

Operating lease expense

$

27,644

$

89,931

50,274

147,575

 

$

27,644

$

89,931

50,274

147,575

 

The following table presents supplemental balance sheet information related to operating leases as of September 30, 2020 and December 31, 2019:

 

 

Balance Sheet Line Item

As of September 30, 2020

 

As of December 31, 2019

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

ROU assets

 

Right of use asset, net

$

185,370

 

$

260,260

 

 

 

Total lease assets

 

 

$

185,370

 

$

260,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Current lease liabilities

 

Lease liability

$

98,846

 

$

94,235

 

 

 

Long-term lease liabilities

 

Lease liability

 

97,368

 

 

171,648

 

 

 

Total lease liabilities

 

 

$

196,214

 

$

265,883

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average remaining lease term (in years)

 

 

 

1.83

 

 

2.60

 

 

 

Weighted-average discount rate

 

 

 

6.55

%

 

6.55

%

 

 

22


 

The following table presents supplemental cash flow information and non-cash activity related to operating leases for the nine months ended September 30, 2020 and 2019:

 

 

 

 

Nine Months Ended September 30, 2020

 

Nine Months Ended September 30, 2019

 

 

 

Operating cash flow information

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

$

(69,669

)

$

(23,466

)

 

 

Supplemental Disclosure of non-cashflow information

 

 

 

 

 

 

 

 

 

 

ROU assets and operating lease obligation recognized

 

 

$

-

 

$

331,477

 

 

 

The following table presents maturities of operating lease liabilities on an undiscounted basis as of September 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Leases

 

 

 

 

 

2020 (excluding the nine months ended September 30, 2020)

 

 

$

24,566

 

 

 

 

 

2021

 

 

 

103,646

 

 

 

 

 

2022

 

 

 

68,002

 

 

 

 

 

 

 

 

$

196,214

 

 

 

 

 

 

Legal Proceedings

Other than the lawsuits described below, we are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.

 

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.

 

Note 9. Stockholders’ Equity

Stock Options

The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,

performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash

awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the

2015 Omnibus Incentive Plan’s prohibitions on repricing) in substitution for any other award (or any other award granted under

another plan of ours or of any of our affiliates).

 

23


The following is a summary of the stock option plan activity during the nine months ended September 30, 2020 and 2019:

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Options

 

 

Exercise Price

 

 

Options

 

 

Exercise Price

 

Options Outstanding at Beginning of the year

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding at September 30,

 

 

19,300

 

 

$

54.68

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercisable at September 30,

 

 

15,134

 

 

$

62.02

 

 

 

7,634

 

 

$

113.81

 

 

Compensation expense recognized from the vesting of stock options was approximately $10,200 and $10,400 for the nine months ended September 30, 2020 and 2019. The remaining unrecognized compensation cost associated with unvested stock options as of September 30, 2020 is approximately $8,000.

 

The aggregate intrinsic value of the outstanding common stock options as of September 30, 2020 and December 31, 2019 was approximately $0 and $0 respectively.

 

Warrants

 

The following is a summary of the warrant activity during the nine months ended September 30, 2020 and 2019:

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

 

Warrants

 

 

Exercise Price

 

Warrants Outstanding at Beginning of the year

 

 

3,959,287

 

 

$

5.36

 

 

 

3,843,587

 

 

$

5.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

11,200,000

 

 

 

0.90

 

 

 

125,000

 

 

 

2.64

 

Exercised

 

 

1,377,700

 

 

 

2.24

 

 

 

9,300

 

 

 

2.40

 

Adjustment

 

 

633,472

 

 

 

0.34

 

 

 

-

 

 

 

-

 

Adjustment

 

 

375,000

 

 

 

0.67

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding at September 30,

 

 

14,790,059

 

 

$

1.79

 

 

 

3,959,287

 

 

$

5.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

During September 2020, the Company received approximately $3,081,480 upon the exercise by warrant holders of warrants for 1,377,700 shares.  The aggregate intrinsic value of the outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was approximately $249,000 and $0 respectively.

 

Common Share Issuance

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,833 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020  at which time the Company issued the 520,838 shares.

24


In connection with an underwritten public offering on August 18, 2020, the Company issued (i) 8,300,000 units (the “Units”) of common stock, par value $0.001 per share (the “Common Stock”) and one warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 1,700,000 pre-funded units (the “Pre-Funded Units”), with each pre-funded unit being comprised of one pre-funded warrant to purchase one share of common stock at an exercise price of $.01 per share (the “Pre-Funded Warrants”) and one warrant to purchase one share of common stock.  Each Unit was sold for a price of $0.90 per Unit, and each Pre-Funded Unit was sold for a price of $0.89 per Pre-Funded Unit.  Pursuant to an over-allotment option in the underwriting agreement, the Company sold an additional 200,000 shares of Common Stock.  The net proceeds of the offering were approximately $8,198,000.

 

Note 10. Discontinued Operations

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes of assets and liabilities of IIU were as follows:

 

 

As of December 31, 2019

Major classes of assets

 

Cash

$   246,914

Related party receivable

27,738

Prepaid expenses

2,301

Total major classes of current assets – discontinued assets

276,953

Fixed assets, net

27,245

Total major classes of assets – discontinued assets

$   304,198

 

 

Accounts payable and accrued expenses

$   144,006

Note payable – short term

100,672

Other liabilities

21,153

Income taxes payable

14,226

Total major classes of current liabilities – discontinued liabilities

280,057

 

 

Debt

517,584

Total major classes of liabilities - discontinued liabilities

$   797,641

 

 

 

The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and nine months ended September 30, 2020 and 2019 as discontinued operations are summarized below:

 

 

Three Months Ended September 30, 2020

Three Months Ended September 30, 2019

 

Nine Months Ended September 30, 2020

 

Nine Months Ended September 30, 2019

Revenue

$              -

$      221,085

$              -

$       501,244

Total operating costs and expenses

-

101,068

-

428,445

Gain (Loss) from discontinued operations

-

120,017

-

72,799

Other expense, net

-

16,455

-

33,166

Gain on disposal of discontinued operations

-

-

16,428

-

Net gain (loss) from discontinued operations

$               -

$  103,562

$     16,428

$   39,633

 

 

 

 

 

Net cash provided by operating activities

$                -

$ (48,205)

$                -

65,624

Net cash (used in) provided by investing activities

  -

(76,695)

(246,914)

(25,368)

Net cash used in financing activities

-

(18,418)

 

(56,304)

 

 

 

25


Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this Quarterly Report on Form 10-Q, including, without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs, and plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” “believes,” or the negative thereof or any variation thereon or similar terminology or expressions.

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Important factors which could materially affect our results and our future performance include, without limitation:

 

our ability to purchase defaulted consumer receivables at appropriate prices,

 

competition to acquire such receivables,

 

our dependence upon third party law firms to service our accounts,

 

our ability to obtain funds to purchase receivables,

 

our ability to manage growth or declines in the business,

 

changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables,

 

the impact of class action suits and other litigation on our business or operations,

 

our ability to keep our software systems updated to operate our business,

 

our ability to employ and retain qualified employees,

 

our ability to establish and maintain internal accounting controls,

 

changes in the credit or capital markets,

 

changes in interest rates,

 

deterioration in economic conditions,

 

negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire,

 

the spread of the novel coronavirus (COVID-19), its impact on the economy generally and, more specifically, the specialty finance industries,

 

negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, and

 

other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and Item 1A of this Quarterly Report on Form 10-Q.

Except as required by law, we assume no duty to update or revise any forward-looking statements.

Overview

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

26


 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

27


Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the nine months ended September 30, 2020.

Specialty Health Insurance

Our former subsidiary IIU through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad; and

 

Non United States citizens or residents who travel to the United States

28


These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered include: HealthCare Abroad, HealthCare Global, HealthCare America, HealthCare International, HealthCare War.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement

In addition, on October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect to his beneficial ownership of shares of common stock of the Company.  In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company’s Board of Directors.  Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.  Furthermore, the Company was informed by Hanfor prior to such termination that Hanfor would be unable to provide audited financial statements for Hanfor for the foreseeable future because of ongoing legal issues in China.  As a result, the Company believes that the purported appointment of Mr. Han to the Company’s Board of Directors is invalid. 

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

 

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

 

On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of Nasdaq stating that the Company was not in compliance with the Minimum Bid Price Rule. The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requests a hearing before a Nasdaq Hearing Panel.  

 

If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the

29


Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company’s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company’s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement.

 

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split was not yet effected pursuant to such approval.

Public Share Offering

In connection with an underwritten public offering on August 18, 2020, the Company issued (i) 8,300,000 units (the “Units”) of common stock, par value $0.001 per share (the “Common Stock”) and one warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 1,700,000 pre-funded units (the “Pre-Funded Units”), with each pre-funded unit being comprised of one pre-funded warrant to purchase one share of common stock at an exercise price of $.01 per share (the “Pre-Funded Warrants”) and one warrant to purchase one share of common stock.  Each Unit was sold for a price of $0.90 per Unit, and each Pre-Funded Unit was sold for a price of $0.89 per Pre-Funded Unit.  Pursuant to an over-allotment option in the underwriting agreement, the Company sold an additional 200,000 shares of Common Stock.  The net proceeds of the offering were approximately $8,198,000.

COVID-19 Update

Although COVID-19 is currently not material to our results of operations, there is uncertainty relating to the potential future impact on our business.  While our employees currently have the ability and are encouraged to work remotely, such measures have and may continue to have an impact on employee attendance or productivity, which, along with the possibility of employees’ illness, may adversely affect our operations. In addition to encouraging employees to work remotely, the Company has increased sanitation of its offices, provided hand gel and masks to its employees and has closed the offices during identified periods of high contagion.

The extent to which COVID-19 impacts our operations, or our ability to obtain financing should we require it, will depend on future developments which are uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions taken by governments and private businesses to contain COVID-19 to treat its impact, among others.  If the disruptions posed by COVID-19 continue for an extended period of time, financial markets may not be available to the Company for raising capital in order to fund future growth. Should the Company not be able to obtain financing when required, in the amounts necessary or under terms which are economically feasible, we may be required to reduce planned future growth and/or the scope of our operations.

On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan (“PPP Loan”). These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers.

The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the fourth quarter of 2020.

Corporate History and Reorganization

The Company was originally organized in January 2008 as a Florida limited liability company under the name LM Funding, LLC. Historically, all of our business was conducted through LM Funding, LLC and its subsidiaries (the “Predecessor”). Immediately prior to our initial public offering in October 2015, the members of the LM Funding, LLC contributed all of their membership interests to LM Funding America, Inc., a Delaware corporation incorporated on April 20, 2015 (“LMFA”), in exchange for an aggregate of 2,100,000 shares of the common stock of LMFA (the “Corporate Reorganization”). Immediately after such contribution and exchange, the former members of LM Funding, LLC became the holders of 100% of the issued and outstanding common stock of LMFA, thereby making LM Funding, LLC a wholly-owned subsidiary of LMFA. As used in this discussion and analysis, unless the context requires otherwise, references to “LMF,” “LM Funding,” “we,” “us,” “our,” “the Company,” “our company,” and similar references refer to (i) following the date of the Corporate Reorganization, LM Funding America, Inc., a Delaware corporation, and its

30


consolidated subsidiaries, and (ii) prior to the date of the Corporate Reorganization, LM Funding, LLC, a Florida limited liability company, and its consolidated subsidiaries.

Results of Operations – Three Months

The Three Months Ended September 30, 2020 compared with the Three Months Ended September 30, 2019

Revenues

During the Three Months ended September 30, 2020, total revenues decreased by $300 thousand, or 54.3%, to $252 thousand from $553 thousand in the Three Months ended September 30, 2019.

Interest on delinquent association fees for the Three Months ended September 30, 2020 decreased $243 thousand or 69.7% as the number of payoffs decreased to 63 payoff occurrences as compared to 128 payoff occurrences for the three months ended September 30, 2019.   We believe these payoffs were impacted in part by the negative impact COVID-19 has had on the general economy. “Payoffs” consist of recovery of the entire legally collectible portion, or a settlement thereof, of our principal investment, accrued interest, and late fees owed to us from the proceeds of the Accounts collected by the Associations in accordance with our contracts with Associations. The decrease in payoff occurrences was also due to a decrease in revenue per unit. The average revenue per unit per the Statement of Operations, excluding rental revenue and net commission revenue decreased to $3,021 for the Three Months ended September 30, 2020 compared with $3,514 for the Three Months ended September 30, 2019.

We saw a decrease in rental revenue in the Three Months ended September 30, 2020 of $28 thousand to $62 thousand from $90 thousand for the Three Months ended September 30, 2019. This was due to a reduced number of rental units in 2020 as compared to 2019.

Operating Expenses

During the Three Months ended September 30, 2020, operating expenses increased approximately $2.1 million, or 227.1%, to $3,006 thousand from $919 thousand for the Three Months ended September 30, 2019. The increase in operating expenses can be attributed to various factors, including $2.2 million increase in compensation relating to severance of $450 thousand, bonus of $630 thousand and a contract buyout of $819 thousand offset in part due to a reduction in real estate management expenses of $31 thousand, and a $100 thousand recovery of bad debt allowance for a related party.

Professional fees, excluding fees from the BLG service agreement, for the Three Months ended September 30, 2020 were approximately $139,000 compared with approximately $125,000 for the Three Months ended September 30, 2019.  In the ordinary course of our business, we are involved in numerous legal proceedings and expenses associated with acquisitions and corporate initiatives. We regularly initiate collection lawsuits, using our network of third party law firms, against debtors. In addition, debtors occasionally initiate litigation against us. The settlement costs of these lawsuits increased by approximately $9,000 to $18,000 compared with a charge of approximately $8,000 for the Three Months ended September 30, 2019.

Legal fees for BLG for the Three Months ended September 30, 2020 were $247 thousand compared to $262 thousand for the Three Months ended September 30, 2019. See Note 5. Due From Related Party for further discussion regarding the service agreements with BLG.  

Interest Expense

During the Three Months ended September 30, 2020, the Company incurred a negative $2 thousand of interest expense as compared to $23 thousand of interest expense for the Three Months ended September 30, 2019.  

Net Loss from Continuing Operations

During the Three Months ended September 30, 2020, the net loss from continuing operations was $2,752 thousand as compared to a net loss of $383 thousand for the Three Months ended September 30, 2019.  

Income from Discontinued Operations

During the Three Months ended September 30, 2020, the income from discontinued operations was $0 as compared to net income of $104 thousand for the Three Months ended September 30, 2019.  

Net Loss

During the Three Months ended September 30, 2020, the net loss was $2,752 thousand as compared to net loss of $280 thousand for the Three Months ended September 30, 2019.  The change in the loss was primarily due to reduced revenue and increased compensation.

31


Results of OperationsNine Months

The Nine Months Ended September 30, 2020 compared with the Nine Months Ended September 30, 2019

Revenues

During the Nine Months ended September 30, 2020, total revenues decreased by $939 thousand, or 50.1%, to $936 thousand from $1,875 thousand in the Nine Months ended September 30, 2019.

Interest on delinquent association fees for the Nine Months ended September 30, 2020 decreased $731 thousand or 59.6% as the number of payoffs decreased to 227 payoff occurrences as compared to 382 payoff occurrences for the Nine months ended September 30, 2019.  We believe these payoffs were impacted in part by the negative impact COVID-19 has had on the general economy. “Payoffs” consist of recovery of the entire legally collectible portion, or a settlement thereof, of our principal investment, accrued interest, and late fees owed to us from the proceeds of the Accounts collected by the Associations in accordance with our contracts with Associations. The decrease in payoff occurrences was also due to a decrease in revenue per unit. The average revenue per unit per the Statement of Operations, excluding rental revenue and net commission revenue decreased to $3,492 for the Nine Months ended September 30, 2020 compared with $4,097 for the Nine Months ended September 30, 2019.

We saw a decrease in rental revenue in the Nine Months ended September 30, 2020 of $167 thousand to $144 thousand from $310 thousand for the Nine Months ended September 30, 2019. This was due to a reduced number of rental units in 2020 as compared to 2019.

Operating Expenses

During the Nine Months ended September 30, 2020, operating expenses increased $1,652 thousand, or54.5%, to $4,683 thousand from $3,032 thousand for the Nine Months ended September 30, 2019. The increase in operating expenses can be attributed to various factors, including $2.2 million increase in compensation relating to severance of $450 thousand, bonus of $630 thousand and contract buyout of $819 thousand offset in part by a reduction in real estate management expenses of $229 thousand and $300 thousand recovery of bad debt allowance for a related party.

Professional fees, excluding fees from the BLG service agreement, for the Nine Months ended September 30, 2020 were approximately $616,000 compared with approximately $739,000 for the Nine Months ended September 30, 2019.  In the ordinary course of our business, we are involved in numerous legal proceedings and expenses associated with acquisitions and corporate initiatives. We regularly initiate collection lawsuits, using our network of third party law firms, against debtors. In addition, debtors occasionally initiate litigation against us. The settlement costs of these lawsuits decreased by approximately $19,000 to approximately $30,000 compared with approximately $49,000 for the Nine Months ended September 30, 2019. We also issued approximately $125,000 of our stock for investment banking services.

Legal fees for BLG for the Nine Months ended September 30, 2020 were $756 thousand compared to $799 thousand for the Nine Months ended September 30, 2019. See Note 5. Due From Related Party for further discussion regarding the service agreements with BLG.  

Interest Expense

During the Nine Months ended September 30, 2020, the Company incurred $10 thousand of interest expense, net as compared to $77 thousand of interest expense for the Nine Months ended September 30, 2019.  

Net Loss from Continuing Operations

During the Nine Months ended September 30, 2020, the net loss from continuing operations was $3,757 thousand as compared to a net loss of $1,227 thousand for the Nine Months ended September 30, 2019.  

Gain on Disposal of Discontinued Operations

During the Nine Months ended September 30, 2020, the Company disposed of IIU which generated a net gain of $16 thousand.

Loss from Discontinued Operations

During the Nine Months ended September 30, 2020, the loss from discontinued operations was $0 as compared to net income of $39 thousand for the Nine Months ended September 30, 2019.  

32


Net Loss

During the Nine Months ended September 30, 2020, the net loss was $3,741 thousand as compared to net loss of $1,187 thousand for the Nine Months ended September 30, 2019.  The change in the loss was primarily due to reduced revenue and increased compensation.

Liquidity and Capital Resources

General

As of September 30, 2020, we had cash and cash equivalents of $12,235 thousand compared with $1,070 thousand which includes $247 thousand held by our discontinued operations at December 31, 2019.

Cash from Operations

Net cash used in operations was $2,797 thousand during the Nine Months ended September 30, 2020 compared with $908 thousand during the Nine Months ended September 30, 2019. This change in cash used by operating activities was primarily driven by compensation payout offset in part by the $300 thousand recovery of related party receivables, $107 thousand of stock compensation and the disposal of IIU.

Cash from Investing Activities

For the Nine Months ended September 30, 2020 net cash generated by investing activities was $1,355 thousand as compared to net cash provided by investing activities of $327 thousand for the Nine Months ended September 30, 2019.  The increase was due to the receipt of a $1.5 million note receivable from related party offset in part by a decrease from the disposal of IIU and the reduced sale of real estate. Net collections from our finance receivables for the Nine Months ended September 30, 2020 was $107 thousand compared to $203 thousand for the Nine Months ended September 30, 2019.

Cash from Financing Activities

Net cash provided by financing activities was $12,607 thousand for the Nine Months ended September 30, 2020 compared with net cash used in financing activities of $113 thousand during the Nine Months ended September 30, 2019. At September 30, 2020, the principal indebtedness of the Company was $340 thousand (excluding lease liability of $220 thousand) compared with $4.2 million at December 31, 2019 and $4.2 million at September 30, 2019. For the Nine Months ended September 30, 2020 the Company repaid $108 thousand of principal repayments compared to $135 thousand principal repayments for the Nine Months ended September 30, 2019. During the Nine Months ended September 30, 2020 the Company received $1,250 thousand from a stock subscription agreement, $8,197 thousand from a public offering of our common stock and $3,081 thousand from the exercise of warrants. During the Nine Months ended September 30, 2019 the Company received $22 thousand from the exercise of warrants.

Shareholders’ Equity

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020  at which time the Company issued the 520,838 shares.

Holders of our warrants exercised such warrants for 1,277,700 shares for total consideration of $2,946,480.

On August 18, 2020, we raised approximately $8.2 million by issuing 10.2 million shares of common stock and 11.2 million warrants to purchase shares of common stock. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.       

Debt of the Company consisted of the following at September 30, 2020 and December 31, 2019:

  

33


 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $20,746 was required upfront and equal installment payments of $19,251 to be made over a 10 month period. The note matures May 1, 2021. Annualized interest is 5.95%

 

$

154,012

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

339,797

 

 

$

4,149,578

 

As of September 30, 2020, minimum required annual principal payments are as follows:

 

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

57,755

 

2021

 

 

96,257

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

339,797

 

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

34


 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to make disclosures under this item.

 

Item 4.

Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Management, with the participation of our Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2020. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as of September 30, 2020 due to the following material weakness in internal control over financial reporting that existed as of December 31, 2019 and that continued to exist through September 30, 2020

The Company did not effectively segregate certain accounting duties due to the small size of its accounting staff.

A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Notwithstanding the determination that there was a material weakness as identified in this Quarterly Report, we believe that our consolidated financial statements contained in this Quarterly Report fairly present our financial position, results of operations and cash flows for the years covered hereby in all material respects.

We expect to be dependent upon our Chief Financial Officer who is knowledgeable and experienced in the application of U.S. Generally Accepted Accounting Principles to maintain our disclosure controls and procedures and the preparation of our financial statements for the foreseeable future. We plan on increasing the size of our accounting staff at the appropriate time for our business and its size to ameliorate our concern that we do not effectively segregate certain accounting duties, which we believe would resolve the material weakness in disclosure controls and procedures, but there can be no assurances as to the timing of any such action or that we will be able to do so. 

(b) Changes in internal control over financial reporting.

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have not to date experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

 

35


PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

We are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.

 

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.

 

Item 1A.

Risk Factors

There have been no material changes from the risk factors previously disclosed in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, except for the addition of the risk factor set forth below:

Our business, results of operations, and financial condition may be impacted by the recent coronavirus (COVID-19) outbreak.

The global spread of COVID-19 has created significant volatility and uncertainty. The COVID-19 pandemic has caused a global economic slowdown that may last for a potentially extended duration, and it is possible that it could cause a global recession.  Deteriorating economic and political conditions caused by COVID-19, such as increased unemployment, decreases in capital spending, declines in customer confidence, or economic slowdowns or recessions, could cause a decrease in demand for our products and services.

While our employees currently have the ability and are encouraged to work remotely, such measures have had, and may continue to have, an impact on employee attendance or productivity, which, along with the possibility of employees’ illness, may adversely affect our operations. Although COVID-19 is currently not material to our results of operations, there is uncertainty relating to the potential future impact on our business. The extent to which COVID-19 impacts our operations, or our ability to obtain financing should we require it, will depend on future developments which are uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions taken by governments and private businesses to contain COVID-19 to treat its impact, among others. If the disruptions posed by COVID-19 continue for an extended period of time, financial markets may not be available to the Company for raising capital in order to fund future growth. Should the Company not be able to obtain financing when required, in the amounts necessary or under terms which are economically feasible, we may be required to reduce planned future growth and/or the scope of our operations. In addition, actions we have taken or may take, or decisions we have made or may make, as a consequence of COVID-19, may result in legal claims or litigation against us.

 

A potential legal dispute between Hanfor Owner and the Company could have material adverse effect on our business, financial condition, and results of operations.

On March 23, 2020, the Company entered into the Share Exchange Agreement with Hanfor and Hanfor Owner.  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.  Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had terminated the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  On October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect his beneficial ownership of shares of common stock of the Company.  In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company’s Board of Directors.  Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.  If the Company and Hanfor Owner cannot resolve this disagreement, any resulting formal legal dispute could have a material adverse effect on the Company’s business, financial conditions, and results of operation.

 

36


Our common shares could be delisted from the Nasdaq Capital Market.

 

On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nadaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  

 

If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company’s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company’s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement. The Company’s receipt of the notice does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission. However, there can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

(a) Sales of Unregistered Securities.

None.

(b) Use of Proceeds.

None.

(c) Repurchase of Securities.

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

Item 5.

Other Information

None

 

37


Item 6.

Exhibits

The following documents are filed as a part of this report or are incorporated herein by reference.

 

 

EXHIBIT

NUMBER

DESCRIPTION

 

 

4.1

Form of Common Warrant (incorporated by reference from Exhibit 4.1 to the Form 8-K filed on August 18, 2020)

4.1

Form of Pre-Funded Warrant (incorporated by reference from Exhibit 4.2 to the Form 8-K filed on August 18, 2020)

 

10.1

Amended and Restated Employment Agreement, dated September 30, 2020, by and between the Company and Bruce M. Rodgers (incorporated by reference from Exhibit 10.1 to the Form 8-K filed on October 2, 2020)

10.2

Amended and Restated Employment Agreement, dated September 30, 2020, by and between the Company and Richard Russell (incorporated by reference from Exhibit 10.2 to the Form 8-K filed on October 2, 2020)

  31.1

Rule 13a – 14(a) Certification of the Principal Executive Officer

 

 

  31.2

Rule 13a – 14(a) Certification of the Principal Financial Officer

 

 

  32.1

Written Statement of the Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. § 1350

 

 

101.INS

XBRL Instance Document.

 

 

101.SCH

XBRL Taxonomy Extension Schema.

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase.

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase.

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase.

 

 

101.PRE

XBRL Taxonomy Extension Presentation Linkbase.

 

 

 

 


38


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized:

 

 

 

LM FUNDING AMERICA, INC.

 

 

 

 

Date: November 16, 2020

 

By:

/s/ Bruce M. Rodgers

 

 

 

Bruce M. Rodgers

 

 

 

Chief Executive Officer and Chairman of the Board

 

 

 

(Principal Executive Officer)

 

 

 

 

Date: November 16, 2020

 

By:

/s/ Richard Russell

 

 

 

Richard Russell

 

 

 

Chief Financial Officer

 

 

 

(Principal Accounting Officer)

 

 

39

EX-31.1 2 lmfa-ex311_6.htm EX-31.1 lmfa-ex311_6.htm

Exhibit 31.1

 

November Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Bruce Rodgers, certify that:

1. I have reviewed this quarterly report on Form 10-Q of LM Funding America, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

/s/ Bruce Rodgers

November 16, 2020

 

Bruce Rodgers

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-31.2 3 lmfa-ex312_8.htm EX-31.2 lmfa-ex312_8.htm

Exhibit 31.2

 

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Richard Russell, certify that:

1. I have reviewed this quarterly report on Form 10-Q of LM Funding America, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

/s/ Richard Russell

November 16, 2020

 

Richard Russell

 

 

Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.1 4 lmfa-ex321_7.htm EX-32.1 lmfa-ex321_7.htm

Exhibit 32.1

 

Written Statement of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350

Solely for the purposes of complying with 18 U.S.C. ss.1350, I, the undersigned Chief Executive Officer of LM Funding America, Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2020 as filed with the Securities and Exchange Commission on November 16, 2020 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

/s/ Bruce Rodgers

 

 

 

 

Bruce Rodgers

 

 

 

 

Chief Executive Officer

 

 

 

 

(Principal Executive Officer)

November 16, 2020

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


 


Exhibit 32.1

 

 

Written Statement of the Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350

Solely for the purposes of complying with 18 U.S.C. ss.1350, I, the undersigned Chief Financial Officer of LM Funding America, Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2020 as filed with the Securities and Exchange Commission on November 16, 2020 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

/s/ Richard Russell

 

 

 

 

Richard Russell

 

 

 

 

Chief Financial Officer

 

 

 

 

(Principal Financial and Accounting Officer)

November 16, 2020

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EX-101.INS 5 lmfa-20200930.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares lmfa:Ownership xbrli:pure iso4217:USD lmfa:Assessment lmfa:Unit iso4217:USD lmfa:Unit 0001640384 2020-01-01 2020-09-30 0001640384 2020-11-16 0001640384 2020-09-30 0001640384 2019-12-31 0001640384 2020-07-01 2020-09-30 0001640384 2019-07-01 2019-09-30 0001640384 2019-01-01 2019-09-30 0001640384 us-gaap:ServiceMember 2020-07-01 2020-09-30 0001640384 us-gaap:ServiceMember 2019-07-01 2019-09-30 0001640384 us-gaap:ServiceMember 2020-01-01 2020-09-30 0001640384 us-gaap:ServiceMember 2019-01-01 2019-09-30 0001640384 lmfa:OriginalProductMember 2020-01-01 2020-09-30 0001640384 lmfa:OriginalProductMember 2019-01-01 2019-09-30 0001640384 lmfa:SpecialProductMember 2020-01-01 2020-09-30 0001640384 lmfa:SpecialProductMember 2019-01-01 2019-09-30 0001640384 2018-12-31 0001640384 2019-09-30 0001640384 us-gaap:CommonStockMember 2018-12-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001640384 us-gaap:RetainedEarningsMember 2018-12-31 0001640384 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001640384 2019-01-01 2019-03-31 0001640384 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001640384 us-gaap:CommonStockMember 2019-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001640384 us-gaap:RetainedEarningsMember 2019-03-31 0001640384 2019-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001640384 2019-04-01 2019-06-30 0001640384 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001640384 us-gaap:CommonStockMember 2019-06-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001640384 us-gaap:RetainedEarningsMember 2019-06-30 0001640384 2019-06-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001640384 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001640384 us-gaap:CommonStockMember 2019-09-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001640384 us-gaap:RetainedEarningsMember 2019-09-30 0001640384 us-gaap:CommonStockMember 2019-12-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001640384 us-gaap:RetainedEarningsMember 2019-12-31 0001640384 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001640384 2020-01-01 2020-03-31 0001640384 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001640384 us-gaap:CommonStockMember 2020-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001640384 us-gaap:RetainedEarningsMember 2020-03-31 0001640384 2020-03-31 0001640384 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001640384 2020-04-01 2020-06-30 0001640384 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001640384 us-gaap:CommonStockMember 2020-06-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001640384 us-gaap:RetainedEarningsMember 2020-06-30 0001640384 2020-06-30 0001640384 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001640384 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001640384 us-gaap:CommonStockMember 2020-09-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001640384 us-gaap:RetainedEarningsMember 2020-09-30 0001640384 lmfa:OriginalProductMember 2020-01-01 2020-09-30 0001640384 lmfa:SpecialProductMember 2020-01-01 2020-09-30 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember 2020-01-01 2020-09-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:SeniorConvertiblePromissoryNotesMember 2018-11-02 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:SeniorConvertiblePromissoryNotesMember 2018-11-01 2018-11-02 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2020-09-30 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2020-01-01 2020-09-30 0001640384 srt:MinimumMember lmfa:IIUIncMember 2020-01-01 2020-09-30 0001640384 srt:MinimumMember lmfa:IIUIncMember 2020-09-30 0001640384 lmfa:IIUIncMember lmfa:ConvertiblePromissoryNoteMember 2019-01-15 2019-01-16 0001640384 lmfa:IIUIncMember lmfa:ConvertiblePromissoryNoteMember 2019-01-16 0001640384 lmfa:IIUIncMember lmfa:ConvertiblePromissoryNoteMember 2020-09-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:IIUIncMember 2020-01-01 2020-09-30 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2019-12-20 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2019-12-19 2019-12-20 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2020-01-01 2020-09-30 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2020-06-29 0001640384 lmfa:CravenHouseCapitalNorthAmericaLLCMember lmfa:StockPurchaseAgreementMember 2020-01-08 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember lmfa:StockPurchaseAgreementMember 2019-01-15 2019-01-16 0001640384 lmfa:IIUIncMember 2019-01-01 2019-01-31 0001640384 lmfa:IIUIncMember 2019-01-31 0001640384 lmfa:IIUIncMember 2020-01-07 2020-01-08 0001640384 srt:SubsidiariesMember lmfa:HealthCareAbroadMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCAreGlobalMember srt:MaximumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCAreGlobalMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareAmericaMember srt:MaximumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareAmericaMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareInternationalMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareWarMember srt:MaximumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareWarMember 2020-01-01 2020-09-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:HanforCaymanLimitedMember 2020-03-23 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:HanforCaymanLimitedMember 2020-06-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:HanforCaymanLimitedMember 2020-03-23 2020-03-23 0001640384 2020-03-27 2020-03-27 0001640384 srt:MaximumMember 2020-01-01 2020-09-30 0001640384 2020-05-11 2020-05-11 0001640384 lmfa:UnderwrittenPublicOfferingMember 2020-07-16 2020-07-18 0001640384 lmfa:UnderwrittenPublicOfferingMember 2020-07-18 0001640384 us-gaap:WarrantMember lmfa:UnderwrittenPublicOfferingMember 2020-07-16 2020-07-18 0001640384 srt:MaximumMember lmfa:REOManagementHoldingsLlcMember lmfa:SubsidiaryLimitedLiabilityMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:SpecialProductMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:OriginalProductMember 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:OriginalProductMember 2019-12-31 0001640384 srt:SubsidiariesMember lmfa:SpecialProductMember 2020-09-30 0001640384 srt:SubsidiariesMember lmfa:SpecialProductMember 2019-12-31 0001640384 2019-01-01 2019-06-30 0001640384 srt:MinimumMember 2020-01-01 2020-09-30 0001640384 us-gaap:FirstMortgageMember srt:MinimumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember 2020-09-30 0001640384 srt:SubsidiariesMember srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember srt:MinimumMember us-gaap:ComputerEquipmentMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember us-gaap:ComputerEquipmentMember srt:MaximumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember srt:MinimumMember us-gaap:OfficeEquipmentMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember us-gaap:OfficeEquipmentMember srt:MaximumMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-09-30 0001640384 srt:SubsidiariesMember 2019-12-31 0001640384 srt:SubsidiariesMember 2020-07-01 2020-09-30 0001640384 srt:SubsidiariesMember 2019-07-01 2019-09-30 0001640384 srt:SubsidiariesMember 2019-01-01 2019-09-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2020-09-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2020-07-01 2020-09-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2019-07-01 2019-09-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2020-01-01 2020-09-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-09-30 0001640384 lmfa:PromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaIncMember 2019-12-20 0001640384 lmfa:PromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaIncMember 2019-12-19 2019-12-20 0001640384 lmfa:IIUIncMember 2019-12-31 0001640384 lmfa:IIUIncMember 2020-01-01 2020-09-30 0001640384 lmfa:IIUIncMember 2019-01-01 2019-12-31 0001640384 2018-11-30 0001640384 2018-10-15 2018-10-15 0001640384 2018-10-15 0001640384 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001640384 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001640384 us-gaap:WarrantMember 2020-01-01 2020-09-30 0001640384 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001640384 us-gaap:ConvertibleNotesPayableMember 2019-01-01 2019-09-30 0001640384 us-gaap:WarrantMember us-gaap:IPOMember 2015-10-23 0001640384 us-gaap:WarrantMember 2018-10-15 2018-10-16 0001640384 us-gaap:WarrantMember 2018-10-16 0001640384 us-gaap:WarrantMember 2020-09-30 0001640384 us-gaap:WarrantMember 2020-01-01 2020-09-30 0001640384 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001640384 us-gaap:WarrantMember us-gaap:IPOMember 2020-09-30 0001640384 us-gaap:WarrantMember us-gaap:IPOMember 2019-12-31 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2018-10-31 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2019-01-01 2019-12-31 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2020-01-01 2020-09-30 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2018-10-31 2018-10-31 0001640384 lmfa:SecondaryOfferingMember lmfa:AdditionalWarrantMember 2018-10-31 0001640384 lmfa:SecondaryOfferingMember lmfa:AdditionalWarrantMember 2018-10-31 2018-10-31 0001640384 us-gaap:WarrantMember 2018-04-02 0001640384 us-gaap:WarrantMember 2018-10-31 0001640384 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001640384 us-gaap:ConvertibleNotesPayableMember lmfa:StockPurchaseAgreementMember 2019-01-15 2019-01-16 0001640384 us-gaap:ConvertibleNotesPayableMember lmfa:StockPurchaseAgreementMember 2019-01-16 0001640384 lmfa:CravenHouseCapitalNorthAmericaLLCMember lmfa:SeniorConvertiblePromissoryNotesMember lmfa:StockPurchaseAgreementMember 2020-01-07 2020-01-08 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2019-01-16 0001640384 2020-07-18 0001640384 2020-07-16 2020-07-18 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:IIUIncMember 2019-01-16 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:PromissoryNoteMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:ConvertiblePromissoryNoteMember lmfa:IIUIncMember 2019-01-16 0001640384 lmfa:ConvertiblePromissoryNoteMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember 2019-01-16 0001640384 lmfa:ConvertiblePromissoryNoteMember lmfa:IIUIncMember 2019-04-15 2019-04-15 0001640384 lmfa:IIUIncAndWallachAndCompanyMember 2019-01-15 2019-01-16 0001640384 lmfa:IIUIncAndWallachAndCompanyMember 2019-01-16 0001640384 2020-01-09 2020-01-10 0001640384 lmfa:OriginalProductMember lmfa:CurrentYearMember 2020-09-30 0001640384 lmfa:OriginalProductMember lmfa:CurrentYearMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForNextOneToTwoYearsMember 2020-09-30 0001640384 lmfa:OriginalProductMember lmfa:FundForNextOneToTwoYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForNextTwoToThreeYearsMember 2020-09-30 0001640384 lmfa:OriginalProductMember lmfa:FundForNextTwoToThreeYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForNextThreeToFourYearsMember 2020-09-30 0001640384 lmfa:OriginalProductMember lmfa:FundForNextThreeToFourYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForGreaterThanFourYearsMember 2020-09-30 0001640384 lmfa:OriginalProductMember lmfa:FundForGreaterThanFourYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember 2020-09-30 0001640384 lmfa:OriginalProductMember 2019-12-31 0001640384 lmfa:OriginalProductMember 2019-01-01 2019-12-31 0001640384 lmfa:SpecialProductMember 2020-09-30 0001640384 lmfa:SpecialProductMember 2019-12-31 0001640384 lmfa:SpecialProductMember 2019-01-01 2019-12-31 0001640384 lmfa:NewNeighborGuarantyMember 2020-09-30 0001640384 lmfa:NewNeighborGuarantyMember 2019-12-31 0001640384 lmfa:BusinessLawGroupMember 2017-01-02 2017-01-02 0001640384 lmfa:BusinessLawGroupMember 2020-07-01 2020-09-30 0001640384 lmfa:BusinessLawGroupMember 2020-01-01 2020-09-30 0001640384 lmfa:BusinessLawGroupMember 2019-07-01 2019-09-30 0001640384 lmfa:BusinessLawGroupMember 2019-01-01 2019-09-30 0001640384 lmfa:BusinessLawGroupMember 2020-09-30 0001640384 lmfa:BusinessLawGroupMember 2019-12-31 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2020-07-01 2020-09-30 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2020-01-01 2020-09-30 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2019-07-01 2019-09-30 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2019-01-01 2019-09-30 0001640384 lmfa:BusinessLawGroupMember 2019-01-01 2019-12-31 0001640384 lmfa:CravenHoldingsNorthAmericaIncMember lmfa:PromissoryNotesMember 2019-12-20 0001640384 lmfa:CravenHoldingsNorthAmericaIncMember lmfa:PromissoryNotesMember 2019-12-19 2019-12-20 0001640384 lmfa:FinancialAgreementOneMember 2019-12-31 0001640384 lmfa:FinancialAgreementTwoMember 2020-09-30 0001640384 lmfa:PromissoryNoteOneMember 2020-09-30 0001640384 lmfa:SeniorSecuredConvertiblePromissoryNoteMember 2019-12-31 0001640384 lmfa:PromissoryNoteTwoMember 2019-12-31 0001640384 lmfa:PromissoryNoteThreeMember 2019-12-31 0001640384 lmfa:FinancialAgreementTwoMember 2020-01-01 2020-09-30 0001640384 lmfa:FinancialAgreementOneMember 2020-01-01 2020-09-30 0001640384 lmfa:FinancialAgreementOneMember 2020-09-30 0001640384 lmfa:SeniorSecuredConvertiblePromissoryNoteMember 2020-09-30 0001640384 lmfa:SeniorSecuredConvertiblePromissoryNoteMember 2020-01-01 2020-09-30 0001640384 lmfa:PromissoryNoteTwoMember 2020-09-30 0001640384 lmfa:PromissoryNoteTwoMember 2020-01-01 2020-09-30 0001640384 lmfa:PromissoryNoteThreeMember 2020-09-30 0001640384 lmfa:PromissoryNoteThreeMember 2020-01-01 2020-09-30 0001640384 lmfa:PromissoryNoteOneMember 2020-01-01 2020-09-30 0001640384 lmfa:PromissoryNoteOneMember lmfa:USFederalGovernmentCoronavirusAidReliefAndEconomicSecurityActMember 2020-09-30 0001640384 lmfa:GoingConcernsMember 2020-01-01 2020-09-30 0001640384 lmfa:GoingConcernsMember 2020-09-30 0001640384 lmfa:GoingConcernsMember us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001640384 lmfa:GoingConcernsMember us-gaap:CommonStockMember 2020-09-30 0001640384 lmfa:GoingConcernsMember 2020-08-01 2020-08-31 0001640384 lmfa:NewOfficeLeaseMember 2020-01-01 2020-09-30 0001640384 us-gaap:WarrantMember 2019-12-31 0001640384 lmfa:ShareExchangeAgreementMember 2020-03-23 2020-03-23 0001640384 2020-04-01 2020-04-30 0001640384 lmfa:UnderwrittenPublicOfferingMember 2020-08-18 2020-08-18 0001640384 lmfa:UnderwrittenPublicOfferingMember 2020-08-18 0001640384 lmfa:UnderwrittenPublicOfferingMember lmfa:PreFundedWarrantMember 2020-08-18 0001640384 us-gaap:OverAllotmentOptionMember 2020-08-18 2020-08-18 0001640384 2020-08-18 2020-08-18 0001640384 lmfa:StockPurchaseAgreementMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2020-01-07 2020-01-08 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2019-12-31 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2019-07-01 2019-09-30 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2019-01-01 2019-09-30 10-Q false 2020-09-30 2020 Q3 Common Stock par value $0.001 per share NASDAQ LMFA LM FUNDING AMERICA, INC. 0001640384 --12-31 Non-accelerated Filer true true Yes Yes false false 15400000 001-37605 DE 47-3844457 1200 West Platt Street Suite 100 Tampa FL 33606 813 222-8996 true false 12234506 822909 169594 273711 95944 129272 217084 145267 125045 276953 12717128 1773157 8378 8288 20281 21084 185370 260260 1500000 4039586 11122 11021 27245 225151 5867484 12942279 7640641 69540 3461782 383058 210870 264412 98846 94235 280057 746316 4116484 97368 171648 339797 517584 437165 689232 1183481 4805716 15419 3134 29978962 17326553 -18235583 -14494762 11758798 2834925 12942279 7640641 0.001 0.001 30000000 30000000 15418799 3134261 15418799 3134261 105592 348451 495280 1226464 19929 33690 78397 116497 37127 30927 122117 57199 27651 49242 96815 164757 62185 90353 143609 310307 252484 552663 936218 1875224 2522481 318823 3151033 924154 385705 380307 1372281 1334380 17934 8825 29854 49003 96483 102027 251434 285430 100000 300000 30000 7641 30000 266 53432 84362 152882 381796 -3383 18122 10383 55513 771 -3974 -28484 -17275 3120 3009 13758 18265 3006543 919142 4683141 3031532 -2754059 -366479 -3746923 -1156308 6421 6421 -2300 23150 10326 76913 -2751759 -383208 -3757249 -1226800 -2751759 -383208 -3757249 -1226800 16428 103561 39632 103561 16428 39632 -2751759 -279647 -3740821 -1187168 -0.28 -0.12 -0.66 -0.39 0.03 0.00 0.01 -0.28 -0.09 -0.66 -0.38 -0.28 -0.12 -0.66 -0.39 0.03 0.00 0.01 -0.28 -0.09 -0.66 -0.38 9790538 3134160 5662035 3133495 9790538 3134160 5662035 3133495 5919 51990 74890 27133 135679 10366 1421 5000 16428 -120598 -79996 272976 91929 689457 -1174 62580 69669 23466 -14200 -2797399 -908435 74117 115769 33328 88046 -3920 80076 1286 13299 5000 1500000 -246914 51327 1355325 326919 185785 108043 135149 3081480 22320 9447535 12606757 -112829 11164683 -694345 1069823 3520753 12234506 2826408 10326 31936 12892 192514 127490 331477 3124961 3125 17295408 -11489884 5808649 9300 9 22311 22320 3500 3500 -457018 -457018 3134261 3134 17321219 -11946902 5377451 3431 3431 -450503 -450503 3134261 3134 17324650 -12397405 4930379 3435 3435 -279647 -279647 3134261 3134 17328085 -12677052 4654167 3134261 3134 17326553 -14494762 186000 186 128661 128847 -551094 -551094 3320261 3320 17455214 -15045856 2412678 520838 521 1249479 1250000 1227700 1228 2945252 2946480 3397 3397 -437968 -437968 5068799 5069 21653342 -15483824 6174587 8500000 8500 8172035 8180535 1700000 1700 15300 17000 3435 3435 150000 150 134850 135000 -2751759 -2751759 15418799 15419 29978962 -18235583 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nature of Operations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding America, Inc. (&#8220;LMFA&#8221; or the &#8220;Company&#8221;) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the &#8220;Predecessor&#8221;). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January&#160;8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company acquired IIU, Inc. on January 16, 2019 <font style="color:#000000;">(&#8220;IIU&#8221;)</font>, which provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as &#8220;Associations,&#8221; a variety of financial products customized to each Association&#8217;s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as &#8220;Accounts,&#8221; in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association&#8217;s financial needs, including under our New Neighbor Guaranty&#8482; program. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Company</font></p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We purchase an Association&#8217;s right to receive a portion of the Association&#8217;s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association&#8217;s right to receive a portion of the Association&#8217;s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the &#8220;Super Lien Amount&#8221;. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.</p> <p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.</p> <p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Products</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Original Product</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called &#8220;super lien&#8221;, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association&#8217;s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months&#8217; past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association&#8217;s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association&#8217;s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment. </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.</p> <p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">New Neighbor Guaranty</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.</p> <p style="margin-top:13pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">IIU Acquisition and Disposal</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the &#8220;IIU Note&#8221;) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (&#8220;Craven&#8221;) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company&#8217;s outstanding stock at the time of the acquisition).&nbsp;&nbsp;The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).&nbsp;&nbsp;The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note&#8217;s maturity date.&nbsp;&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 16, 2019, the Company entered into a Stock Purchase Agreement with <font style="color:#000000;">Craven</font> (the &#8220;IIU SPA&#8221;) to purchase all of the outstanding capital stock of <font style="color:#000000;">IIU</font> as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.&nbsp;&nbsp;IIU provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company purchased <font style="color:#000000;">100</font>% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.&nbsp;&nbsp;IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows: </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the &#8220;Craven Convertible Note&#8221;) for the balance of the purchase price.&nbsp;&nbsp;At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.&nbsp;&nbsp;The Craven Convertible Note bore simple interest at 3% per annum.&nbsp;&nbsp;The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $<font style="color:#000000;">4,969,200</font>.</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven&#8217;s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;<font style="font-weight:bold;">SPA</font>&#8221;) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $<font style="color:#000000;">4,969,200</font> for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Health Insurance</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our former subsidiary IIU Inc. (&#8220;IIU&#8221;) through its wholly owned company Wallach and Company (&#8220;Wallach&#8221;) offered health insurance, travel insurance and other travel services to:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States citizens and residents traveling abroad</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non United States citizens or residents who travel to the United States</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.&nbsp;&nbsp;The policies offered included:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Abroad - <font style="Background-color:#FFFFFF;color:#000000;">Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Global &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare America &#8211; up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare International &#8211; International medical insurance &amp; assistance for persons living outside their home country.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare War &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such, IIU is considered a discontinued operation. <font style="color:#000000;">We did not report any activity from operations from IIU for the nine months ended September 30, 2020.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Entry into and Termination of Hanfor Share Exchange Agreement</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the &#8220;Share Exchange Agreement&#8221;), with <font style="color:#000000;">Hanfor (Cayman) Limited, a Cayman Islands exempted company (&#8220;Hanfor&#8221;), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (&#8220;Hanfor Owner&#8221;).</font>&nbsp;&nbsp;The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company&#8217;s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).&nbsp;&nbsp;In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares. </p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor&#8217;s inability to provide audited financial statements by June 30, 2020.&nbsp;&nbsp;Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company&#8217;s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.&nbsp;&nbsp;</p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, on October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect to his beneficial ownership of shares of common stock of the Company.&#160; In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company&#8217;s Board of Directors.&#160; Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.&#160; Furthermore, the Company was informed by Hanfor prior to such termination that Hanfor would be unable to provide audited financial statements for Hanfor for the foreseeable future because of ongoing legal issues in China.&#160; As a result, the Company believes that the purported appointment of Mr. Han to the Company&#8217;s Board of Directors is invalid.&#160;&#160;&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nasdaq Listing</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company&#8217;s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company&#8217;s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.&nbsp;&nbsp;The Company has timely requested a hearing.&nbsp;&nbsp;However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through <font style="color:#000000;">June 30, 2020. On&#160;July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company&#8217;s common stock was&#160;$1.00&#160;per share or greater for ten (10) consecutive business days. </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.&nbsp;&nbsp;The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of Nasdaq stating that the Company was not in compliance with the Minimum Bid Price Rule. The notification stated that the Company&#8217;s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company&#8217;s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company&#8217;s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement.&#160;<font style="color:#000000;"> </font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reverse Stock Split Approval</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company&#8217;s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.&nbsp;&nbsp;However, a reverse stock split was not effected pursuant to such approval.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Registered Public Offering</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 18, 2020, in connection with an underwritten public offering, we raised approximately $8.2 million in net proceeds by issuing 10.2 million shares of common stock, the exercise of 1.7 million pre-funded warrants and 11.2 million warrants to purchase shares of common stock. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Principles of Consolidation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary, Wallach &amp; Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Basis of Presentation</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of September 30, 2020 and for the three and nine months ended September 30, 2020 and September 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company&#8217;s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company&#8217;s <font style="font-style:italic;">New Neighbor Guaranty</font> program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Revenue Recognition</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Standards Codification<font style="font-style:normal;">&#160;(&#8220;ASC&#8221;) 606 of the Financial Accounting Standards Board (&#8220;FASB&#8221;) states </font><font style="font-style:normal;color:#000000;">an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. </font><font style="font-style:normal;"> </font><font style="font-style:normal;color:#000000;">That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. </font><font style="font-style:normal;">The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the &#8220;accounts&#8221;). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social </font><font style="font-style:normal;color:#000000;">factors affecting the real estate environment in general. The Company&#8217;s contracts with its customers have very specific performance obligations.&nbsp;&nbsp;The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.&nbsp;&nbsp;</font><font style="font-style:normal;">The Company determined rental income from leasing arrangements is specifically excluded from the standard.&#160; The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Original Product<font style="font-style:normal;">: Under the Company&#8217;s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company&#8217;s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3))&#160;and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Special Product (New Neighbor Guaranty program)<font style="font-style:normal;">: During 2012, the Company began offering associations an alternative product under the </font>New Neighbor Guaranty<font style="font-style:normal;"> program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i)&#160;a negotiated amount or (ii)&#160;on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the</font> collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company&#8217;s funded or principal amount, then a loss is recognized.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Commission Revenue:<font style="font-style:normal;">&#160;The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.&nbsp;&nbsp;If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Cash</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation&#8217;s (&#8220;FDIC&#8221;) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Finance Receivables</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company&#8217;s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at September 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $142,027 and $112,027. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the&#160;<font style="font-style:italic;">New Neighbor Guaranty</font>&#160;program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area.&#160;The Company estimated an allowance for credit losses for this program of $6,564 as of&#160;September 30, 2020 and $20,016 at December&#160;31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company&#8217;s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the nine months ended September 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $51,080, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Real Estate Assets Owned</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens.&#160;In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10,&#160;<font style="font-style:italic;">Fair Value Measurements</font>. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.&#160;&#160;These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.&#160;&#160;These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.&#160;&#160;Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.&#160;&#160;As of September 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $20,281 and $21,084, respectively.&#160;&#160;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three and nine month period ended September 30, 2020 and 2019, depreciation expense was $(4,990) and $4,723 for 2020 and $5,385 and $17,354 for 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.<font style="color:#000000;"> </font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fixed Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company&#8217;s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of September 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and nine month period ended September 30, 2020 and 2019 was $nil and $nil for 2020 and $5,814 and $17,444 for 2019, respectively.&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Right to Use Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all leased assets pursuant to <font style="color:#000000;">ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.&nbsp;&nbsp;</font>As of September 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $185,370 and $260,260, respectively. Amortization expense for right to use assets for the three and nine month period ended September 30, 2020 and 2019 was $23,661 and $74,890 for 2020 and was $22,281 and $27,133 for 2019, respectively while the payments totaled $69,669 for the nine months ended September 30, 2020.&#160;</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Other Investments &#8211; Note Receivable - Related Party</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven&#8217;s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Goodwill</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually </font><font style="color:#000000;">or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the&#160;2019&#160;annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.&nbsp;&nbsp;This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of September 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively.<font style="font-size:12pt;color:#000000;">&#160;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<font style="font-weight:bold;text-decoration:underline;">Debt Issue Costs</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. <font style="color:#000000;">The Company did not have any unamortized debt issue costs at September 30, 2020 and</font><font style="font-size:12pt;">&#160;</font><font style="color:#000000;">at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2015-03 (see below).&#160;The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under</font><font style="color:#000000;">&#160;</font><font style="color:#000000;">ASU 2015-03 (ASC 835-30-45-3).&#160;&#160;</font><font style="font-size:12pt;">&#160;&#160;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Settlement Costs with Associations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and nine months ended September 30, 2020 and 2019 were approximately $18,000&nbsp;&nbsp;and $30,000 for 2020 and $9,000&nbsp;&nbsp;and $49,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Income Taxes</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 740-10-30-5, <font style="font-style:italic;">Income Taxes</font>, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Loss Per Share</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 15, 2018, the Company effected a common share consolidation (&#8220;Reverse Stock Split&#8221;) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.&nbsp;&nbsp;<font style="color:#000000;">The Reverse Stock Split became effective on October 16, 2018 and the Company&#8217;s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has restated all share amounts to reflect the Reverse Stock Split.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The anti-dilutive stock based compensation awards and convertible notes consisted of:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td colspan="3" valign="bottom" style="width:14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of September 30,</p></td> </tr> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Warrants</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,790,059</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,879,287</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible Note</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,436,424</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its initial public offering, o<font style="color:#000000;">n October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of September 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.&nbsp;&nbsp;</font>The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was $0 and $0, respectively. These warrants will expire on October 31, 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,875,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.&nbsp;&nbsp;During the twelve months ended December 31, 2019, warrants for 9,300 shares were exercised for $22,320. During the nine months ended September 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480. There are 1,638,000 warrants remaining. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.67 per share.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its underwriting agreement dated, <font style="color:#000000;">October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.90 per share.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018 and August 18, 2020, these warrants now have the right to purchase 777,059 shares at an exercise price of $0.34 per share. These warrants expire in the year 2023.&nbsp;&nbsp;<font style="color:#000000;">The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was approximately $249,000.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares.<font style="color:#000000;"> On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;</font><font style="font-weight:bold;color:#000000;">SPA</font><font style="color:#000000;">&#8221;) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (&#8220;IIU&#8221;), for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. </font>LMFA <font style="color:#000000;">originally paid $</font>4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;<font style="color:#000000;"> </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its underwritten public offering o<font style="color:#000000;">n August 18, 2020 the Company issued 11,200,000 warrants that allowed for the right to purchase 11,200,000 shares of common stock at an average exercise price of $0.90 per share. These warrants have a weighted average remaining life of 4.88 years as of September 30, 2020. These warrants expire in the year 2025.&nbsp;&nbsp;</font>The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was $0. <font style="color:#000000;">Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand. </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock-Based Compensation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records all equity-based incentive grants to employees and non-employee members of the Company&#8217;s Board of Directors in operating expenses in the Company&#8217;s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters. &nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fair Value of Financial Instruments </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables. </font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Risks and Uncertainties </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Non-cash Financing and Investing Activities</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the nine months ended September 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.&#160;&#160;Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.&#160;&#160;The fair value of these properties was first applied to recover the Company&#8217;s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the nine months ended September 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Recent Accounting Pronouncements</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU 2016-13, <font style="font-style:italic;">Financial Instruments - Credit Losses,</font> which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.&nbsp;&nbsp;The guidance is effective January 1, 2020 with a one-year early adoption permitted.&nbsp;&nbsp;<font style="color:#000000;">We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reclassifications</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to the current period presentation.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Subsequent Events</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued.&#160; </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Note 2. Goodwill and Acquisition </font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 2, 2018, the Company invested cash by purchasing stock under a Securities Purchase Agreement (the &#8220;IIU SPA&#8221;) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House N.A. (whose ownership excluding unexercised warrants is approximately 20% of the Company&#8217;s outstanding stock as of the date of acquisition), pursuant to which IIU issued to the Company a Senior Convertible Promissory Note (&#8220;IIU Note&#8221;) in the original principal amount of $1,500,000 in exchange for a purchase price of $1,500,000.&nbsp;&nbsp;The maturity date of the Note is 360 dates after the date of issuance (subject to acceleration upon an event of default).&nbsp;&nbsp;The Note carries a 3.0% interest rate, with accrued but unpaid interest being payable on the Note&#8217;s maturity date.&nbsp;&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The IIU Note allows the Company the right on or after the maturity date to convert any unpaid principal and accrued and unpaid interest of the IIU Note into shares of IIU based on a conversion amount which is the fair value of the common shares of IIU at the time. The conversion price will be reset if IIU issues or sells common shares, convertibles securities or options at a price per share that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale of such dilutive issuance.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven House North America, LLC (<font style="color:#000000;">&#8220;Craven&#8221;</font>) to purchase all of the outstanding shares of <font style="color:#000000;">IIU</font> as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.&nbsp;&nbsp;IIU provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies are fully underwritten with no claim risk remaining with IIU.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board of Directors of LMFA approved the purchase of IIU. LMFA purchased 100% of the outstanding stock of IIU for $5,089,357.&nbsp;&nbsp;LMFA paid the Purchase Price at closing as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancellation by LMFA of all principal and accrued interest of IIU&#8217;s Promissory Note dated November 3, 2018 and issued to LMFA for principal indebtedness and accrued interest of $1,507,375.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LMFA issued to Craven a $3,581,982 Senior Convertible Promissory Note (&#8220;Craven Convertible Note&#8221;) for the balance of the Purchase Price.&nbsp;&nbsp;At the option of Craven, the Convertible Note may be paid in restricted common shares of LMFA or cash.&nbsp;&nbsp;The Craven Convertible Note shall bear simple interest at 3% per annum.&nbsp;&nbsp;The Craven Convertible Note shall be due and payable 360 days from the Closing Date. If repaid by LMFA in restricted common stock, the outstanding principal and interest of the Craven Convertible Note shall be paid by LMFA by issuing to Seller a number of restricted common shares equal to the adjusted principal and accrued interest owing on the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42. The note principal was subsequently reduced by $120,200 arising from lower than expected Closing Cash and Net Working Capital. Craven had verbally agreed to extend repayment of this Craven Convertible Note 12 months from April 15, 2019.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Net cash received in the business acquisition was $51,327.</font><font style="color:#000000;">As such, the $1.5 million note receivable was cancelled as of January 16, 2019.</font></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 16, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total adjusted purchase price </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,969,200</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Profit on purchased policies</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,600</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,100</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,100</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62,686</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,500</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,300</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(703,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preliminary estimate of the fair value of assets and liabilities assumed</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(720,386</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,689,586</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We performed an assessment effective as of December 31, 2019 in light of the Company&#8217;s sale of IIU on January 8, 2020 which resulted in a $1.65 million goodwill impairment.&nbsp;&nbsp;<font style="color:#000000;">On January 8, 2020, the Company entered into a SPA with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Convertible Promissory Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. </font>See Note 10 Discontinued Operations. </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Note 3. Finance Receivables &#8211; Original Product</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company&#8217;s original funding product provides financing to community associations only up to the secured or &#8220;Super Lien Amount&#8221; as discussed in Note 1.&nbsp;&nbsp;Finance receivables for the original product as of September 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funded during the current year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1-2 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2-3 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3-4 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greater than 4 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">256,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">312,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for credit losses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(142,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">489</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">598</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amount of outstanding interest and late fees on active units</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,682,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,167,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company reserved $30,000 on financing receivables during the three month period ended September 30, 2020</font>.</p></div> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Note 4. Finance Receivables &#8211; Special Product (New Neighbor Guaranty program)</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company typically funds amounts equal to or less than the &#8220;Super Lien Amount&#8221;.&nbsp;&nbsp;During 2012 the Company began offering Associations an alternative product under the New Neighbor Guaranty program where the Company funds amounts in excess of the &#8220;Super Lien Amount&#8221;.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under this special product, the Company purchases substantially all of the outstanding past due assessments due from delinquent property owners, in addition to all interest, late fees and other charges in exchange for the Company&#8217;s commitment to pay monthly assessments on a going forward basis up to 48 months.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020, maximum future contingent payments under these arrangements was approximately $34,000.&#160;&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments and accrued charges under these arrangements as of September 30, 2020 and December 31, 2019, are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables, net</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">374,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest and late fees</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses are recorded for losses that are considered &#8220;probable&#8221; and can be &#8220;reasonably estimated&#8221; in accordance with ASC 450-20.&nbsp;&nbsp;Recoverability of the Company&#8217;s Original Product is generally assured because of the protection of the Super Lien under Florida statute and as such no allowance is recorded.&nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credit losses on the NNG product were estimated by the Company based on analyzing the investment in each unit and comparing that balance to the average payout for completed units for the past 12 months. The allowance for losses based on these analyses, had a remaining balance of $7,000 and $20,000 as of September 30, 2020 and December 31, 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5. Due to Related Party</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal services for the Company associated with the collection of delinquent assessments from property owners are performed by a law firm, Business Law Group (&#8220;BLG&#8221;), which was owned solely by Bruce M. Rodgers, the Chief Executive Officer of LMFA until and through the date of the initial public offering. Following the offering, Mr. Rodgers transferred his interest in BLG to other attorneys at the firm through a redemption of his interest in the firm, and BLG is now under control of those lawyers. <font style="color:#000000;">The law firm has historically performed collection work primarily on a deferred billing basis wherein the law firm receives payment for services rendered upon collection from the property owners or at amounts ultimately subject to negotiations with the Company. </font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2016, the Company experienced a decline in collection events that affected revenues both to the Company and BLG.&nbsp;&nbsp;That resulted in an increase in the related party receivable and reflects the decision by the Company to advance funds to BLG based on the amount of their unpaid legal fees due from property owners.&nbsp;&nbsp;Effective January 1, 2017, the Company entered into a new services agreement with BLG which partially alters the traditional deferred billing arrangement noted above.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the new agreement, the Company pays BLG a fixed monthly fee of $82,000 for services rendered.&nbsp;&nbsp;The Company will continue to pay BLG a minimum per unit fee of $700 in any case where there is a collection event and BLG receives no payment from the property owner.&nbsp;&nbsp;This provision has been expanded to also include any unit where the Company has taken title to the unit or where the association has terminated its contract with either BLG or the Company.&nbsp;&nbsp;<font style="color:#000000;">&nbsp;&nbsp;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts expensed by the Company to BLG for the three and nine months ended September 30, 2020 and 2019, respectively were approximately $247,000 and $756,000 for 2020 and $262,000 and $799,000 for 2019, respectively.&nbsp;&nbsp;As of September 30, 2020 and December 31, 2019, receivables from property owners for charges ultimately payable to BLG approximate $1,542,000 and $1,883,000, respectively.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the related party agreement with BLG in effect during 2020 and 2019, the Company pays all costs (lien filing fees, process and serve costs) incurred in connection with the collection of amounts due from property owners.&nbsp;&nbsp;Any recovery of these collection costs is accounted for as a reduction in expense incurred.&nbsp;&nbsp;<font style="color:#000000;">The Company incurred expenses related to these types of costs for the three and nine months ended September 30, 2020 and 2019 were $28,000 and $95,000 for 2020 and $49,000 and $158,000 for 2019, respectively.</font> Recoveries during the three and nine months ended September 30, 2020 and 2019, related to those costs were approximately $28,000 and $124,000 for 2020 and $53,000 and $175,000 for 2019, respectively.&nbsp;&nbsp; </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also shares office space and related common expenses with BLG.&nbsp;&nbsp;All shared expenses, including rent, are charged to the legal firm based on an estimate of actual usage.&nbsp;&nbsp;Any expenses of BLG paid by the Company that have not been reimbursed or settled against other amounts are reflected as due from related parties in the accompanying consolidated balance sheet. BLG was charged approximately $45,000 for the office sub-lease. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts (payable) receivable from BLG as of September 30, 2020 and December 31, 2019 were approximately ($264,400) and $152,800, respectively. <font style="color:#000000;">In the first nine months of September 30, 2020, the Company subsequently recouped $300,000 of previously write-off amounts to BLG.</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven in the form of a secured promissory note (the &#8220;Craven Secured</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company subsequently extended the due date of the Craven Secured Promissory Note and the monthly interest payments to August 1, 2021. The Craven Secured Promissory Note is secured by, among other things, stock pledge of Craven&#8217;s 640,000 common stock of the Company and the assignment of the assets of Craven in favor of the Company.&nbsp;&nbsp;This loan and the accrued interest was repaid on June 29, 2020.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 6. Debt and Other Financing Arrangements </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing agreement with FlatIron capital that is unsecured.&nbsp;&nbsp;Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,540</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing agreement with FlatIron capital that is unsecured.&nbsp;&nbsp;Down payment of $20,746 was required upfront and equal installment payments of $19,251 to be made over a 10 month period. The note matures May 1, 2021. Annualized interest is 5.95%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,012</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.&nbsp;&nbsp; The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration&#8217;s Paycheck Protection Program (the &#8220;PPP Loan&#8221;)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.&nbsp;&nbsp;Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,461,782</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.&nbsp;&nbsp;Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.&nbsp;&nbsp;The note matures on August 26, 2023.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,802</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.&nbsp;&nbsp;The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company&#8217;s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606,454</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339,797</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,149,578</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020, minimum annual principal payments are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years Ending</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,755</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,257</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After 2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339,797</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan. These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the fourth quarter of 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 7.&#160;Going Concern</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<font style="Background-color:#FFFFFF;font-size:10pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has experienced significant operating losses over the past 4 years (2016 through September 30, 2020) with cumulative losses of approximately $18,236,000 and negative cashflows from operations.&#160;These losses resulted in the usage of all cash proceeds from the Company&#8217;s initial public offering in 2015. For the year ended December 31, 2019, the Company disclosed the substantial doubt about the Company&#8217;s ability to continue as a going concern</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received a total of approximately $14.0 million during the nine months ended September 30, 2020 due to a number of factors including:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Holders of our warrants exercised such warrants for 1.2 million shares in June 2020 which resulted in the Company receiving approximately $2.9 million. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was repaid approximately $1.5 million on a related party receivable. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received $1.25 million for the issuance of 520,838 common shares.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received $8.3 million for the issuance of 10,200,000 common shares.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Holders of our warrants exrcised such warrants for 150 thousand in August 2020 which resulted in the Company receiving approximately $0.1 million. </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such, we have $12.2 million of cash as of September 30, 2020 which will be enough to satisfy our estimated liquidity needs for the 12 months from the issuance of these financial statements. These factors mitigated the substantial doubt about the Company&#8217;s ability to continue as a going concern as defined by ASU 2014-15.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 8. Commitments and Contingencies</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases certain office space, construction and office equipment, vehicles and temporary housing generally&#160;under non-cancelable operating leases.&#160;Leases with an initial term of one year or less are not recorded on the balance sheet, and the Company generally recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;As of September 30, 2020,&#160;the Company&#8217;s operating leases have remaining lease terms ranging from less than one year to 3 years, some of which include options to renew the leases. The exercise of lease renewal options is generally at the Company&#8217;s sole discretion. The Company&#8217;s leases do not contain any material residual value guarantees or material restrictive covenants.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company determines if an arrangement is a lease at inception. Operating lease ROU assets and current and long-term operating lease liabilities are separately stated on the Consolidated Balance Sheet as of September 30, 2020. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The present value of future lease payments are discounted using either the implicit rate in the lease, if known, or the Company&#8217;s incremental borrowing rate for the specific lease as of the lease commencement date. <font style="color:#000000;">The rate was determined as a fair value of the lease over a 37 month period using a 6.5% interest rate for the present value calculation.</font><font style="font-size:12pt;color:#000000;"> </font>The ROU asset is also adjusted for any prepayments made or incentives received. The lease terms include options to extend or terminate the lease only to the extent it is reasonably certain any of those options will be exercised. Lease expense is recognized on a straight-line basis over the lease term. The Company accounts for lease components (e.g., fixed payments) separate from the non-lease components (e.g., common-area maintenance costs).<font style="font-size:11pt;font-family:Calibri;">&#160;</font>The Company does not have any material financing leases.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leased its office under an operating lease beginning March 1, 2014 and ending July 31, 2019. The Company&#8217;s new office lease began July 15, 2019 and ends July 31, 2022. It also had a month to month lease for its IIU operations in 2019. A related party has a sub-lease for approximately $4,900 per month plus operating expenses.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company shares this space and the related costs associated with this operating lease with a related party (see Note 5) that also performs legal services associated with the collection of delinquent assessments.&nbsp;&nbsp;Net rent expense recognized for the three and nine months ended September 30, 2020 and 2019 were approximately $26,000 and $76,000 for 2020 and $50,000 and $148,000 for 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents components of lease expense excluding discontinued operations for the three and nine months ended September 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76.5%;"> <tr> <td valign="top" style="width:49.86%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease expense</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,644</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,931</p></td> <td valign="top" bgcolor="#CCECFF" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,274</p></td> <td valign="top" bgcolor="#CCECFF" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,575</p></td> </tr> <tr> <td valign="top" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,644</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,931</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,274</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,575</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental balance sheet information related to operating leases as of September 30, 2020 and December 31, 2019<font style="color:#000000;">:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Line Item</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset, net</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,370</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,370</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,846</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,235</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,368</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">171,648</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,214</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">265,883</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.83</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.60</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental cash flow information and non-cash activity related to operating leases for the nine months ended September 30, 2020 and 2019:</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,669</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,466</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental Disclosure of non-cashflow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets and operating lease obligation recognized</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">331,477</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents maturities of operating lease liabilities on an undiscounted basis as of September 30, 2020:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020 (excluding the nine months ended September 30, 2020)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,566</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,646</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,002</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,214</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Legal Proceedings </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than the lawsuits described below, we are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note&#160;9. Stockholders&#8217; Equity</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock Options</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015 Omnibus Incentive Plan&#8217;s prohibitions on repricing) in substitution for any other award (or any other award granted under</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">another plan of ours or of any of our affiliates).</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the stock option plan activity during the nine months ended September 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at September 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.68</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable at September 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,134</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.02</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,634</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.81</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation expense recognized from the vesting of stock options was approximately $10,200 and $10,400 for the nine months ended September 30, 2020 and 2019. The remaining unrecognized compensation cost associated with unvested stock options as of September 30, 2020 is approximately $8,000. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of the outstanding common stock options as of September 30, 2020 and December 31, 2019 was approximately $0 and $0 respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Warrants</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the warrant activity during the nine months ended September 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:71.96%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,843,587</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.44</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,200,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.90</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.64</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,377,700</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.24</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,300</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">633,472</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.34</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">375,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.67</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at September 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,790,059</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.79</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During September 2020, the Company received approximately $3,081,480 upon the exercise by warrant holders of warrants for 1,377,700 shares.&nbsp;&nbsp;<font style="color:#000000;">The aggregate intrinsic value of the outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was approximately $249,000 and $0 respectively.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Common Share Issuance</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the &#8220;Share Exchange Agreement&#8221;), with <font style="color:#000000;">Hanfor (Cayman) Limited, a Cayman Islands exempted company (&#8220;Hanfor&#8221;), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (&#8220;Hanfor Owner&#8221;).</font>&nbsp;&nbsp;In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,833 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020&nbsp;&nbsp;at which time the Company issued the 520,838 shares. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with an underwritten public offering on August 18, 2020, the Company issued (i) 8,300,000 units (the &#8220;Units&#8221;) of common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) and one warrant to purchase one share of common stock (the &#8220;Common Warrants&#8221;), and (ii) 1,700,000 pre-funded units (the &#8220;Pre-Funded Units&#8221;), with each pre-funded unit being comprised of one pre-funded warrant to purchase one share of common stock at an exercise price of $.01 per share (the &#8220;Pre-Funded Warrants&#8221;) and one warrant to purchase one share of common stock.&nbsp;&nbsp;Each Unit was sold for a price of $0.90 per Unit, and each Pre-Funded Unit was sold for a price of $0.89 per Pre-Funded Unit.&nbsp;&nbsp;Pursuant to an over-allotment option in the underwriting agreement, the Company sold an additional 200,000 shares of Common Stock.&nbsp;&nbsp;The net proceeds of the offering were approximately $8,198,000. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note&#160;10. Discontinued Operations</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;<font style="font-weight:bold;">SPA</font>&#8221;) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest.<font style="color:#000000;"> The Company originally paid $4,969,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.</font>&nbsp;&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes <font style="Background-color:#FFFFFF;">of assets and liabilities of IIU were as follows:</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:67.67%;"> <tr> <td style="width:55.17%;"></td> <td style="width:12.5%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major classes of assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 246,914</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related party receivable</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,738</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,301</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,953</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed assets, net</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,245</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 304,198</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 144,006</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note payable &#8211; short term</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,672</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,153</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes payable</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,226</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current liabilities &#8211; discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,057</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">517,584</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of liabilities - discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 797,641</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and nine months ended September 30, 2020 and 2019 as discontinued operations are summarized below:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:102%;"> <tr> <td style="width:53.3%;"></td> <td style="width:12.01%;"></td> <td style="width:12.01%;"></td> <td style="width:12.34%;"></td> <td style="width:12.34%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended September 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended September 30, 2019</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;221,085</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 501,244</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating costs and expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,068</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">428,445</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain (Loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,017</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,799</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense, net</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,455</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,166</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on disposal of discontinued operations</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net gain (loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;103,562</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp; 16,428</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$ &nbsp;&nbsp;39,633</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by operating activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$ (48,205)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,624</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by investing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,695)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(246,914)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,368)</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in financing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,418)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(56,304)</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nature of Operations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding America, Inc. (&#8220;LMFA&#8221; or the &#8220;Company&#8221;) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the &#8220;Predecessor&#8221;). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January&#160;8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company acquired IIU, Inc. on January 16, 2019 <font style="color:#000000;">(&#8220;IIU&#8221;)</font>, which provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as &#8220;Associations,&#8221; a variety of financial products customized to each Association&#8217;s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as &#8220;Accounts,&#8221; in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association&#8217;s financial needs, including under our New Neighbor Guaranty&#8482; program. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Company</font></p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We purchase an Association&#8217;s right to receive a portion of the Association&#8217;s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association&#8217;s right to receive a portion of the Association&#8217;s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the &#8220;Super Lien Amount&#8221;. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.</p> <p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.</p> <p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Products</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Original Product</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called &#8220;super lien&#8221;, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association&#8217;s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months&#8217; past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association&#8217;s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association&#8217;s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment. </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.</p> <p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">New Neighbor Guaranty</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.</p> <p style="margin-top:13pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">IIU Acquisition and Disposal</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the &#8220;IIU Note&#8221;) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (&#8220;Craven&#8221;) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company&#8217;s outstanding stock at the time of the acquisition).&nbsp;&nbsp;The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).&nbsp;&nbsp;The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note&#8217;s maturity date.&nbsp;&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 16, 2019, the Company entered into a Stock Purchase Agreement with <font style="color:#000000;">Craven</font> (the &#8220;IIU SPA&#8221;) to purchase all of the outstanding capital stock of <font style="color:#000000;">IIU</font> as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.&nbsp;&nbsp;IIU provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company purchased <font style="color:#000000;">100</font>% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.&nbsp;&nbsp;IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows: </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the &#8220;Craven Convertible Note&#8221;) for the balance of the purchase price.&nbsp;&nbsp;At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.&nbsp;&nbsp;The Craven Convertible Note bore simple interest at 3% per annum.&nbsp;&nbsp;The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $<font style="color:#000000;">4,969,200</font>.</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven&#8217;s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;<font style="font-weight:bold;">SPA</font>&#8221;) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $<font style="color:#000000;">4,969,200</font> for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Health Insurance</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our former subsidiary IIU Inc. (&#8220;IIU&#8221;) through its wholly owned company Wallach and Company (&#8220;Wallach&#8221;) offered health insurance, travel insurance and other travel services to:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States citizens and residents traveling abroad</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non United States citizens or residents who travel to the United States</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.&nbsp;&nbsp;The policies offered included:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Abroad - <font style="Background-color:#FFFFFF;color:#000000;">Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Global &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare America &#8211; up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare International &#8211; International medical insurance &amp; assistance for persons living outside their home country.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare War &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such, IIU is considered a discontinued operation. <font style="color:#000000;">We did not report any activity from operations from IIU for the nine months ended September 30, 2020.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Entry into and Termination of Hanfor Share Exchange Agreement</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the &#8220;Share Exchange Agreement&#8221;), with <font style="color:#000000;">Hanfor (Cayman) Limited, a Cayman Islands exempted company (&#8220;Hanfor&#8221;), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (&#8220;Hanfor Owner&#8221;).</font>&nbsp;&nbsp;The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company&#8217;s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).&nbsp;&nbsp;In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares. </p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor&#8217;s inability to provide audited financial statements by June 30, 2020.&nbsp;&nbsp;Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company&#8217;s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.&nbsp;&nbsp;</p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, on October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect to his beneficial ownership of shares of common stock of the Company.&#160; In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company&#8217;s Board of Directors.&#160; Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.&#160; Furthermore, the Company was informed by Hanfor prior to such termination that Hanfor would be unable to provide audited financial statements for Hanfor for the foreseeable future because of ongoing legal issues in China.&#160; As a result, the Company believes that the purported appointment of Mr. Han to the Company&#8217;s Board of Directors is invalid.&#160;&#160;&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nasdaq Listing</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company&#8217;s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company&#8217;s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.&nbsp;&nbsp;The Company has timely requested a hearing.&nbsp;&nbsp;However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through <font style="color:#000000;">June 30, 2020. On&#160;July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company&#8217;s common stock was&#160;$1.00&#160;per share or greater for ten (10) consecutive business days. </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.&nbsp;&nbsp;The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of Nasdaq stating that the Company was not in compliance with the Minimum Bid Price Rule. The notification stated that the Company&#8217;s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company&#8217;s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company&#8217;s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement.&#160;<font style="color:#000000;"> </font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reverse Stock Split Approval</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company&#8217;s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.&nbsp;&nbsp;However, a reverse stock split was not effected pursuant to such approval.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Registered Public Offering</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 18, 2020, in connection with an underwritten public offering, we raised approximately $8.2 million in net proceeds by issuing 10.2 million shares of common stock, the exercise of 1.7 million pre-funded warrants and 11.2 million warrants to purchase shares of common stock. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Principles of Consolidation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary, Wallach &amp; Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Basis of Presentation</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of September 30, 2020 and for the three and nine months ended September 30, 2020 and September 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company&#8217;s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company&#8217;s <font style="font-style:italic;">New Neighbor Guaranty</font> program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Revenue Recognition</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Standards Codification<font style="font-style:normal;">&#160;(&#8220;ASC&#8221;) 606 of the Financial Accounting Standards Board (&#8220;FASB&#8221;) states </font><font style="font-style:normal;color:#000000;">an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. </font><font style="font-style:normal;"> </font><font style="font-style:normal;color:#000000;">That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. </font><font style="font-style:normal;">The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the &#8220;accounts&#8221;). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social </font><font style="font-style:normal;color:#000000;">factors affecting the real estate environment in general. The Company&#8217;s contracts with its customers have very specific performance obligations.&nbsp;&nbsp;The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.&nbsp;&nbsp;</font><font style="font-style:normal;">The Company determined rental income from leasing arrangements is specifically excluded from the standard.&#160; The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Original Product<font style="font-style:normal;">: Under the Company&#8217;s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company&#8217;s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3))&#160;and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Special Product (New Neighbor Guaranty program)<font style="font-style:normal;">: During 2012, the Company began offering associations an alternative product under the </font>New Neighbor Guaranty<font style="font-style:normal;"> program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i)&#160;a negotiated amount or (ii)&#160;on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the</font> collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company&#8217;s funded or principal amount, then a loss is recognized.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Commission Revenue:<font style="font-style:normal;">&#160;The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.&nbsp;&nbsp;If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Cash</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation&#8217;s (&#8220;FDIC&#8221;) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Finance Receivables</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company&#8217;s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at September 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $142,027 and $112,027. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the&#160;<font style="font-style:italic;">New Neighbor Guaranty</font>&#160;program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area.&#160;The Company estimated an allowance for credit losses for this program of $6,564 as of&#160;September 30, 2020 and $20,016 at December&#160;31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company&#8217;s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the nine months ended September 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $51,080, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Real Estate Assets Owned</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens.&#160;In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10,&#160;<font style="font-style:italic;">Fair Value Measurements</font>. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.&#160;&#160;These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.&#160;&#160;These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.&#160;&#160;Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.&#160;&#160;As of September 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $20,281 and $21,084, respectively.&#160;&#160;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three and nine month period ended September 30, 2020 and 2019, depreciation expense was $(4,990) and $4,723 for 2020 and $5,385 and $17,354 for 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.<font style="color:#000000;"> </font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fixed Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company&#8217;s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of September 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and nine month period ended September 30, 2020 and 2019 was $nil and $nil for 2020 and $5,814 and $17,444 for 2019, respectively.&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Right to Use Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all leased assets pursuant to <font style="color:#000000;">ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.&nbsp;&nbsp;</font>As of September 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $185,370 and $260,260, respectively. Amortization expense for right to use assets for the three and nine month period ended September 30, 2020 and 2019 was $23,661 and $74,890 for 2020 and was $22,281 and $27,133 for 2019, respectively while the payments totaled $69,669 for the nine months ended September 30, 2020.&#160;</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Other Investments &#8211; Note Receivable - Related Party</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven&#8217;s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Goodwill</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually </font><font style="color:#000000;">or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the&#160;2019&#160;annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.&nbsp;&nbsp;This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of September 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively.<font style="font-size:12pt;color:#000000;">&#160;</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. <font style="color:#000000;">The Company did not have any unamortized debt issue costs at September 30, 2020 and</font><font style="font-size:12pt;">&#160;</font><font style="color:#000000;">at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2015-03 (see below).&#160;The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under</font><font style="color:#000000;">&#160;</font><font style="color:#000000;">ASU 2015-03 (ASC 835-30-45-3).&#160;&#160;</font><font style="font-size:12pt;">&#160;&#160;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Settlement Costs with Associations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and nine months ended September 30, 2020 and 2019 were approximately $18,000&nbsp;&nbsp;and $30,000 for 2020 and $9,000&nbsp;&nbsp;and $49,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Income Taxes</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 740-10-30-5, <font style="font-style:italic;">Income Taxes</font>, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Loss Per Share</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 15, 2018, the Company effected a common share consolidation (&#8220;Reverse Stock Split&#8221;) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.&nbsp;&nbsp;<font style="color:#000000;">The Reverse Stock Split became effective on October 16, 2018 and the Company&#8217;s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has restated all share amounts to reflect the Reverse Stock Split.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The anti-dilutive stock based compensation awards and convertible notes consisted of:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td colspan="3" valign="bottom" style="width:14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of September 30,</p></td> </tr> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Warrants</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,790,059</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,879,287</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible Note</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,436,424</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its initial public offering, o<font style="color:#000000;">n October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of September 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.&nbsp;&nbsp;</font>The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was $0 and $0, respectively. These warrants will expire on October 31, 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,875,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.&nbsp;&nbsp;During the twelve months ended December 31, 2019, warrants for 9,300 shares were exercised for $22,320. During the nine months ended September 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480. There are 1,638,000 warrants remaining. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.67 per share.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its underwriting agreement dated, <font style="color:#000000;">October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.90 per share.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018 and August 18, 2020, these warrants now have the right to purchase 777,059 shares at an exercise price of $0.34 per share. These warrants expire in the year 2023.&nbsp;&nbsp;<font style="color:#000000;">The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was approximately $249,000.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares.<font style="color:#000000;"> On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;</font><font style="font-weight:bold;color:#000000;">SPA</font><font style="color:#000000;">&#8221;) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (&#8220;IIU&#8221;), for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. </font>LMFA <font style="color:#000000;">originally paid $</font>4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;<font style="color:#000000;"> </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its underwritten public offering o<font style="color:#000000;">n August 18, 2020 the Company issued 11,200,000 warrants that allowed for the right to purchase 11,200,000 shares of common stock at an average exercise price of $0.90 per share. These warrants have a weighted average remaining life of 4.88 years as of September 30, 2020. These warrants expire in the year 2025.&nbsp;&nbsp;</font>The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was $0. <font style="color:#000000;">Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand. </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock-Based Compensation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records all equity-based incentive grants to employees and non-employee members of the Company&#8217;s Board of Directors in operating expenses in the Company&#8217;s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters. &nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fair Value of Financial Instruments </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables. </font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Risks and Uncertainties </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Non-cash Financing and Investing Activities</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the nine months ended September 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.&#160;&#160;Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.&#160;&#160;The fair value of these properties was first applied to recover the Company&#8217;s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the nine months ended September 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Recent Accounting Pronouncements</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU 2016-13, <font style="font-style:italic;">Financial Instruments - Credit Losses,</font> which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.&nbsp;&nbsp;The guidance is effective January 1, 2020 with a one-year early adoption permitted.&nbsp;&nbsp;<font style="color:#000000;">We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reclassifications</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to the current period presentation.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Subsequent Events</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued.&#160; </p> The anti-dilutive stock based compensation awards and convertible notes consisted of: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td colspan="3" valign="bottom" style="width:14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of September 30,</p></td> </tr> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Warrants</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,790,059</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,879,287</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible Note</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,436,424</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 16, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total adjusted purchase price </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,969,200</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Profit on purchased policies</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,600</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,100</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,100</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62,686</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,500</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,300</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(703,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preliminary estimate of the fair value of assets and liabilities assumed</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(720,386</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,689,586</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company&#8217;s original funding product provides financing to community associations only up to the secured or &#8220;Super Lien Amount&#8221; as discussed in Note 1.&nbsp;&nbsp;Finance receivables for the original product as of September 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funded during the current year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1-2 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2-3 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3-4 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greater than 4 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">256,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">312,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for credit losses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(142,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">489</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">598</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amount of outstanding interest and late fees on active units</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,682,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,167,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company reserved $30,000 on financing receivables during the three month period ended September 30, 2020</font>.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments and accrued charges under these arrangements as of September 30, 2020 and December 31, 2019, are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables, net</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">374,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest and late fees</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing agreement with FlatIron capital that is unsecured.&nbsp;&nbsp;Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,540</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing agreement with FlatIron capital that is unsecured.&nbsp;&nbsp;Down payment of $20,746 was required upfront and equal installment payments of $19,251 to be made over a 10 month period. The note matures May 1, 2021. Annualized interest is 5.95%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,012</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.&nbsp;&nbsp; The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration&#8217;s Paycheck Protection Program (the &#8220;PPP Loan&#8221;)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.&nbsp;&nbsp;Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,461,782</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.&nbsp;&nbsp;Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.&nbsp;&nbsp;The note matures on August 26, 2023.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,802</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.&nbsp;&nbsp;The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company&#8217;s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606,454</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339,797</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,149,578</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020, minimum annual principal payments are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years Ending</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,755</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,257</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After 2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339,797</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents components of lease expense excluding discontinued operations for the three and nine months ended September 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76.5%;"> <tr> <td valign="top" style="width:49.86%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease expense</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,644</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,931</p></td> <td valign="top" bgcolor="#CCECFF" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,274</p></td> <td valign="top" bgcolor="#CCECFF" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,575</p></td> </tr> <tr> <td valign="top" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,644</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89,931</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,274</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,575</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental balance sheet information related to operating leases as of September 30, 2020 and December 31, 2019<font style="color:#000000;">:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Line Item</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset, net</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,370</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,370</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,846</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,235</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,368</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">171,648</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,214</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">265,883</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.83</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.60</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental cash flow information and non-cash activity related to operating leases for the nine months ended September 30, 2020 and 2019:</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,669</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,466</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental Disclosure of non-cashflow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets and operating lease obligation recognized</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">331,477</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents maturities of operating lease liabilities on an undiscounted basis as of September 30, 2020:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020 (excluding the nine months ended September 30, 2020)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,566</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,646</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,002</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,214</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the stock option plan activity during the nine months ended September 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at September 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54.68</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable at September 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,134</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62.02</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,634</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.81</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Warrants</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the warrant activity during the nine months ended September 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:71.96%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,843,587</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.44</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,200,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.90</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.64</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,377,700</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.24</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,300</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">633,472</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.34</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">375,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.67</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at September 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,790,059</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.79</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes <font style="Background-color:#FFFFFF;">of assets and liabilities of IIU were as follows:</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:67.67%;"> <tr> <td style="width:55.17%;"></td> <td style="width:12.5%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major classes of assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 246,914</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related party receivable</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,738</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,301</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,953</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed assets, net</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,245</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 304,198</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 144,006</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note payable &#8211; short term</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,672</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,153</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes payable</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,226</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current liabilities &#8211; discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,057</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">517,584</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of liabilities - discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 797,641</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and nine months ended September 30, 2020 and 2019 as discontinued operations are summarized below:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:102%;"> <tr> <td style="width:53.3%;"></td> <td style="width:12.01%;"></td> <td style="width:12.01%;"></td> <td style="width:12.34%;"></td> <td style="width:12.34%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended September 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended September 30, 2019</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Nine Months Ended September 30, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;221,085</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 501,244</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating costs and expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,068</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">428,445</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain (Loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,017</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,799</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense, net</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,455</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,166</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on disposal of discontinued operations</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net gain (loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;103,562</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp; 16,428</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$ &nbsp;&nbsp;39,633</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by operating activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$ (48,205)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,624</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by investing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,695)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(246,914)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,368)</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in financing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,418)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(56,304)</p></td> </tr> </table></div> 2 0.010 0.18 25 0.05 0.20 1500000 P360D 0.030 1.00 5089357 15000 152000 1507375 3581982 0.03 P360D 2.41 1.42 -120200 4969200 1500000 2020-04-15 0.005 640000 2021-08-01 1503719 3562569 3461782 100787 4969200 -720386 5689586 1650000 16428 P84Y P6M P70Y P90D P70Y P70Y P6M P70Y 0.865 520838 2.40 250000 1000000 1.00 1.00 On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors 0.1 0.5 8200000 10200000 11200000 1700000 150000 135000 1.00 P48M 142027 112027 6564 20016 13452 51080 P20Y P3Y 20281 21084 -4990 5385 4723 17354 500 P3Y P5Y P3Y P5Y P3Y P5Y P5Y 0 0 0 5814 0 17444 185370 260260 23661 22281 74890 27133 69669 1500000 2020-04-15 0.005 640000 5700000 0 4000000 0 0 18000 9000 30000 49000 3634857 2500000 one-for-ten 0.1 0.001 625318 19300 19300 14790059 2879287 1436424 1200000 12.50 one-tenth 12.50 12.50 P44Y P94Y 2020 0 0 2020-10-31 2875000 2.40 9300 22320 1277700 2946480 2023 1638000 0.67 125000 2.64 2022-05-02 0.90 40000 777059 6.605 0.34 2023 249000 1436424 0.030 2020-01-14 3461782 4969200 720386 5689586 16428 11200000 11200000 0.90 P4Y10M17D 2025 0 150000 135000 0 0 1500000 1.00 5089357 1507375 3581982 0.03 P360D 2.41 1.42 120200 P12M 51327 1500000 4969200 51300 5200 14600 17100 5100 62686 28500 9300 703000 720386 5689586 1650000 16000 40000 14000 15000 9000 20000 17000 11000 256000 300000 312000 386000 142000 112000 170000 274000 489 598 8682000 9167000 30000 P48M 34000 96000 129000 205000 374000 91000 235000 20 31 7000 20000 82000 700 247000 756000 262000 799000 1542000 1883000 28000 95000 49000 158000 28000 124000 53000 175000 45000 -264400 152800 300000 1500000 0.005 2020-04-15 2021-08-01 640000 69540 154012 185785 3461782 11802 606454 339797 4149578 20746 19251 2021-05-01 0.0595 19170 11590 2020-06-01 0.068 0.030 2019-01-16 2020-01-14 1436424 0 0.0909 323 2019-07-26 12892 2023-08-26 0.0585 10932 2018-05-31 608000 141000 51000 2025-05-30 0.010 2022-04-30 57755 96257 185785 339797 185785 P2Y 18236000 14000000 1200000 2900000 1500000 1250000 520838 12200000 8300000 10200000 150000 100000 P1Y P3Y P37M 0.065 2014-03-01 2019-07-31 2019-07-15 2022-07-31 4900 26000 76000 50000 148000 27644 89931 50274 147575 27644 89931 50274 147575 us-gaap:OperatingLeaseRightOfUseAsset us-gaap:OperatingLeaseRightOfUseAsset us-gaap:OperatingLeaseLiability us-gaap:OperatingLeaseLiability us-gaap:OperatingLeaseLiability 196214 265883 P1Y9M29D P2Y7M6D 0.0655 0.0655 24566 103646 68002 196214 19300 19300 19300 19300 15134 7634 60.51 60.51 54.68 60.51 62.02 113.81 10200 10400 8000 0 0 3959287 3843587 11200000 125000 1377700 9300 633472 375000 14790059 3959287 5.36 5.44 0.90 2.64 2.24 2.40 0.34 0.67 1.79 5.36 3081480 1377700 0 520833 2.40 250000 1000000 8300000 0.001 1 1700000 1 0.01 0.89 0.90 200000 8198000 4969586 1650000 246914 27738 2301 276953 27245 304198 144006 100672 21153 14226 280057 517584 797641 221085 501244 101068 428445 120017 72799 16455 33166 16428 103562 16428 39633 -48205 65624 -76695 -246914 -25368 -18418 -56304 EX-101.SCH 6 lmfa-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Goodwill and Acquisition link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Finance Receivables - Original Product link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Due to Related Party link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Debt and Other Financing Arrangements link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Going Concern link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Discontinued Operations link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Goodwill and Acquisition (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Finance Receivables - Original Product (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Debt and Other Financing Arrangements (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Stockholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Discontinued Operations (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Summary of Significant Accounting Policies - Additional information (Detail) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Goodwill and Acquisition - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Financing Receivable - Original Product - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Due to Related Party - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Debt and Other Financing Arrangements - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Going Concern - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Commitments and Contingencies - Components of Lease Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Stockholders' Equity - Summary of Stock Warrants (Detail) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Discontinued Operations - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 lmfa-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 lmfa-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 lmfa-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Shell Company Entity Shell Company Entity Ex Transition Period Entity Ex Transition Period Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Finance receivables original product. Finance receivables special product. Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Cash Cash Finance receivables: Notes Receivable Net [Abstract] Original product - net (Note 3) Finance Receivables Original Product Special product - New Neighbor Guaranty program, net of allowance for credit losses of (Note 4) Finance Receivables Special Product Prepaid expenses and other assets Prepaid Expense And Other Assets Current Due from related party (Note 5) Due From Related Parties Current Discontinued operations - current assets (Note 10) Assets Of Disposal Group Including Discontinued Operation Current Current assets Assets Current Fixed assets, net (Note 1) Property Plant And Equipment Net Real estate assets owned (Note 1) Real Estate Investments Other Operating lease - right of use assets (Note 8) Operating Lease Right Of Use Asset Other investments - related party (Note 1) Other Investments Goodwill (Note 2) Goodwill Other Assets Other Assets Noncurrent Discontinued operations - long-term assets, net (Note 10) Disposal Group Including Discontinued Operation Assets Noncurrent Long-term assets Assets Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities And Stockholders Equity [Abstract] Note payable (Note 6) Short Term Borrowings Related party convertible note payable Notes Payable Related Parties Classified Current Accounts payable and accrued expenses Accounts Payable And Accrued Liabilities Current Due to related party (Note 5) Due To Related Parties Current Current portion of lease liability (Note 8) Operating Lease Liability Current Discontinued operations - current liabilities (Note 10) Liabilities Of Disposal Group Including Discontinued Operation Current Total current liabilities Liabilities Current Lease liability - long-term (Note 8) Operating Lease Liability Noncurrent Note payable - long-term (Note 6) Long Term Debt Discontinued operations - long-term liabilities (Note 10) Liabilities Of Disposal Group Including Discontinued Operation Noncurrent Long-term liabilities Liabilities Noncurrent Total liabilities Liabilities Stockholders’ equity: Stockholders Equity [Abstract] Common stock, par value $.001; 30,000,000 shares authorized; 15,418,799 and 3,134,261 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Interest on delinquent association fees. Administrative and late fees. Recoveries on collection of assessments in excess of cost. Underwriting fees and other revenues. Rental revenue. Real estate management and disposal. The adjustment to depreciation, depletion and amortization for an adjustment to production volumes. Collection cost. Represents an adjustment to interest expense. Income Statement [Abstract] Statement [Table] Statement [Table] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] Service [Member] Service [Member] Statement [Line Items] Statement [Line Items] Revenues: Revenues [Abstract] Interest on delinquent association fees Interest On Delinquent Association Fees Administrative and late fees Administrative And Late Fees Recoveries in excess of cost - special product Recoveries On Collection Of Assessments In Excess Of Cost Underwriting and other revenues Underwriting Fees And Other Revenues Rental revenue Rental Revenue Total revenues Revenues Operating Expenses: Operating Expenses [Abstract] Staff costs and payroll Cost Direct Labor Professional fees Professional Fees Settlement costs with associations Litigation Settlement Expense Selling, general and administrative Selling General And Administrative Expense Recovery of cost from related party receivable Allowance For Doubtful Accounts Receivable Recoveries Provision for credit losses Provision For Doubtful Accounts Real estate management and disposal Real Estate Management And Disposal Depreciation and amortization Depreciation And Amortization Adjustment Collection costs Collection Cost Other operating expenses Other Cost And Expense Operating Total operating expenses Operating Expenses Operating loss from continuing operations Operating Income Loss Gain on disposal of assets Gain Loss On Disposition Of Assets1 Interest expense Interest Expense Adjustment Loss from continuing operations before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit Income Tax Expense Benefit Net loss from continuing operations Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Gain on disposal of discontinued operations Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax Gain from operations of discontinued operations Discontinued Operation Income Loss From Discontinued Operation Before Income Tax Net gain/(loss) from discontinued operations Income Loss From Discontinued Operations Net Of Tax Net loss Profit Loss Earnings/(loss) per share: Earnings Per Share [Abstract] Basic loss per common share - continuing operations Income Loss From Continuing Operations Per Basic Share Basic earnings/(loss) per common share - discontinued operations Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share Basic loss per common share - net loss Earnings Per Share Basic Diluted loss per common share - continuing operations Income Loss From Continuing Operations Per Diluted Share Diluted earnings/(loss) per common share - discontinued operations Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share Diluted loss per common share - net loss Earnings Per Share Diluted Weighted average number of common shares outstanding: Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Right to use asset depreciation. Increase decrease in deferred taxes. Proceeds from (payments) to sale and collection of finance receivables. Proceeds from (payments) for real estate assets owned. Net cash received from business acquisition. Financing loan for purchase of fixed asset. Non-cash investing and financing activities insurance financing. Statement Of Cash Flows [Abstract] Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Axis] Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Domain] Original product. Original Product [Member] Original Product [Member] Special product. Special Product [Member] Special Product [Member] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Adjustments to reconcile net loss to cash used in operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation Depletion And Amortization Right to use asset depreciation Right To Use Asset Depreciation Stock compensation Share Based Compensation Gain on termination of operating lease Gain Loss On Termination Of Lease Gain on sale of fixed assets Gains Losses On Sales Of Assets Gain on disposal of discontinued operations Reserve for accounts Change in assets and liabilities Increase Decrease In Operating Capital [Abstract] Prepaid expenses and other assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable and accrued expenses Increase Decrease In Accounts Payable And Accrued Liabilities Advances (repayments) from related party Increase Decrease In Due To Related Parties Other liabilities Increase Decrease In Other Operating Liabilities Lease liability payments Operating Lease Payments Deferred taxes Increase Decrease In Deferred Taxes Net cash used in operating activities Net Cash Provided By Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided By Used In Investing Activities [Abstract] Net collections of finance receivables Proceeds From Payments To Sale And Collection Of Finance Receivables (Payments)/proceeds for real estate assets owned Proceeds From Payments For Real Estate Assets Owned Purchase of fixed assets Payments To Acquire Property Plant And Equipment Proceeds from sale of fixed assets Proceeds From Sale Of Property Plant And Equipment Cash received from investment in note receivable - related party Proceeds From Collection Of Notes Receivable Net cash received from business acquisition Net Cash Received From Business Acquisition Net cash provided by investing activities Net Cash Provided By Used In Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided By Used In Financing Activities [Abstract] Borrowings Proceeds From Issuance Of Debt Principal repayments Repayments Of Debt Exercise of warrants Proceeds From Warrant Exercises Proceeds from stock subscription Proceeds From Issuance Of Common Stock Net cash provided by (used in) financing activities Net Cash Provided By Used In Financing Activities NET INCREASE (DECREASE) IN CASH Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CASH - BEGINNING OF YEAR Cash And Cash Equivalents At Carrying Value CASH - END OF YEAR SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid Net Income taxes Income Taxes Paid Net SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION Noncash Investing And Financing Items [Abstract] Financing loan for purchase of fixed assets Financing Loan For Purchase Of Fixed Asset Insurance financing Noncash Investing And Financing Activities Insurance Financing ROU asset obligation recognized Right Of Use Asset Obtained In Exchange For Operating Lease Liability Stock issued shares for warrants exercised. Stock issued for warrants exercised. Stock option issuance. Common stock shares issued for cash. Common stock value issued for cash. Exercise of prefunded warrants. Exercise of prefunded warrants, value. Statement Of Stockholders Equity [Abstract] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Balance Balance, shares Shares Outstanding Warrants exercised for cash Exercise Of Prefunded Warrants Value Warrants exercised for cash, shares Exercise Of Prefunded Warrants Warrants exercised for cash Stock Issued For Warrants Exercised Warrants exercised for cash, shares Stock Issued Shares For Warrants Exercised Stock compensation expense Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Stock compensation expense, shares Stock Option Issuance Common stock issued for cash Common Stock Value Issued For Cash Common stock issued for cash, Shares Common Stock Shares Issued For Cash Net loss Net Income Loss Balance Balance, shares Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] The entire disclosure for goodwill and business combination. Business Combinations [Abstract] Goodwill and Acquisition Goodwill And Business Combination Disclosure [Text Block] Receivables [Abstract] Finance Receivables Financing Receivables [Text Block] Schedule Of Accounts Notes Loans And Financing Receivable [Table] Schedule Of Accounts Notes Loans And Financing Receivable [Table] Special Product (New Neighbor Guaranty Program) [Member] Accounts Notes And Loans Receivable [Line Items] Accounts Notes And Loans Receivable [Line Items] Related Party Transactions [Abstract] Due to Related Party Related Party Transactions Disclosure [Text Block] Debt Disclosure [Abstract] Debt and Other Financing Arrangements Debt Disclosure [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Going Concern Substantial Doubt About Going Concern [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Equity [Abstract] Stockholders' Equity Stockholders Equity Note Disclosure [Text Block] Discontinued Operations And Disposal Groups [Abstract] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table] Disposal Group Name Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Axis] Disposal Group Name Disposal Groups Including Discontinued Operations Name [Domain] IIU Inc. I I U Inc I I U Inc [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Stock purchase agreement Stock Purchase Agreement Stock Purchase Agreement [Member] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] Discontinued Operations Disposal Groups Including Discontinued Operations Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Nature of operation. Nature of Operations Nature Of Operation Policy [Text Block] Principles of Consolidation Consolidation Policy [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Use of Estimates Use Of Estimates Revenue Recognition Revenue Recognition Policy [Text Block] Cash Cash And Cash Equivalents Policy [Text Block] Disclosure of accounting policy for financing receivables. Financing Receivables Financing Receivables Policy [Text Block] Real Estate Assets Owned Real Estate Held For Development And Sale Policy Fixed Assets Property Plant And Equipment Policy [Text Block] Disclosure of accounting policy related to Right to use assets. Right to Use Assets Right To Use Assets Policy [Text Block] Other investments policy. Other Investments - Note Receivable - Related Party Other Investments Policy [Text Block] Goodwill Goodwill And Intangible Assets Goodwill Policy Debt Issue Costs Debt Policy [Text Block] Settlement costs with associations. Settlement Costs with Associations Settlement Costs With Associations Policy [Text Block] Income Taxes Income Tax Policy [Text Block] Loss Per Share Earnings Per Share Policy [Text Block] Stock-Based Compensation Share Based Compensation Option And Incentive Plans Policy Contingencies Commitments And Contingencies Policy [Text Block] Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Risks and uncertainties policy. Risks and Uncertainties Risks And Uncertainties Policy [Text Block] Non cash financing and investing activities policy. Non-cash Financing and Investing Activities Non Cash Financing And Investing Activities Policy Policy [Text Block] Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements Policy Policy [Text Block] Reclassifications policy. Reclassifications Reclassifications Policy Policy [Text Block] Subsequent Events Subsequent Events Policy Policy [Text Block] Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block] Finance receivables outstanding. Schedule of Finance Receivables for Original Product Finance Receivables Outstanding Table [Text Block] Schedule of delinquent assessments and accrued charges. Schedule of Delinquent Assessments and Accrued Charges Schedule Of Delinquent Assessments And Accrued Charges Table [Text Block] Schedule of Debt Schedule Of Debt Table [Text Block] Schedule of Principal Payments of Debt Schedule Of Maturities Of Long Term Debt Table [Text Block] Components of Lease Expense Lease Cost Table [Text Block] Schedule of supplemental balance sheet information related to operating leases. Summary of Supplemental Balance Sheet Information Related to Operating Leases Schedule Of Supplemental Balance Sheet Information Related To Operating Leases Table [Text Block] Schedule of supplemental cash flow information and non cash activity related to operating leases. Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases Schedule Of Supplemental Cash Flow Information And Non Cash Activity Related To Operating Leases Table [Text Block] Schedule of Future Minimum Lease Payment Due Lessee Operating Lease Liability Maturity Table [Text Block] Summary of Stock Option Plan Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Stock Warrants Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Summary of major classes of assets and liabilities and operating results of IIU Schedule Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Text Block] Number of owners. Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Consolidated Entities Consolidated Entities [Axis] Consolidated Entities Consolidated Entities [Domain] Subsidiaries [Member] Subsidiaries [Member] Securities purchase agreement. Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Senior convertible promissory notes. Senior Convertible Promissory Notes [Member] Senior Convertible Promissory Notes [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Convertible promissory note. Convertible Promissory Note [Member] Convertible Promissory Note [Member] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Craven House Capital North America LLC. Craven House Capital North America LLC [Member] Craven House Capital North America L L C [Member] HealthCare abroad. HealthCare Abroad [Member] Health Care Abroad [Member] HealthCAre Global. HealthCare Global [Member] Health C Are Global [Member] HealthCare America. HealthCare America [Member] Health Care America [Member] HealthCare International. HealthCare International [Member] Health Care International [Member] HealthCare War. HealthCare War [Member] Health Care War [Member] Hanfor (Cayman) Limited. Hanfor-Owner [Member] Hanfor Cayman Limited [Member] Stock Warrants [Member] Warrant [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Underwritten Public Offering. Registered Public Offering [Member] Underwritten Public Offering [Member] REO Management Holdings Llc. REO Management Holdings, LLC [Member] R E O Management Holdings Llc [Member] Ownership Ownership [Axis] Ownership Ownership [Domain] Subsidiary limited liability. Subsidiary Limited Liability [Member] Subsidiary Limited Liability [Member] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category Mortgage Loans On Real Estate Description Loan Category [Axis] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category Mortgage Loans On Real Estate Loan Category [Domain] First Mortgage [Member] First Mortgage [Member] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Furniture [Member] Furniture And Fixtures [Member] Computer [Member] Computer Equipment [Member] Office Equipment [Member] Office Equipment [Member] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Capitalized Software [Member] Computer Software Intangible Asset [Member] Accounting Standards Update Adjustments For New Accounting Pronouncements [Axis] Accounting Standards Update Type Of Adoption [Member] ASU 2016-02 [Member] Accounting Standards Update201602 [Member] Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Promissory notes. Secured Promissory Note [Member] Promissory Notes [Member] Share Exchange Agreement [Member] Craven House Capital North America Inc. Craven [member] Craven House Capital North America Inc [Member] Hanfor (Cayman) Ltd Initial Public Offering [Member] I P O [Member] Secondary offering. Secondary Offering [Member] Secondary Offering [Member] Additional warrant. Additional Warrants [Member] Additional Warrant [Member] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Convertible Notes [Member] Convertible Notes Payable [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of members Number Of Owners Minimum percentage of original principal amount on mortgage. Minimum percentage of original principal amount on mortgage Minimum Percentage Of Original Principal Amount On Mortgage Maximum statutory delinquent assessments rate. Maximum administrative late fees per assessment. Percentage of maximum administrative late fees on delinquent assessment. Maximum statutory delinquent assessments rate Maximum Statutory Delinquent Assessments Rate Maximum administrative late fees Maximum Administrative Late Fees Per Assessment Percentage of maximum administrative late fees on delinquent assessment Percentage Of Maximum Administrative Late Fees On Delinquent Assessment Ownership excluding unexercised warrants percentage Equity Method Investment Ownership Percentage Principal amount Debt Instrument Carrying Amount Debt instrument term Debt Instrument Term Debt instrument, interest rate percentage Debt Instrument Interest Rate Stated Percentage Business combination working capital. Denominator for conversion of convertible note to restricted common stock. Percentage of stock purchased Business Acquisition Percentage Of Voting Interests Acquired Purchase price Business Combination Consideration Transferred1 Working capital Business Combination Working Capital Extinguishment of principal indebtedness and accrued interest Extinguishment Of Debt Amount Face amount of debt instrument Debt Instrument Face Amount Denominator for conversion of convertible note to restricted common shares Denominator For Conversion Of Convertible Note To Restricted Common Stock Closing price of share price Share Price Debt instrument reduced amount Debt Instrument Increase Decrease For Period Net Common stock shares pledge. Loans receivable principal and interest income amount. Loan amount Secured Debt Debt instrument, maturity date Debt Instrument Maturity Date Common shares pledge Common Stock Shares Pledge Full principal and accrued interest amount received Loans Receivable Principal And Interest Income Amount Proceeds from issuance of debt funded in repurchase and cancellation of debt. Sale of stock under agreement Common Unit Issuance Value Proceeds from issuance of debt funded in repurchase and cancellation of debt Proceeds From Issuance Of Debt Funded In Repurchase And Cancellation Of Debt Forgave amount accrued interest Debt Instrument Decrease Forgiveness Net fair value of assets Fair Value Net Asset Liability Goodwill impairment loss Goodwill Impairment Loss Goodwill impairment Goodwill Impaired Accumulated Impairment Loss Health insurance coverage age limit. Health insurance coverage period. Age limit Health Insurance Coverage Age Limit Coverage period Health Insurance Coverage Period Minimum bid price. Closing bid price of common stock. Purchase of outstanding warrants Class Of Warrant Or Right Outstanding Sale of stock price per share Sale Of Stock Price Per Share Proceeds from issuance of stock Proceeds From Issuance Or Sale Of Equity Notes receivable Notes Receivable Related Parties Minimum bid price Minimum Bid Price Closing bid price of common stock Closing Bid Price Of Common Stock Reverse stock split percentage of issued common stock. Reverse stock split percentage of outstanding common stock. Reverse stock split, description Stockholders Equity Reverse Stock Split Reverse stock split percentage of issued common stock Reverse Stock Split Percentage Of Issued Common Stock Reverse stock split percentage of outstanding common stock Reverse Stock Split Percentage Of Outstanding Common Stock Share based compensation arrangement by share based payment award equity instruments other than options exercised in period. Warrants issued to purchase of common stock Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Number of warrants, exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Percentage of ownership in subsidiary limited liability companies Subsidiary Of Limited Liability Company Or Limited Partnership Ownership Interest Delinquent assessments maximum due period purchases basis. Delinquent assessments maximum due period purchases basis Delinquent Assessments Maximum Due Period Purchases Basis Allowance for credit losses Financing Receivable Allowance For Credit Losses Finance receivables, allowance for credit losses, write offs Financing Receivable Allowance For Credit Losses Write Offs Capitalized real estate costs accumulated depreciation net. Estimated useful lives Property Plant And Equipment Useful Life Capitalized real estate costs, net of accumulated depreciation Capitalized Real Estate Costs Accumulated Depreciation Net Adjustments for depreciation expense. Depreciation expense Depreciation Adjustment Minimum acquisition cost of fixed assets that requires capitalization to fixed asset accounts. Minimum acquisition cost that requires capitalization to fixed assets Minimum Acquisition Amount Limit For Capitalization Of Fixed Assets Estimated useful life Finite Lived Intangible Asset Useful Life Capitalized software costs, net of accumulated amortization Capitalized Computer Software Net Amortization expense for capitalized software costs Capitalized Computer Software Amortization1 Financing and operating lease right of use asset. Finance and operating lease right of use asset amortization. Right of use asset, net Financing And Operating Lease Right Of Use Asset Amortization expense for right to use assets Finance And Operating Lease Right Of Use Asset Amortization Operating lease, payments Stock pledge against secured Investment. Maturity period. Loaned to related party Loans And Leases Receivable Related Parties Maturity of note Maturity Period Interest rate Loans Receivable Basis Spread On Variable Rate Stock pledge against investment Stock Pledge Against Secured Investment Unamortized debt issue costs Unamortized Debt Issuance Expense Settlement costs with associations Valuation allowance deferred tax assets Deferred Tax Assets Valuation Allowance Reverse stock split, conversion ratio Stockholders Equity Note Stock Split Conversion Ratio1 Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Stock Options [Member] Employee Stock Option [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Anti-dilutive stock based compensation awards Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Class of warrant or right weighted average exercise price. Class of warrants and rights weighted average remaining contractual terms. Class of warrants expiration year. Class of warrant or right exercise price of warrants or rights aggregate intrinsic value outstanding. Warrants expire date. Warrants issued to purchase of common stock average exercise price per share Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Warrants, weighted average price Class Of Warrant Or Right Weighted Average Exercise Price Warrants, weighted average remaining life Class Of Warrants And Rights Weighted Average Remaining Contractual Terms Warrants, year of expiration Class Of Warrants Expiration Year Warrants, aggregate intrinsic value outstanding Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Aggregate Intrinsic Value Outstanding Warrants Expire Date Warrants Expire Date Class of warrant or right, exercised. Warrant Class Of Warrant Or Right Exercised Class of warrants expiration period. Exercise Price Warrants Per Share. Warrants, year of expiration Class Of Warrants Expiration Period Exercise Price Warrants Per Share Exercise Price Warrants Per Share Business combination, adjusted consideration transferred. Disposal Group Including Discontinued Operation Gain On Disposal Of Business Convertible notes conversion to common shares Interest rate Short Term Debt Percentage Bearing Fixed Interest Rate Total adjusted purchase price Business Combination Adjusted Consideration Transferred Preliminary estimate of the fair value of assets and liabilities assumed Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Gain on disposal of discontinued operations Disposal Group Including Discontinued Operation Gain On Disposal Of Business Common stock shares issued for warrant. Common Stock Shares Issued For Warrant Common Stock Shares Issued For Warrant Fair value of property, plant and equipment less the cost to dispose. Fair value of properties Fair Value Property Plant And Equipment Less Cost To Dispose Closing share price of company. Schedule Of Business Acquisitions By Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Promissory note. Promissory Notes [Member] Promissory Note [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Principal amount Purchase price of notes issued Proceeds From Convertible Debt Closing share price Closing Share Price Net cash received from business acquisition Cash Acquired From Acquisition Business combination recognized identifiable assets acquired and liabilities assumed profit on purchased policies. Business combination recognized identifiable assets acquired and liabilities assumed accrued expenses and other liabilities. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets [Abstract] I I U Inc and Wallach and Company. IIU, Inc and Wallach and Company [Member] I I U Inc And Wallach And Company [Member] Cash Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents Prepaid and other current assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets Profit on purchased policies Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Profit On Purchased Policies Property, plant and equipment Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment Accounts payable Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Accrued expenses and other liabilities Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses And Other Liabilities Income taxes Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent Deferred revenue Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue Debt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt Preliminary estimate of the fair value of assets and liabilities assumed Goodwill Number of units with delinquent assessment. Outstanding interest and late fees on active units. Information by period in which financing receivables are outstanding. Financing Receivables Period Outstanding Financing Receivables Period Outstanding [Axis] Period in which financing receivables are outstanding. Financing Receivables Period Outstanding Financing Receivables Period Outstanding [Domain] Current year. Funded During The Current Year [Member] Current Year [Member] Fund for next one to two years. 1-2 Years Outstanding [Member] Fund For Next One To Two Years [Member] Fund for next two to three years. 2-3 Years Outstanding [Member] Fund For Next Two To Three Years [Member] Fund for next three to four years. 3-4 Years Outstanding [Member] Fund For Next Three To Four Years [Member] Fund for greater than four years. Greater Than 4 Years Outstanding [Member] Fund For Greater Than Four Years [Member] Finance receivables outstanding Notes Receivable Gross Reserve for credit losses Finance receivables, net Notes Receivable Net Number of active units with delinquent assessments Number Of Units With Delinquent Assessment Amount of outstanding interest and late fees on active units Outstanding Interest And Late Fees On Active Units Amount of financing receivable that can be reserved. Financing Receivable, Reserved Financing Receivable Reserved New neighbor guaranty. New Neighbor Guaranty (NNG) [Member] New Neighbor Guaranty [Member] Maximum future contingent payments. Maximum future contingent payments Maximum Future Contingent Payments Delinquent assessments. Accrued interest and late fee. Finance receivables, net Delinquent assessments Delinquent Assessments Accrued interest and late fees Accrued Interest And Late Fee Minimum fee paid per unit. Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Related Party Transactions By Related Party [Axis] Related Party Related Party [Domain] Business law group. Business Law Group [Member] Business Law Group [Member] Related Party Transaction Related Party Transaction [Axis] Related Party Transaction Related Party Transaction [Domain] Out of pocket collection costs. Out of Pocket Collection Costs [Member] Out Of Pocket Collection Costs [Member] Craven Holdings North America Inc. Craven Holdings North America Inc [Member] Craven Holdings North America Inc [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Monthly payment for cases Payments For Legal Settlements Minimum fee paid per unit Minimum Fee Paid Per Unit Payment for law firm service. Service amount paid Payment For Law Firm Service Expenses incurred by company Related Party Transaction Expenses From Transactions With Related Party Recoveries incurred Proceeds From Customers Office sub lease income Operating Lease Lease Income Recoupment of amount written off. Debt Instruments Maturity Date . Debt instrument extended maturity period. Stock issued during period shares for payment on promissory notes issued in exchange for shares of common stock. Receivable (Payable)from related party Proceeds From Repayments Of Related Party Debt Amount written-off regained Recoupment Of Amount Written Off Debt instrument, due date Debt Instruments Maturity Date Debt Instrument, extended maturity date Debt Instrument Extended Maturity Period Common shares pledged other than secured promissory notes Stock Issued During Period Shares For Payment On Promissory Notes Issued In Exchange For Shares Of Common Stock Debt Instruments [Abstract] Debt Instrument [Table] Debt Instrument [Table] Financial agreement one. Financing agreement with FlatIron capital maturing in June 1, 2020 [Member] Financial Agreement One [Member] Financial agreement two. Financing agreement with FlatIron capital maturing in June 1, 2021 [Member] Financial Agreement Two [Member] Promissory note one. Promissory note issued by a financial institution maturing in April 30, 2022 [Member] Promissory Note One [Member] Senior secured convertible promissory note. Convertible Senior Note [Member] Senior Secured Convertible Promissory Note [Member] Promissory note two. Promissory note issued by a financial institution maturing in August 26, 2023 [Member] Promissory Note Two [Member] Promissory Note Three Member. Promissory note issued by a financial institution maturing in May 30, 2025 [Member] Promissory Note Three [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Notes payable Notes Payable Subsequent borrowings. Down payment for note payable Repayments Of Notes Payable Debt instrument, periodic payment Debt Instrument Periodic Payment Debt instrument, issuance date Debt Instrument Issuance Date1 Debt instrument, to be converted shares Debt Instrument Convertible Number Of Equity Instruments Debt instrument, convertible, beneficial conversion feature Debt Instrument Convertible Beneficial Conversion Feature Subsequent borrowings Subsequent Borrowings Repayments Repayments Of Medium Term Notes 2020 Long Term Debt Maturities Repayments Of Principal In Next Twelve Months 2021 Long Term Debt Maturities Repayments Of Principal In Year Two 2022 Long Term Debt Maturities Repayments Of Principal In Year Three 2023 Long Term Debt Maturities Repayments Of Principal In Year Four 2024 Long Term Debt Maturities Repayments Of Principal In Year Five After 2024 Long Term Debt Maturities Repayments Of Principal After Year Five Debt Instrument Carrying Amount Debt instrument maturity period. Unusual Risk or Uncertainty, Nature Unusual Risk Or Uncertainty By Nature [Axis] Unusual Risk or Uncertainty, Nature Unusual Risk Or Uncertainty Nature [Domain] US Federal Government Coronavirus Aid, Relief, and Economic Security Act [Member] U S Federal Government Coronavirus Aid Relief And Economic Security Act [Member] Debt Instrument Maturity Period Debt Instrument Maturity Period Cumulative operating losses. Financial Support For Nonconsolidated Legal Entity [Table] Financial Support For Nonconsolidated Legal Entity [Table] Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] Going concerns [Member]. Going Concerns [Member] Going Concerns [Member] Financial Support For Nonconsolidated Legal Entity [Line Items] Financial Support For Nonconsolidated Legal Entity [Line Items] Cumulative operating losses Cumulative Operating Losses Proceeds from issuance of common stock, warrants exercised and related party receivable. Proceeds from issuance of common stock, warrants exercised and related party receivable Proceeds From Issuance Of Common Stock Warrants Exercised And Related Party Receivable Warrants Exercised Proceeds from warrants exercised Related party receivable Accounts Receivable Related Parties Operating lease remaining lease term. Loss Contingencies [Table] Loss Contingencies [Table] Lease Contractual Term Lease Contractual Term [Axis] Lease Contractual Term Lease Contractual Term [Domain] New Office Lease. New Office Lease [Member] New Office Lease [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Operating lease remaining lease term Operating Lease Remaining Lease Term Lease expiration period. Lease expiration period Lease Expiration Period Operating lease discount rate Lessee Operating Lease Discount Rate Lease contract beginning date. Operating lease beginning date Lease Contract Beginning Date Operating lease ending date Lease Expiration Date1 Sublease Income Sublease Income Rent expense Lease And Rental Expense Lease Cost [Abstract] Operating lease expense Operating Lease Cost Lease cost Lease Cost Assets And Liabilities Lessee [Abstract] ROU assets Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List Current lease liabilities Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease Liability Current Statement Of Financial Position Extensible List Long-term lease liabilities Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List Total lease liabilities Operating Lease Liability Weighted-average remaining lease term (in years) Operating Lease Weighted Average Remaining Lease Term1 Weighted-average discount rate Operating Lease Weighted Average Discount Rate Percent Cash flows operating activities lessee. Leases [Abstract] Operating cash flow information Cash Flows Operating Activities Lessee [Abstract] 2020 (excluding the nine months ended September 30, 2020) Lessee Operating Lease Liability Payments Remainder Of Fiscal Year 2021 Lessee Operating Lease Liability Payments Due Next Twelve Months 2022 Lessee Operating Lease Liability Payments Due Year Two Total future minimum lease payments due Lessee Operating Lease Liability Payments Due Share based compensation arrangement by share based payment award options adjustments in period adjustment. Number of Options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward Number of Options, Outstanding at Beginning of the year Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Options, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Number of Options, Exercised Stock Issued During Period Shares Stock Options Exercised Number of Options, Adjustment Share Based Compensation Arrangement By Share Based Payment Award Options Adjustments In Period Adjustment Number of Options, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Options, Outstanding at End of Year Number of Options, Exercisable at End of Year Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Share based compensation arrangements by share based payment award options adjustments in period weighted average exercise price. Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Weighted Average Exercise Price, Outstanding at Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, Adjustment Share Based Compensation Arrangements By Share Based Payment Award Options Adjustments In Period Weighted Average Exercise Price Weighted Average Exercise Price, Forfeited Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted Average Exercise Price, Outstanding at Ending Balance Weighted Average Exercise Price, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Share exchange agreement. Share Exchange Agreement Share Exchange Agreement [Member] Over-Allotment Option [Member] Over Allotment Option [Member] Pre Funded Warrants. Pre-Funded Warrants [Member] Pre Funded Warrant [Member] Class Of Stock [Line Items] Class Of Stock [Line Items] Recognized compensation expense of stock options Allocated Share Based Compensation Expense Remaining unrecognized compensation cost Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Aggregate intrinsic value of outstanding common stock options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Share based compensation arrangement by share based payment award equity instruments other than options period increase decrease1. Number of Warrants, beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of warrants, granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Number of Warrants, adjustment Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease Number of Warrants, adjustment Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease1 Number of warrants, forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Number of Warrants, ending balance Share based compensation arrangement by share based payment award equity instruments other than options exercised in period weighted average grant date fair value. Share based compensation arrangement by share based payment award equity instruments other than options adjustment weighted average grant date fair value. Share based compensation arrangement by share based payment award equity instruments other than options adjustment weighted average grant date fair value1. Weighted Average Exercise Price, Outstanding at Ending Balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted Average Exercise Price, granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Weighted Average Exercise Price, exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value Weighted Average Exercise Price, adjustment Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustment Weighted Average Grant Date Fair Value Weighted Average Exercise Price, adjustment Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustment Weighted Average Grant Date Fair Value1 Weighted Average Exercise Price, forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Weighted Average Exercise Price, Outstanding at Ending Balance Common stock issued Stock Issued During Period Shares Issued For Services Cash received for shares issued Stock Issued During Period Value Issued For Services Common stock issued Stock Issued During Period Shares New Issues Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right Warrants issued to purchase of common stock Shares Issued, Price Per Share Shares Issued Price Per Share Net proceeds of the offering Stock Issued During Period Value New Issues Goodwill paid Disposal Group Including Discontinued Operation Goodwill1 Current assets of disposal group including discontinued operation. Disposal group including discontinued operation short term notes payable.. Current liabilities of disposal group including discontinued operation. Disposal group including discontinued operation debt. Major classes of assets Assets Of Disposal Group Including Discontinued Operation [Abstract] Cash Disposal Group Including Discontinued Operation Cash And Cash Equivalents Related party receivable Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net Prepaid expenses Disposal Group Including Discontinued Operation Prepaid And Other Assets Total major classes of current assets – discontinued assets Current Assets Of Disposal Group Including Discontinued Operation Fixed assets, net Disposal Group Including Discontinued Operation Property Plant And Equipment Total major classes of assets – discontinued assets Assets Of Disposal Group Including Discontinued Operation Accounts payable and accrued expenses Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Note payable – short term Disposal Group Including Discontinued Operation Short Term Notes Payable Other liabilities Disposal Group Including Discontinued Operation Other Liabilities Income taxes payable Disposal Group Including Discontinued Operation Accrued Income Tax Payable Total major classes of current liabilities – discontinued liabilities Current Liabilities Of Disposal Group Including Discontinued Operation Debt Disposal Group Including Discontinued Operation Debt Total major classes of liabilities - discontinued liabilities Liabilities Of Disposal Group Including Discontinued Operation Disposal Group Including Discontinued Operation Loss On Disposal Of Business. Revenue Disposal Group Including Discontinued Operation Revenue Total operating costs and expenses Disposal Group Including Discontinued Operation Operating Expense Gain (Loss) from discontinued operations Disposal Group Including Discontinued Operation Loss On Disposal Of Business Other expense, net Disposal Group Including Discontinued Operation Other Expense Net gain (loss) from discontinued operations Net cash provided by operating activities Cash Provided By Used In Operating Activities Discontinued Operations Net cash (used in) provided by investing activities Cash Provided By Used In Investing Activities Discontinued Operations Net cash used in financing activities Cash Provided By Used In Financing Activities Discontinued Operations EX-101.PRE 10 lmfa-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
shares in Millions
9 Months Ended
Sep. 30, 2020
Nov. 16, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Title of 12(b) Security Common Stock par value $0.001 per share  
Security Exchange Name NASDAQ  
Trading Symbol LMFA  
Entity Registrant Name LM FUNDING AMERICA, INC.  
Entity Central Index Key 0001640384  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   15.4
Entity File Number 001-37605  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 47-3844457  
Entity Address, Address Line One 1200 West Platt Street  
Entity Address, Address Line Two Suite 100  
Entity Address, City or Town Tampa  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33606  
City Area Code 813  
Local Phone Number 222-8996  
Document Quarterly Report true  
Document Transition Report false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
ASSETS    
Cash $ 12,234,506 $ 822,909
Finance receivables:    
Original product - net (Note 3) 169,594 273,711
Special product - New Neighbor Guaranty program, net of allowance for credit losses of (Note 4) 95,944 129,272
Prepaid expenses and other assets 217,084 145,267
Due from related party (Note 5)   125,045
Discontinued operations - current assets (Note 10)   276,953
Current assets 12,717,128 1,773,157
Fixed assets, net (Note 1) 8,378 8,288
Real estate assets owned (Note 1) 20,281 21,084
Operating lease - right of use assets (Note 8) 185,370 260,260
Other investments - related party (Note 1)   1,500,000
Goodwill (Note 2)   4,039,586
Other Assets 11,122 11,021
Discontinued operations - long-term assets, net (Note 10)   27,245
Long-term assets 225,151 5,867,484
Total assets 12,942,279 7,640,641
LIABILITIES AND STOCKHOLDERS' EQUITY    
Note payable (Note 6)   69,540
Related party convertible note payable   3,461,782
Accounts payable and accrued expenses 383,058 210,870
Due to related party (Note 5) 264,412  
Current portion of lease liability (Note 8) 98,846 94,235
Discontinued operations - current liabilities (Note 10)   280,057
Total current liabilities 746,316 4,116,484
Lease liability - long-term (Note 8) 97,368 171,648
Note payable - long-term (Note 6) 339,797  
Discontinued operations - long-term liabilities (Note 10)   517,584
Long-term liabilities 437,165 689,232
Total liabilities 1,183,481 4,805,716
Stockholders’ equity:    
Common stock, par value $.001; 30,000,000 shares authorized; 15,418,799 and 3,134,261 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 15,419 3,134
Additional paid-in capital 29,978,962 17,326,553
Accumulated deficit (18,235,583) (14,494,762)
Total stockholders’ equity 11,758,798 2,834,925
Total liabilities and stockholders’ equity $ 12,942,279 $ 7,640,641
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 15,418,799 3,134,261
Common stock, shares outstanding 15,418,799 3,134,261
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Interest on delinquent association fees $ 105,592 $ 348,451 $ 495,280 $ 1,226,464
Administrative and late fees 19,929 33,690 78,397 116,497
Recoveries in excess of cost - special product 37,127 30,927 122,117 57,199
Underwriting and other revenues 27,651 49,242 96,815 164,757
Rental revenue 62,185 90,353 143,609 310,307
Total revenues 252,484 552,663 936,218 1,875,224
Operating Expenses:        
Professional fees 385,705 380,307 1,372,281 1,334,380
Settlement costs with associations 17,934 8,825 29,854 49,003
Selling, general and administrative 96,483 102,027 251,434 285,430
Recovery of cost from related party receivable (100,000)   (300,000)  
Provision for credit losses 30,000 7,641 30,000 266
Real estate management and disposal 53,432 84,362 152,882 381,796
Depreciation and amortization (3,383) 18,122 10,383 55,513
Collection costs 771 (3,974) (28,484) (17,275)
Other operating expenses 3,120 3,009 13,758 18,265
Total operating expenses 3,006,543 919,142 4,683,141 3,031,532
Operating loss from continuing operations (2,754,059) (366,479) (3,746,923) (1,156,308)
Gain on disposal of assets   (6,421)   (6,421)
Interest expense (2,300) 23,150 10,326 76,913
Loss from continuing operations before income taxes (2,751,759) (383,208) (3,757,249) (1,226,800)
Net loss from continuing operations (2,751,759) (383,208) (3,757,249) (1,226,800)
Gain on disposal of discontinued operations     16,428  
Gain from operations of discontinued operations   103,561 16,428 39,632
Net gain/(loss) from discontinued operations   103,561 16,428 39,632
Net loss $ (2,751,759) $ (279,647) $ (3,740,821) $ (1,187,168)
Earnings/(loss) per share:        
Basic loss per common share - continuing operations $ (0.28) $ (0.12) $ (0.66) $ (0.39)
Basic earnings/(loss) per common share - discontinued operations   0.03 0.00 0.01
Basic loss per common share - net loss (0.28) (0.09) (0.66) (0.38)
Diluted loss per common share - continuing operations (0.28) (0.12) (0.66) (0.39)
Diluted earnings/(loss) per common share - discontinued operations   0.03 0.00 0.01
Diluted loss per common share - net loss $ (0.28) $ (0.09) $ (0.66) $ (0.38)
Weighted average number of common shares outstanding:        
Basic 9,790,538 3,134,160 5,662,035 3,133,495
Diluted 9,790,538 3,134,160 5,662,035 3,133,495
Service [Member]        
Operating Expenses:        
Staff costs and payroll $ 2,522,481 $ 318,823 $ 3,151,033 $ 924,154
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss $ (2,751,759) $ (279,647) $ (3,740,821) $ (1,187,168)  
Adjustments to reconcile net loss to cash used in operating activities          
Depreciation and amortization     5,919 51,990  
Right to use asset depreciation     74,890 27,133  
Stock compensation     135,679 10,366  
Recovery of cost from related party receivable (100,000)   (300,000)    
Gain on termination of operating lease       (1,421)  
Gain on sale of fixed assets       (5,000)  
Gain on disposal of discontinued operations   (103,561) (16,428) (39,632)  
Reserve for accounts 30,000 7,641 30,000 266  
Change in assets and liabilities          
Prepaid expenses and other assets     120,598 79,996  
Accounts payable and accrued expenses     272,976 91,929  
Advances (repayments) from related party     689,457 (1,174)  
Other liabilities       62,580  
Lease liability payments     (69,669) (23,466)  
Deferred taxes       (14,200)  
Net cash used in operating activities     (2,797,399) (908,435)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
(Payments)/proceeds for real estate assets owned     (3,920) 80,076  
Purchase of fixed assets     (1,286) (13,299)  
Proceeds from sale of fixed assets       5,000  
Cash received from investment in note receivable - related party     1,500,000    
Net cash received from business acquisition     (246,914) 51,327  
Net cash provided by investing activities     1,355,325 326,919  
CASH FLOWS FROM FINANCING ACTIVITIES:          
Borrowings     185,785    
Principal repayments     (108,043) (135,149)  
Exercise of warrants     3,081,480 22,320  
Proceeds from stock subscription     9,447,535    
Net cash provided by (used in) financing activities     12,606,757 (112,829)  
NET INCREASE (DECREASE) IN CASH     11,164,683 (694,345)  
CASH - BEGINNING OF YEAR     1,069,823 3,520,753 $ 3,520,753
CASH - END OF YEAR $ 12,234,506 $ 2,826,408 12,234,506 2,826,408 $ 1,069,823
SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION          
Cash paid for interest     10,326 31,936  
Income taxes      
SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION          
Financing loan for purchase of fixed assets       12,892  
Insurance financing     192,514 127,490  
ROU asset obligation recognized       331,477  
Original Product [Member]          
CASH FLOWS FROM INVESTING ACTIVITIES:          
Net collections of finance receivables     74,117 115,769  
Special Product [Member]          
CASH FLOWS FROM INVESTING ACTIVITIES:          
Net collections of finance receivables     $ 33,328 $ 88,046  
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2018 $ 5,808,649 $ 3,125 $ 17,295,408 $ (11,489,884)
Balance, shares at Dec. 31, 2018   3,124,961    
Warrants exercised for cash 22,320 $ 9 22,311  
Warrants exercised for cash, shares   9,300    
Stock compensation expense 3,500   3,500  
Net loss (457,018)     (457,018)
Balance at Mar. 31, 2019 5,377,451 $ 3,134 17,321,219 (11,946,902)
Balance, shares at Mar. 31, 2019   3,134,261    
Stock compensation expense 3,431   3,431  
Net loss (450,503)     (450,503)
Balance at Jun. 30, 2019 4,930,379 $ 3,134 17,324,650 (12,397,405)
Balance, shares at Jun. 30, 2019   3,134,261    
Stock compensation expense 3,435   3,435  
Net loss (279,647)     (279,647)
Balance at Sep. 30, 2019 4,654,167 $ 3,134 17,328,085 (12,677,052)
Balance, shares at Sep. 30, 2019   3,134,261    
Balance at Dec. 31, 2019 2,834,925 $ 3,134 17,326,553 (14,494,762)
Balance, shares at Dec. 31, 2019   3,134,261    
Stock compensation expense 128,847 $ 186 128,661  
Stock compensation expense, shares   186,000    
Net loss (551,094)     (551,094)
Balance at Mar. 31, 2020 2,412,678 $ 3,320 17,455,214 (15,045,856)
Balance, shares at Mar. 31, 2020   3,320,261    
Warrants exercised for cash 2,946,480 $ 1,228 2,945,252  
Warrants exercised for cash, shares   1,227,700    
Stock compensation expense 3,397   3,397  
Common stock issued for cash 1,250,000 $ 521 1,249,479  
Common stock issued for cash, Shares   520,838    
Net loss (437,968)     (437,968)
Balance at Jun. 30, 2020 6,174,587 $ 5,069 21,653,342 (15,483,824)
Balance, shares at Jun. 30, 2020   5,068,799    
Warrants exercised for cash 17,000 $ 1,700 15,300  
Warrants exercised for cash, shares   1,700,000    
Warrants exercised for cash 135,000 $ 150 134,850  
Warrants exercised for cash, shares   150,000    
Stock compensation expense 3,435   3,435  
Common stock issued for cash 8,180,535 $ 8,500 8,172,035  
Common stock issued for cash, Shares   8,500,000    
Net loss (2,751,759)     (2,751,759)
Balance at Sep. 30, 2020 $ 11,758,798 $ 15,419 $ 29,978,962 $ (18,235,583)
Balance, shares at Sep. 30, 2020   15,418,799    
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

LM Funding America, Inc. (“LMFA” or the “Company”) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the “Predecessor”). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.

LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January 8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering.

The Company acquired IIU, Inc. on January 16, 2019 (“IIU”), which provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

Specialty Health Insurance

Our former subsidiary IIU Inc. (“IIU”) through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad

 

Non United States citizens or residents who travel to the United States

These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered included:

 

HealthCare Abroad - Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.

 

HealthCare Global – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.  There is an age limit of 70 years old.

 

HealthCare America – up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old.

 

HealthCare International – International medical insurance & assistance for persons living outside their home country.  There is an age limit of 70 years old.

 

HealthCare War – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.  There is an age limit of 70 years old.

 

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the nine months ended September 30, 2020.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  

In addition, on October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect to his beneficial ownership of shares of common stock of the Company.  In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company’s Board of Directors.  Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.  Furthermore, the Company was informed by Hanfor prior to such termination that Hanfor would be unable to provide audited financial statements for Hanfor for the foreseeable future because of ongoing legal issues in China.  As a result, the Company believes that the purported appointment of Mr. Han to the Company’s Board of Directors is invalid.   

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

 

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

 

On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of Nasdaq stating that the Company was not in compliance with the Minimum Bid Price Rule. The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  

 

If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company’s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company’s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement. 

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split was not effected pursuant to such approval.

Registered Public Offering

On August 18, 2020, in connection with an underwritten public offering, we raised approximately $8.2 million in net proceeds by issuing 10.2 million shares of common stock, the exercise of 1.7 million pre-funded warrants and 11.2 million warrants to purchase shares of common stock. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.

 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary, Wallach & Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of September 30, 2020 and for the three and nine months ended September 30, 2020 and September 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.

 

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s New Neighbor Guaranty program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.

We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

 

Revenue Recognition

Accounting Standards Codification (“ASC”) 606 of the Financial Accounting Standards Board (“FASB”) states an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the “accounts”). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social factors affecting the real estate environment in general. The Company’s contracts with its customers have very specific performance obligations.  The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.  The Company determined rental income from leasing arrangements is specifically excluded from the standard.  The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.

Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:

Finance Receivables—Original Product: Under the Company’s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company’s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3)) and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.

Finance Receivables—Special Product (New Neighbor Guaranty program): During 2012, the Company began offering associations an alternative product under the New Neighbor Guaranty program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i) a negotiated amount or (ii) on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company’s funded or principal amount, then a loss is recognized.

Net Commission Revenue: The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.  If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.

Cash

The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation’s (“FDIC”) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.

Finance Receivables

Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company’s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at September 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $142,027 and $112,027.

Under the New Neighbor Guaranty program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area. The Company estimated an allowance for credit losses for this program of $6,564 as of September 30, 2020 and $20,016 at December 31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.

The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company’s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

During the nine months ended September 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $51,080, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

Real Estate Assets Owned

In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.

Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens. In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10, Fair Value Measurements. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.

The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.  These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.  These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.  Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.  As of September 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $20,281 and $21,084, respectively.  

During the three and nine month period ended September 30, 2020 and 2019, depreciation expense was $(4,990) and $4,723 for 2020 and $5,385 and $17,354 for 2019, respectively.

If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.

If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.

Fixed Assets

The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company’s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of September 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and nine month period ended September 30, 2020 and 2019 was $nil and $nil for 2020 and $5,814 and $17,444 for 2019, respectively. 

Right to Use Assets

The Company capitalizes all leased assets pursuant to ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.  As of September 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $185,370 and $260,260, respectively. Amortization expense for right to use assets for the three and nine month period ended September 30, 2020 and 2019 was $23,661 and $74,890 for 2020 and was $22,281 and $27,133 for 2019, respectively while the payments totaled $69,669 for the nine months ended September 30, 2020. 

Other Investments – Note Receivable - Related Party

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.   The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven’s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

Goodwill

Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.

During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the 2019 annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.  This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of September 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively. 

 Debt Issue Costs

The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. The Company did not have any unamortized debt issue costs at September 30, 2020 and at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (“ASU”) 2015-03 (see below). The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under ASU 2015-03 (ASC 835-30-45-3).    

Settlement Costs with Associations

Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and nine months ended September 30, 2020 and 2019 were approximately $18,000  and $30,000 for 2020 and $9,000  and $49,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.  

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Under ASC 740-10-30-5, Income Taxes, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.

Loss Per Share

Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.  

The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.

On October 15, 2018, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.  The Reverse Stock Split became effective on October 16, 2018 and the Company’s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.

The Company has restated all share amounts to reflect the Reverse Stock Split.

Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.  

The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

 

As of September 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

14,790,059

 

2,879,287

Convertible Note

 

-

 

1,436,424

 

As part of its initial public offering, on October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of September 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was $0 and $0, respectively. These warrants will expire on October 31, 2020.

 

On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,875,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.  During the twelve months ended December 31, 2019, warrants for 9,300 shares were exercised for $22,320. During the nine months ended September 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480. There are 1,638,000 warrants remaining. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.67 per share.

 

As part of its underwriting agreement dated, October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.90 per share.

 

On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018 and August 18, 2020, these warrants now have the right to purchase 777,059 shares at an exercise price of $0.34 per share. These warrants expire in the year 2023.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was approximately $249,000.

 

A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares. On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (“IIU”), for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. LMFA originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.  

 

As part of its underwritten public offering on August 18, 2020 the Company issued 11,200,000 warrants that allowed for the right to purchase 11,200,000 shares of common stock at an average exercise price of $0.90 per share. These warrants have a weighted average remaining life of 4.88 years as of September 30, 2020. These warrants expire in the year 2025.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was $0. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.

 

Stock-Based Compensation

The Company records all equity-based incentive grants to employees and non-employee members of the Company’s Board of Directors in operating expenses in the Company’s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards.

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters.     

Fair Value of Financial Instruments

FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables.

Risks and Uncertainties

Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.  

In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.

Non-cash Financing and Investing Activities

During the nine months ended September 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.  Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.  The fair value of these properties was first applied to recover the Company’s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.

During the nine months ended September 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.  

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.  The guidance is effective January 1, 2020 with a one-year early adoption permitted.  We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.

Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

Subsequent Events

The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued. 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition
9 Months Ended
Sep. 30, 2020
Business Combinations [Abstract]  
Goodwill and Acquisition

Note 2. Goodwill and Acquisition

On November 2, 2018, the Company invested cash by purchasing stock under a Securities Purchase Agreement (the “IIU SPA”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House N.A. (whose ownership excluding unexercised warrants is approximately 20% of the Company’s outstanding stock as of the date of acquisition), pursuant to which IIU issued to the Company a Senior Convertible Promissory Note (“IIU Note”) in the original principal amount of $1,500,000 in exchange for a purchase price of $1,500,000.  The maturity date of the Note is 360 dates after the date of issuance (subject to acceleration upon an event of default).  The Note carries a 3.0% interest rate, with accrued but unpaid interest being payable on the Note’s maturity date.  

The IIU Note allows the Company the right on or after the maturity date to convert any unpaid principal and accrued and unpaid interest of the IIU Note into shares of IIU based on a conversion amount which is the fair value of the common shares of IIU at the time. The conversion price will be reset if IIU issues or sells common shares, convertibles securities or options at a price per share that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale of such dilutive issuance.

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven House North America, LLC (“Craven”) to purchase all of the outstanding shares of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies are fully underwritten with no claim risk remaining with IIU.

The Board of Directors of LMFA approved the purchase of IIU. LMFA purchased 100% of the outstanding stock of IIU for $5,089,357.  LMFA paid the Purchase Price at closing as follows:

 

 

Cancellation by LMFA of all principal and accrued interest of IIU’s Promissory Note dated November 3, 2018 and issued to LMFA for principal indebtedness and accrued interest of $1,507,375.

 

LMFA issued to Craven a $3,581,982 Senior Convertible Promissory Note (“Craven Convertible Note”) for the balance of the Purchase Price.  At the option of Craven, the Convertible Note may be paid in restricted common shares of LMFA or cash.  The Craven Convertible Note shall bear simple interest at 3% per annum.  The Craven Convertible Note shall be due and payable 360 days from the Closing Date. If repaid by LMFA in restricted common stock, the outstanding principal and interest of the Craven Convertible Note shall be paid by LMFA by issuing to Seller a number of restricted common shares equal to the adjusted principal and accrued interest owing on the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42. The note principal was subsequently reduced by $120,200 arising from lower than expected Closing Cash and Net Working Capital. Craven had verbally agreed to extend repayment of this Craven Convertible Note 12 months from April 15, 2019.

 

Net cash received in the business acquisition was $51,327.As such, the $1.5 million note receivable was cancelled as of January 16, 2019.

 

The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:

 

 

January 16, 2019

 

 

Total adjusted purchase price

$

4,969,200

 

 

Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:

 

 

 

 

Cash

 

51,300

 

 

Prepaid and other current assets

 

5,200

 

 

Profit on purchased policies

 

14,600

 

 

Property, plant and equipment

 

17,100

 

 

Accounts payable

 

(5,100

)

 

Accrued expenses and other liabilities

 

(62,686

)

 

Income taxes

 

(28,500

)

 

Deferred revenue

 

(9,300

)

 

Debt

 

(703,000

)

 

Preliminary estimate of the fair value of assets and liabilities assumed

 

(720,386

)

 

 

 

 

 

 

Goodwill

$

5,689,586

 

 

 

We performed an assessment effective as of December 31, 2019 in light of the Company’s sale of IIU on January 8, 2020 which resulted in a $1.65 million goodwill impairment.  On January 8, 2020, the Company entered into a SPA with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Convertible Promissory Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. See Note 10 Discontinued Operations.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Original Product
9 Months Ended
Sep. 30, 2020
Original Product [Member]  
Finance Receivables

Note 3. Finance Receivables – Original Product

The Company’s original funding product provides financing to community associations only up to the secured or “Super Lien Amount” as discussed in Note 1.  Finance receivables for the original product as of September 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Funded during the current year

 

$

16,000

 

 

$

40,000

 

1-2 years outstanding

 

 

14,000

 

 

 

15,000

 

2-3 years outstanding

 

 

9,000

 

 

 

20,000

 

3-4 years outstanding

 

 

17,000

 

 

 

11,000

 

Greater than 4 years outstanding

 

 

256,000

 

 

 

300,000

 

 

 

 

312,000

 

 

 

386,000

 

Reserve for credit losses

 

 

(142,000

)

 

 

(112,000

)

 

 

$

170,000

 

 

$

274,000

 

Number of active units with delinquent assessments

 

 

489

 

 

 

598

 

Amount of outstanding interest and late fees on active units

 

$

8,682,000

 

 

$

9,167,000

 

The Company reserved $30,000 on financing receivables during the three month period ended September 30, 2020.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program)
9 Months Ended
Sep. 30, 2020
Special Product (New Neighbor Guaranty Program) [Member]  
Accounts Notes And Loans Receivable [Line Items]  
Finance Receivables

Note 4. Finance Receivables – Special Product (New Neighbor Guaranty program)

The Company typically funds amounts equal to or less than the “Super Lien Amount”.  During 2012 the Company began offering Associations an alternative product under the New Neighbor Guaranty program where the Company funds amounts in excess of the “Super Lien Amount”.  

Under this special product, the Company purchases substantially all of the outstanding past due assessments due from delinquent property owners, in addition to all interest, late fees and other charges in exchange for the Company’s commitment to pay monthly assessments on a going forward basis up to 48 months.  

As of September 30, 2020, maximum future contingent payments under these arrangements was approximately $34,000.  

Delinquent assessments and accrued charges under these arrangements as of September 30, 2020 and December 31, 2019, are as follows:

 

 

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Finance receivables, net

 

$

96,000

 

 

$

129,000

 

Delinquent assessments

 

 

205,000

 

 

 

374,000

 

Accrued interest and late fees

 

 

91,000

 

 

 

235,000

 

Number of active units with delinquent assessments

 

 

20

 

 

 

31

 

 

Allowance for credit losses are recorded for losses that are considered “probable” and can be “reasonably estimated” in accordance with ASC 450-20.  Recoverability of the Company’s Original Product is generally assured because of the protection of the Super Lien under Florida statute and as such no allowance is recorded.    

Credit losses on the NNG product were estimated by the Company based on analyzing the investment in each unit and comparing that balance to the average payout for completed units for the past 12 months. The allowance for losses based on these analyses, had a remaining balance of $7,000 and $20,000 as of September 30, 2020 and December 31, 2019, respectively.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Due to Related Party
9 Months Ended
Sep. 30, 2020
Related Party Transactions [Abstract]  
Due to Related Party

Note 5. Due to Related Party

Legal services for the Company associated with the collection of delinquent assessments from property owners are performed by a law firm, Business Law Group (“BLG”), which was owned solely by Bruce M. Rodgers, the Chief Executive Officer of LMFA until and through the date of the initial public offering. Following the offering, Mr. Rodgers transferred his interest in BLG to other attorneys at the firm through a redemption of his interest in the firm, and BLG is now under control of those lawyers. The law firm has historically performed collection work primarily on a deferred billing basis wherein the law firm receives payment for services rendered upon collection from the property owners or at amounts ultimately subject to negotiations with the Company.

During 2016, the Company experienced a decline in collection events that affected revenues both to the Company and BLG.  That resulted in an increase in the related party receivable and reflects the decision by the Company to advance funds to BLG based on the amount of their unpaid legal fees due from property owners.  Effective January 1, 2017, the Company entered into a new services agreement with BLG which partially alters the traditional deferred billing arrangement noted above.  

 

Under the new agreement, the Company pays BLG a fixed monthly fee of $82,000 for services rendered.  The Company will continue to pay BLG a minimum per unit fee of $700 in any case where there is a collection event and BLG receives no payment from the property owner.  This provision has been expanded to also include any unit where the Company has taken title to the unit or where the association has terminated its contract with either BLG or the Company.    

Amounts expensed by the Company to BLG for the three and nine months ended September 30, 2020 and 2019, respectively were approximately $247,000 and $756,000 for 2020 and $262,000 and $799,000 for 2019, respectively.  As of September 30, 2020 and December 31, 2019, receivables from property owners for charges ultimately payable to BLG approximate $1,542,000 and $1,883,000, respectively.

Under the related party agreement with BLG in effect during 2020 and 2019, the Company pays all costs (lien filing fees, process and serve costs) incurred in connection with the collection of amounts due from property owners.  Any recovery of these collection costs is accounted for as a reduction in expense incurred.  The Company incurred expenses related to these types of costs for the three and nine months ended September 30, 2020 and 2019 were $28,000 and $95,000 for 2020 and $49,000 and $158,000 for 2019, respectively. Recoveries during the three and nine months ended September 30, 2020 and 2019, related to those costs were approximately $28,000 and $124,000 for 2020 and $53,000 and $175,000 for 2019, respectively.  

The Company also shares office space and related common expenses with BLG.  All shared expenses, including rent, are charged to the legal firm based on an estimate of actual usage.  Any expenses of BLG paid by the Company that have not been reimbursed or settled against other amounts are reflected as due from related parties in the accompanying consolidated balance sheet. BLG was charged approximately $45,000 for the office sub-lease.

Amounts (payable) receivable from BLG as of September 30, 2020 and December 31, 2019 were approximately ($264,400) and $152,800, respectively. In the first nine months of September 30, 2020, the Company subsequently recouped $300,000 of previously write-off amounts to BLG.

On December 20, 2019, the Company loaned $1.5 million to Craven in the form of a secured promissory note (the “Craven Secured

Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly.

The Company subsequently extended the due date of the Craven Secured Promissory Note and the monthly interest payments to August 1, 2021. The Craven Secured Promissory Note is secured by, among other things, stock pledge of Craven’s 640,000 common stock of the Company and the assignment of the assets of Craven in favor of the Company.  This loan and the accrued interest was repaid on June 29, 2020.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements
9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Debt and Other Financing Arrangements

Note 6. Debt and Other Financing Arrangements

 

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $20,746 was required upfront and equal installment payments of $19,251 to be made over a 10 month period. The note matures May 1, 2021. Annualized interest is 5.95%

 

$

154,012

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

339,797

 

 

$

4,149,578

 

 


As of September 30, 2020, minimum annual principal payments are as follows:

 

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

57,755

 

2021

 

 

96,257

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

339,797

 

On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan. These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers.

 

The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the fourth quarter of 2020.

 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern
9 Months Ended
Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Going Concern

Note 7. Going Concern

 The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company has experienced significant operating losses over the past 4 years (2016 through September 30, 2020) with cumulative losses of approximately $18,236,000 and negative cashflows from operations. These losses resulted in the usage of all cash proceeds from the Company’s initial public offering in 2015. For the year ended December 31, 2019, the Company disclosed the substantial doubt about the Company’s ability to continue as a going concern

The Company received a total of approximately $14.0 million during the nine months ended September 30, 2020 due to a number of factors including:

 

Holders of our warrants exercised such warrants for 1.2 million shares in June 2020 which resulted in the Company receiving approximately $2.9 million.

 

The Company was repaid approximately $1.5 million on a related party receivable.

 

The Company received $1.25 million for the issuance of 520,838 common shares.

 

The Company received $8.3 million for the issuance of 10,200,000 common shares.

 

Holders of our warrants exrcised such warrants for 150 thousand in August 2020 which resulted in the Company receiving approximately $0.1 million.

 

As such, we have $12.2 million of cash as of September 30, 2020 which will be enough to satisfy our estimated liquidity needs for the 12 months from the issuance of these financial statements. These factors mitigated the substantial doubt about the Company’s ability to continue as a going concern as defined by ASU 2014-15.

  

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2020
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 8. Commitments and Contingencies

Leases

The Company leases certain office space, construction and office equipment, vehicles and temporary housing generally under non-cancelable operating leases. Leases with an initial term of one year or less are not recorded on the balance sheet, and the Company generally recognizes lease expense for these leases on a straight-line basis over the lease term. As of September 30, 2020, the Company’s operating leases have remaining lease terms ranging from less than one year to 3 years, some of which include options to renew the leases. The exercise of lease renewal options is generally at the Company’s sole discretion. The Company’s leases do not contain any material residual value guarantees or material restrictive covenants.

The Company determines if an arrangement is a lease at inception. Operating lease ROU assets and current and long-term operating lease liabilities are separately stated on the Consolidated Balance Sheet as of September 30, 2020. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The present value of future lease payments are discounted using either the implicit rate in the lease, if known, or the Company’s incremental borrowing rate for the specific lease as of the lease commencement date. The rate was determined as a fair value of the lease over a 37 month period using a 6.5% interest rate for the present value calculation. The ROU asset is also adjusted for any prepayments made or incentives received. The lease terms include options to extend or terminate the lease only to the extent it is reasonably certain any of those options will be exercised. Lease expense is recognized on a straight-line basis over the lease term. The Company accounts for lease components (e.g., fixed payments) separate from the non-lease components (e.g., common-area maintenance costs). The Company does not have any material financing leases.

The Company leased its office under an operating lease beginning March 1, 2014 and ending July 31, 2019. The Company’s new office lease began July 15, 2019 and ends July 31, 2022. It also had a month to month lease for its IIU operations in 2019. A related party has a sub-lease for approximately $4,900 per month plus operating expenses.

 

The Company shares this space and the related costs associated with this operating lease with a related party (see Note 5) that also performs legal services associated with the collection of delinquent assessments.  Net rent expense recognized for the three and nine months ended September 30, 2020 and 2019 were approximately $26,000 and $76,000 for 2020 and $50,000 and $148,000 for 2019, respectively.

 

The following table presents components of lease expense excluding discontinued operations for the three and nine months ended September 30, 2020 and 2019:

 

 

Three Months

Ended

September 30,

2020

 

Nine Months

Ended

September 30,

2020

Three Months

Ended

September 30,

2019

Nine Months

Ended

September 30,

2019

Operating lease expense

$

27,644

$

89,931

50,274

147,575

 

$

27,644

$

89,931

50,274

147,575

 

The following table presents supplemental balance sheet information related to operating leases as of September 30, 2020 and December 31, 2019:

 

 

Balance Sheet Line Item

As of September 30, 2020

 

As of December 31, 2019

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

ROU assets

 

Right of use asset, net

$

185,370

 

$

260,260

 

 

 

Total lease assets

 

 

$

185,370

 

$

260,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Current lease liabilities

 

Lease liability

$

98,846

 

$

94,235

 

 

 

Long-term lease liabilities

 

Lease liability

 

97,368

 

 

171,648

 

 

 

Total lease liabilities

 

 

$

196,214

 

$

265,883

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average remaining lease term (in years)

 

 

 

1.83

 

 

2.60

 

 

 

Weighted-average discount rate

 

 

 

6.55

%

 

6.55

%

 

 

 

The following table presents supplemental cash flow information and non-cash activity related to operating leases for the nine months ended September 30, 2020 and 2019:

 

 

 

 

Nine Months Ended September 30, 2020

 

Nine Months Ended September 30, 2019

 

 

 

Operating cash flow information

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

$

(69,669

)

$

(23,466

)

 

 

Supplemental Disclosure of non-cashflow information

 

 

 

 

 

 

 

 

 

 

ROU assets and operating lease obligation recognized

 

 

$

-

 

$

331,477

 

 

 

The following table presents maturities of operating lease liabilities on an undiscounted basis as of September 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Leases

 

 

 

 

 

2020 (excluding the nine months ended September 30, 2020)

 

 

$

24,566

 

 

 

 

 

2021

 

 

 

103,646

 

 

 

 

 

2022

 

 

 

68,002

 

 

 

 

 

 

 

 

$

196,214

 

 

 

 

 

 

Legal Proceedings

Other than the lawsuits described below, we are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.

 

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Stockholders' Equity

Note 9. Stockholders’ Equity

Stock Options

The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,

performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash

awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the

2015 Omnibus Incentive Plan’s prohibitions on repricing) in substitution for any other award (or any other award granted under

another plan of ours or of any of our affiliates).

 

The following is a summary of the stock option plan activity during the nine months ended September 30, 2020 and 2019:

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Options

 

 

Exercise Price

 

 

Options

 

 

Exercise Price

 

Options Outstanding at Beginning of the year

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding at September 30,

 

 

19,300

 

 

$

54.68

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercisable at September 30,

 

 

15,134

 

 

$

62.02

 

 

 

7,634

 

 

$

113.81

 

 

Compensation expense recognized from the vesting of stock options was approximately $10,200 and $10,400 for the nine months ended September 30, 2020 and 2019. The remaining unrecognized compensation cost associated with unvested stock options as of September 30, 2020 is approximately $8,000.

 

The aggregate intrinsic value of the outstanding common stock options as of September 30, 2020 and December 31, 2019 was approximately $0 and $0 respectively.

 

Warrants

 

The following is a summary of the warrant activity during the nine months ended September 30, 2020 and 2019:

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

 

Warrants

 

 

Exercise Price

 

Warrants Outstanding at Beginning of the year

 

 

3,959,287

 

 

$

5.36

 

 

 

3,843,587

 

 

$

5.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

11,200,000

 

 

 

0.90

 

 

 

125,000

 

 

 

2.64

 

Exercised

 

 

1,377,700

 

 

 

2.24

 

 

 

9,300

 

 

 

2.40

 

Adjustment

 

 

633,472

 

 

 

0.34

 

 

 

-

 

 

 

-

 

Adjustment

 

 

375,000

 

 

 

0.67

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding at September 30,

 

 

14,790,059

 

 

$

1.79

 

 

 

3,959,287

 

 

$

5.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

During September 2020, the Company received approximately $3,081,480 upon the exercise by warrant holders of warrants for 1,377,700 shares.  The aggregate intrinsic value of the outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was approximately $249,000 and $0 respectively.

 

Common Share Issuance

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,833 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020  at which time the Company issued the 520,838 shares.

In connection with an underwritten public offering on August 18, 2020, the Company issued (i) 8,300,000 units (the “Units”) of common stock, par value $0.001 per share (the “Common Stock”) and one warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 1,700,000 pre-funded units (the “Pre-Funded Units”), with each pre-funded unit being comprised of one pre-funded warrant to purchase one share of common stock at an exercise price of $.01 per share (the “Pre-Funded Warrants”) and one warrant to purchase one share of common stock.  Each Unit was sold for a price of $0.90 per Unit, and each Pre-Funded Unit was sold for a price of $0.89 per Pre-Funded Unit.  Pursuant to an over-allotment option in the underwriting agreement, the Company sold an additional 200,000 shares of Common Stock.  The net proceeds of the offering were approximately $8,198,000.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations
9 Months Ended
Sep. 30, 2020
I I U Inc | Stock Purchase Agreement  
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]  
Discontinued Operations

Note 10. Discontinued Operations

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes of assets and liabilities of IIU were as follows:

 

 

As of December 31, 2019

Major classes of assets

 

Cash

$   246,914

Related party receivable

27,738

Prepaid expenses

2,301

Total major classes of current assets – discontinued assets

276,953

Fixed assets, net

27,245

Total major classes of assets – discontinued assets

$   304,198

 

 

Accounts payable and accrued expenses

$   144,006

Note payable – short term

100,672

Other liabilities

21,153

Income taxes payable

14,226

Total major classes of current liabilities – discontinued liabilities

280,057

 

 

Debt

517,584

Total major classes of liabilities - discontinued liabilities

$   797,641

 

 

 

The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and nine months ended September 30, 2020 and 2019 as discontinued operations are summarized below:

 

 

Three Months Ended September 30, 2020

Three Months Ended September 30, 2019

 

Nine Months Ended September 30, 2020

 

Nine Months Ended September 30, 2019

Revenue

$              -

$      221,085

$              -

$       501,244

Total operating costs and expenses

-

101,068

-

428,445

Gain (Loss) from discontinued operations

-

120,017

-

72,799

Other expense, net

-

16,455

-

33,166

Gain on disposal of discontinued operations

-

-

16,428

-

Net gain (loss) from discontinued operations

$               -

$  103,562

$     16,428

$   39,633

 

 

 

 

 

Net cash provided by operating activities

$                -

$ (48,205)

$                -

65,624

Net cash (used in) provided by investing activities

  -

(76,695)

(246,914)

(25,368)

Net cash used in financing activities

-

(18,418)

 

(56,304)

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Nature of Operations

Nature of Operations

LM Funding America, Inc. (“LMFA” or the “Company”) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the “Predecessor”). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.

LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January 8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering.

The Company acquired IIU, Inc. on January 16, 2019 (“IIU”), which provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

Specialty Health Insurance

Our former subsidiary IIU Inc. (“IIU”) through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad

 

Non United States citizens or residents who travel to the United States

These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered included:

 

HealthCare Abroad - Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.

 

HealthCare Global – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.  There is an age limit of 70 years old.

 

HealthCare America – up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old.

 

HealthCare International – International medical insurance & assistance for persons living outside their home country.  There is an age limit of 70 years old.

 

HealthCare War – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.  There is an age limit of 70 years old.

 

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the nine months ended September 30, 2020.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  

In addition, on October 23, 2020, an amended Schedule 13D was filed by Xueyuan Han, the principal owner of Hanfor, with respect to his beneficial ownership of shares of common stock of the Company.  In the amended Schedule 13D, Mr. Han alleged, among other things, that the Company misinterpreted the termination provisions of the Share Exchange Agreement, that Hanfor is still within a cure period under the Share Exchange Agreement, and that Hanfor is purporting to appoint a director to the Company’s Board of Directors.  Following the filing of the amended Schedule 13D, the Company continues to believe that its termination of the Share Exchange Agreement was proper because, among other reasons, the failure of Hanfor to provide audited financial statements by June 30, 2020, was an uncurable default under the Share Exchange Agreement.  Furthermore, the Company was informed by Hanfor prior to such termination that Hanfor would be unable to provide audited financial statements for Hanfor for the foreseeable future because of ongoing legal issues in China.  As a result, the Company believes that the purported appointment of Mr. Han to the Company’s Board of Directors is invalid.   

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

 

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

 

On September 28, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of Nasdaq stating that the Company was not in compliance with the Minimum Bid Price Rule. The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on March 29, 2021 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  

 

If the Company is not in compliance by March 29, 2021, the Company may be afforded a second 180-calendar day period to regain compliance. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for Minimum Bid Price Rule. In addition, the Company would be required to notify Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not regain compliance within the allotted 180-day compliance period and is not eligible for a second 180-day compliance period, the Company’s common stock would be subject to delisting unless it requested a hearing before an independent Nasdaq Hearings Panel. A request for a hearing would stay any suspension or delisting action pending the hearing and any additional extension period granted by the Panel. The Company intends to monitor the closing bid price of the Company’s common stock and consider its available options to resolve the non-compliance with the minimum bid price requirement. 

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split was not effected pursuant to such approval.

Registered Public Offering

On August 18, 2020, in connection with an underwritten public offering, we raised approximately $8.2 million in net proceeds by issuing 10.2 million shares of common stock, the exercise of 1.7 million pre-funded warrants and 11.2 million warrants to purchase shares of common stock. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.

 

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary, Wallach & Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.

 

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of September 30, 2020 and for the three and nine months ended September 30, 2020 and September 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.

 

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s New Neighbor Guaranty program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.

We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

Revenue Recognition

Revenue Recognition

Accounting Standards Codification (“ASC”) 606 of the Financial Accounting Standards Board (“FASB”) states an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the “accounts”). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social factors affecting the real estate environment in general. The Company’s contracts with its customers have very specific performance obligations.  The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.  The Company determined rental income from leasing arrangements is specifically excluded from the standard.  The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.

Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:

Finance Receivables—Original Product: Under the Company’s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company’s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3)) and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.

Finance Receivables—Special Product (New Neighbor Guaranty program): During 2012, the Company began offering associations an alternative product under the New Neighbor Guaranty program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i) a negotiated amount or (ii) on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company’s funded or principal amount, then a loss is recognized.

Net Commission Revenue: The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.  If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.

Cash

Cash

The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation’s (“FDIC”) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.

Financing Receivables

Finance Receivables

Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company’s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at September 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $142,027 and $112,027.

Under the New Neighbor Guaranty program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area. The Company estimated an allowance for credit losses for this program of $6,564 as of September 30, 2020 and $20,016 at December 31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.

The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company’s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

During the nine months ended September 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $51,080, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

Real Estate Assets Owned

Real Estate Assets Owned

In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.

Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens. In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10, Fair Value Measurements. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.

The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.  These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.  These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.  Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.  As of September 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $20,281 and $21,084, respectively.  

During the three and nine month period ended September 30, 2020 and 2019, depreciation expense was $(4,990) and $4,723 for 2020 and $5,385 and $17,354 for 2019, respectively.

If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.

If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.

Fixed Assets

Fixed Assets

The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company’s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of September 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and nine month period ended September 30, 2020 and 2019 was $nil and $nil for 2020 and $5,814 and $17,444 for 2019, respectively. 

Right to Use Assets

Right to Use Assets

The Company capitalizes all leased assets pursuant to ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.  As of September 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $185,370 and $260,260, respectively. Amortization expense for right to use assets for the three and nine month period ended September 30, 2020 and 2019 was $23,661 and $74,890 for 2020 and was $22,281 and $27,133 for 2019, respectively while the payments totaled $69,669 for the nine months ended September 30, 2020. 

Other Investments - Note Receivable - Related Party

Other Investments – Note Receivable - Related Party

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.   The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven’s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

Goodwill

Goodwill

Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.

During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the 2019 annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.  This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of September 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively. 

Debt Issue Costs

The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. The Company did not have any unamortized debt issue costs at September 30, 2020 and at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (“ASU”) 2015-03 (see below). The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under ASU 2015-03 (ASC 835-30-45-3).    

Settlement Costs with Associations

Settlement Costs with Associations

Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and nine months ended September 30, 2020 and 2019 were approximately $18,000  and $30,000 for 2020 and $9,000  and $49,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.  

Income Taxes

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Under ASC 740-10-30-5, Income Taxes, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.

Loss Per Share

Loss Per Share

Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.  

The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.

On October 15, 2018, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.  The Reverse Stock Split became effective on October 16, 2018 and the Company’s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.

The Company has restated all share amounts to reflect the Reverse Stock Split.

Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.  

The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

 

As of September 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

14,790,059

 

2,879,287

Convertible Note

 

-

 

1,436,424

 

As part of its initial public offering, on October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of September 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 and December 31, 2019 was $0 and $0, respectively. These warrants will expire on October 31, 2020.

 

On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,875,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.  During the twelve months ended December 31, 2019, warrants for 9,300 shares were exercised for $22,320. During the nine months ended September 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480. There are 1,638,000 warrants remaining. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.67 per share.

 

As part of its underwriting agreement dated, October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022. Due to the underwritten public offering on August 18, 2020, the exercise price of these warrants are now $0.90 per share.

 

On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018 and August 18, 2020, these warrants now have the right to purchase 777,059 shares at an exercise price of $0.34 per share. These warrants expire in the year 2023.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was approximately $249,000.

 

A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares. On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (“IIU”), for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. LMFA originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.  

 

As part of its underwritten public offering on August 18, 2020 the Company issued 11,200,000 warrants that allowed for the right to purchase 11,200,000 shares of common stock at an average exercise price of $0.90 per share. These warrants have a weighted average remaining life of 4.88 years as of September 30, 2020. These warrants expire in the year 2025.  The aggregate intrinsic value of these outstanding common stock warrants as of September 30, 2020 was $0. Holders of the warrants subsequently exercised such warrants for 150,000 shares of common stock for $135 thousand.

 

Stock-Based Compensation

Stock-Based Compensation

The Company records all equity-based incentive grants to employees and non-employee members of the Company’s Board of Directors in operating expenses in the Company’s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards.

Contingencies

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters.     

Fair Value of Financial Instruments

Fair Value of Financial Instruments

FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables.

Risks and Uncertainties

Risks and Uncertainties

Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.  

In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.

Non-cash Financing and Investing Activities

Non-cash Financing and Investing Activities

During the nine months ended September 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.  Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.  The fair value of these properties was first applied to recover the Company’s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.

During the nine months ended September 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.  

Recent Accounting Pronouncements Not Yet Adopted

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.  The guidance is effective January 1, 2020 with a one-year early adoption permitted.  We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.

Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.

Reclassifications

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

Subsequent Events

Subsequent Events

The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued. 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

As of September 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

14,790,059

 

2,879,287

Convertible Note

 

-

 

1,436,424

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition (Tables)
9 Months Ended
Sep. 30, 2020
Business Combinations [Abstract]  
Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed

The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:

 

 

January 16, 2019

 

 

Total adjusted purchase price

$

4,969,200

 

 

Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:

 

 

 

 

Cash

 

51,300

 

 

Prepaid and other current assets

 

5,200

 

 

Profit on purchased policies

 

14,600

 

 

Property, plant and equipment

 

17,100

 

 

Accounts payable

 

(5,100

)

 

Accrued expenses and other liabilities

 

(62,686

)

 

Income taxes

 

(28,500

)

 

Deferred revenue

 

(9,300

)

 

Debt

 

(703,000

)

 

Preliminary estimate of the fair value of assets and liabilities assumed

 

(720,386

)

 

 

 

 

 

 

Goodwill

$

5,689,586

 

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Original Product (Tables)
9 Months Ended
Sep. 30, 2020
Receivables [Abstract]  
Schedule of Finance Receivables for Original Product

The Company’s original funding product provides financing to community associations only up to the secured or “Super Lien Amount” as discussed in Note 1.  Finance receivables for the original product as of September 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Funded during the current year

 

$

16,000

 

 

$

40,000

 

1-2 years outstanding

 

 

14,000

 

 

 

15,000

 

2-3 years outstanding

 

 

9,000

 

 

 

20,000

 

3-4 years outstanding

 

 

17,000

 

 

 

11,000

 

Greater than 4 years outstanding

 

 

256,000

 

 

 

300,000

 

 

 

 

312,000

 

 

 

386,000

 

Reserve for credit losses

 

 

(142,000

)

 

 

(112,000

)

 

 

$

170,000

 

 

$

274,000

 

Number of active units with delinquent assessments

 

 

489

 

 

 

598

 

Amount of outstanding interest and late fees on active units

 

$

8,682,000

 

 

$

9,167,000

 

The Company reserved $30,000 on financing receivables during the three month period ended September 30, 2020.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables)
9 Months Ended
Sep. 30, 2020
Receivables [Abstract]  
Schedule of Delinquent Assessments and Accrued Charges

Delinquent assessments and accrued charges under these arrangements as of September 30, 2020 and December 31, 2019, are as follows:

 

 

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Finance receivables, net

 

$

96,000

 

 

$

129,000

 

Delinquent assessments

 

 

205,000

 

 

 

374,000

 

Accrued interest and late fees

 

 

91,000

 

 

 

235,000

 

Number of active units with delinquent assessments

 

 

20

 

 

 

31

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements (Tables)
9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Debt

 

 

September 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $20,746 was required upfront and equal installment payments of $19,251 to be made over a 10 month period. The note matures May 1, 2021. Annualized interest is 5.95%

 

$

154,012

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

339,797

 

 

$

4,149,578

 

 

Schedule of Principal Payments of Debt

As of September 30, 2020, minimum annual principal payments are as follows:

 

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

57,755

 

2021

 

 

96,257

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

339,797

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2020
Commitments And Contingencies Disclosure [Abstract]  
Components of Lease Expense

The following table presents components of lease expense excluding discontinued operations for the three and nine months ended September 30, 2020 and 2019:

 

 

Three Months

Ended

September 30,

2020

 

Nine Months

Ended

September 30,

2020

Three Months

Ended

September 30,

2019

Nine Months

Ended

September 30,

2019

Operating lease expense

$

27,644

$

89,931

50,274

147,575

 

$

27,644

$

89,931

50,274

147,575

Summary of Supplemental Balance Sheet Information Related to Operating Leases

The following table presents supplemental balance sheet information related to operating leases as of September 30, 2020 and December 31, 2019:

 

 

Balance Sheet Line Item

As of September 30, 2020

 

As of December 31, 2019

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

ROU assets

 

Right of use asset, net

$

185,370

 

$

260,260

 

 

 

Total lease assets

 

 

$

185,370

 

$

260,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Current lease liabilities

 

Lease liability

$

98,846

 

$

94,235

 

 

 

Long-term lease liabilities

 

Lease liability

 

97,368

 

 

171,648

 

 

 

Total lease liabilities

 

 

$

196,214

 

$

265,883

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average remaining lease term (in years)

 

 

 

1.83

 

 

2.60

 

 

 

Weighted-average discount rate

 

 

 

6.55

%

 

6.55

%

 

 

Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases

The following table presents supplemental cash flow information and non-cash activity related to operating leases for the nine months ended September 30, 2020 and 2019:

 

 

 

 

Nine Months Ended September 30, 2020

 

Nine Months Ended September 30, 2019

 

 

 

Operating cash flow information

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

$

(69,669

)

$

(23,466

)

 

 

Supplemental Disclosure of non-cashflow information

 

 

 

 

 

 

 

 

 

 

ROU assets and operating lease obligation recognized

 

 

$

-

 

$

331,477

 

 

 

Schedule of Future Minimum Lease Payment Due

The following table presents maturities of operating lease liabilities on an undiscounted basis as of September 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Leases

 

 

 

 

 

2020 (excluding the nine months ended September 30, 2020)

 

 

$

24,566

 

 

 

 

 

2021

 

 

 

103,646

 

 

 

 

 

2022

 

 

 

68,002

 

 

 

 

 

 

 

 

$

196,214

 

 

 

 

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Summary of Stock Option Plan Activity

The following is a summary of the stock option plan activity during the nine months ended September 30, 2020 and 2019:

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Options

 

 

Exercise Price

 

 

Options

 

 

Exercise Price

 

Options Outstanding at Beginning of the year

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding at September 30,

 

 

19,300

 

 

$

54.68

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercisable at September 30,

 

 

15,134

 

 

$

62.02

 

 

 

7,634

 

 

$

113.81

 

 

Summary of Stock Warrants

 

Warrants

 

The following is a summary of the warrant activity during the nine months ended September 30, 2020 and 2019:

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

 

Warrants

 

 

Exercise Price

 

Warrants Outstanding at Beginning of the year

 

 

3,959,287

 

 

$

5.36

 

 

 

3,843,587

 

 

$

5.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

11,200,000

 

 

 

0.90

 

 

 

125,000

 

 

 

2.64

 

Exercised

 

 

1,377,700

 

 

 

2.24

 

 

 

9,300

 

 

 

2.40

 

Adjustment

 

 

633,472

 

 

 

0.34

 

 

 

-

 

 

 

-

 

Adjustment

 

 

375,000

 

 

 

0.67

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding at September 30,

 

 

14,790,059

 

 

$

1.79

 

 

 

3,959,287

 

 

$

5.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations (Tables)
9 Months Ended
Sep. 30, 2020
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]  
Summary of major classes of assets and liabilities and operating results of IIU

 

Three Months Ended September 30, 2020

Three Months Ended September 30, 2019

 

Nine Months Ended September 30, 2020

 

Nine Months Ended September 30, 2019

Revenue

$              -

$      221,085

$              -

$       501,244

Total operating costs and expenses

-

101,068

-

428,445

Gain (Loss) from discontinued operations

-

120,017

-

72,799

Other expense, net

-

16,455

-

33,166

Gain on disposal of discontinued operations

-

-

16,428

-

Net gain (loss) from discontinued operations

$               -

$  103,562

$     16,428

$   39,633

 

 

 

 

 

Net cash provided by operating activities

$                -

$ (48,205)

$                -

65,624

Net cash (used in) provided by investing activities

  -

(76,695)

(246,914)

(25,368)

Net cash used in financing activities

-

(18,418)

 

(56,304)

I I U Inc | Stock Purchase Agreement  
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]  
Summary of major classes of assets and liabilities and operating results of IIU

The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes of assets and liabilities of IIU were as follows:

 

 

As of December 31, 2019

Major classes of assets

 

Cash

$   246,914

Related party receivable

27,738

Prepaid expenses

2,301

Total major classes of current assets – discontinued assets

276,953

Fixed assets, net

27,245

Total major classes of assets – discontinued assets

$   304,198

 

 

Accounts payable and accrued expenses

$   144,006

Note payable – short term

100,672

Other liabilities

21,153

Income taxes payable

14,226

Total major classes of current liabilities – discontinued liabilities

280,057

 

 

Debt

517,584

Total major classes of liabilities - discontinued liabilities

$   797,641

 

 

The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and nine months ended September 30, 2020 and 2019 as discontinued operations are summarized below:

 

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Additional information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 18, 2020
USD ($)
$ / shares
shares
May 11, 2020
Mar. 27, 2020
$ / shares
Mar. 23, 2020
USD ($)
Jan. 10, 2020
USD ($)
Jan. 08, 2020
USD ($)
Dec. 20, 2019
USD ($)
shares
Jan. 16, 2019
USD ($)
$ / shares
shares
Nov. 02, 2018
USD ($)
Oct. 31, 2018
$ / shares
shares
Oct. 16, 2018
$ / shares
Oct. 15, 2018
$ / shares
shares
Jan. 31, 2019
USD ($)
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Ownership
$ / shares
$ / Assessment
shares
Sep. 30, 2019
USD ($)
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Aug. 18, 2020
$ / shares
Jun. 30, 2020
$ / shares
shares
Jun. 29, 2020
USD ($)
Nov. 30, 2018
shares
Apr. 02, 2018
$ / shares
shares
Oct. 23, 2015
$ / shares
shares
Summary Of Significant Accounting Policies [Line Items]                                                  
Principal amount                                     $ 339,797            
Cash                           $ 12,234,506     $ 12,234,506   822,909            
Goodwill (Note 2)                                     $ 4,039,586            
Goodwill impairment loss         $ 1,650,000                                        
Common stock, shares outstanding | shares                       625,318   15,418,799     15,418,799   3,134,261            
Minimum bid price | $ / shares     $ 1.00                                            
Reverse stock split, description   On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors                             one-for-ten                
Reverse stock split percentage of issued common stock   0.1                                              
Reverse stock split percentage of outstanding common stock   0.5                                              
Proceeds from stock subscription                                 $ 9,447,535                
Common stock, shares issued | shares                           15,418,799     15,418,799   3,134,261       2,500,000    
Warrants issued to purchase of common stock | shares 11,200,000                                                
Number of warrants, exercised | shares 150,000                               1,377,700 9,300              
Exercise of warrants $ 135,000                               $ 3,081,480 $ 22,320              
Finance receivables, allowance for credit losses, write offs                               $ 51,080 13,452                
Capitalized real estate costs, net of accumulated depreciation                           $ 20,281     20,281   $ 21,084            
Depreciation expense                           (4,990) $ 5,385   4,723 17,354              
Operating lease, payments                                 69,669 23,466              
Settlement costs with associations                           $ 17,934 8,825   $ 29,854 $ 49,003              
Valuation allowance deferred tax assets                                     $ 3,634,857            
Reverse stock split, conversion ratio                       0.1                          
Common stock, par value | $ / shares                       $ 0.001   $ 0.001     $ 0.001   $ 0.001            
Warrants issued to purchase of common stock average exercise price per share | $ / shares $ 0.90                                                
Warrants, weighted average remaining life 4 years 10 months 17 days                                                
Warrants, year of expiration 2025                                                
Warrants, aggregate intrinsic value outstanding $ 0                                                
Common Stock Shares Issued For Warrant | shares 11,200,000                                                
Convertible Notes [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Convertible notes conversion to common shares | shares                                   1,436,424              
ASU 2016-02 [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Right of use asset, net                           $ 185,370     $ 185,370   $ 260,260            
Amortization expense for right to use assets                           $ 23,661 22,281   74,890 $ 27,133              
Operating lease, payments                                 $ 69,669                
Registered Public Offering [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Proceeds from stock subscription $ 8,200,000                                                
Common stock, shares issued | shares 10,200,000                                                
Warrants issued to purchase of common stock | shares 11,200,000                                                
Warrants exercised for cash, shares | shares 1,700,000                                                
Exercise of warrants $ 135,000                                                
Common stock, par value | $ / shares                                       $ 0.001          
Stock Warrants [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Reverse stock split, description                     one-tenth                            
Warrants issued to purchase of common stock | shares                   777,059       1,638,000     1,638,000             40,000  
Number of warrants, exercised | shares                                 1,377,700                
Exercise of warrants                                 $ 3,081,480                
Warrants issued to purchase of common stock average exercise price per share | $ / shares                   $ 0.34 $ 12.50     $ 0.67     $ 0.67             $ 6.605  
Warrants, weighted average price | $ / shares                           $ 12.50     $ 12.50                
Warrants, weighted average remaining life                                 44 years   94 years            
Warrants, year of expiration                                 2020 2023              
Warrants, aggregate intrinsic value outstanding                           $ 249,000     $ 249,000   $ 0            
Warrants Expire Date                                 Oct. 31, 2020                
Stock Warrants [Member] | Registered Public Offering [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Number of warrants, exercised | shares 150,000                                                
Stock Warrants [Member] | Initial Public Offering [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Warrants issued to purchase of common stock | shares                                                 1,200,000
Warrants issued to purchase of common stock average exercise price per share | $ / shares                                                 $ 12.50
Warrants, aggregate intrinsic value outstanding                           0     $ 0   0            
Stock Warrants [Member] | Secondary Offering [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Warrants issued to purchase of common stock | shares                   2,875,000                              
Exercise of warrants                                 $ 2,946,480   $ 22,320            
Warrants issued to purchase of common stock average exercise price per share | $ / shares                   $ 2.40                              
Warrants, year of expiration                   2023                              
Warrant | shares                                 1,277,700   9,300            
Additional Warrants [Member] | Secondary Offering [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Warrants issued to purchase of common stock | shares                   125,000                              
Warrants issued to purchase of common stock average exercise price per share | $ / shares                   $ 2.64                              
Warrants, year of expiration                   May 02, 2022                              
Exercise Price Warrants Per Share | $ / shares                   $ 0.90                              
Special Product [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Delinquent assessments maximum due period purchases basis                                 48 months                
Original Product [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Allowance for credit losses                           142,000     $ 142,000   $ 112,000            
Hanfor (Cayman) Ltd | Share Exchange Agreement [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Loaned to related party             $ 1,500,000                                    
Maturity of note             Apr. 15, 2020                                    
Interest rate             0.50%                                    
Stock pledge against investment | shares             640,000                                    
I I U Inc                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Purchase price                         $ 4,969,200                        
Net fair value of assets                         720,386                        
Goodwill (Note 2)                         5,689,586           5,700,000            
Goodwill impairment loss           $ 1,650,000                     $ 0   4,000,000            
Goodwill impairment                         $ 16,428                        
Minimum [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 20 years                
Minimum [Member] | First Mortgage [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 3 years                
Minimum [Member] | I I U Inc                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Working capital                                 $ 15,000                
Cash                           $ 152,000     $ 152,000                
Maximum [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Closing bid price of common stock | $ / shares                                 $ 1.00                
Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Debt instrument, interest rate percentage             0.50%                                    
Loan amount             $ 1,500,000                                    
Debt instrument, maturity date             Apr. 15, 2020                   Aug. 01, 2021                
Common shares pledge | shares             640,000                                    
Full principal and accrued interest amount received                                           $ 1,503,719      
Convertible Promissory Note [Member] | I I U Inc                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Debt instrument term               360 days                                  
Debt instrument, interest rate percentage               3.00%                                  
Extinguishment of principal indebtedness and accrued interest               $ 1,507,375                                  
Face amount of debt instrument               $ 3,581,982                                  
Denominator for conversion of convertible note to restricted common shares | $ / shares               $ 2.41                                  
Closing price of share price | $ / shares                           $ 1.42     $ 1.42                
Debt instrument reduced amount               $ (120,200)                                  
Securities Purchase Agreement [Member] | Hanfor-Owner [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Ownership excluding unexercised warrants percentage       86.50%                                          
Common stock, shares outstanding | shares                                         520,838        
Sale of stock price per share | $ / shares                                         $ 2.40        
Proceeds from issuance of stock       $ 250,000                                          
Notes receivable       $ 1,000,000                                          
Securities Purchase Agreement [Member] | I I U Inc                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Percentage of stock purchased               100.00%                                  
Purchase price               $ 5,089,357                 $ 4,969,200                
Securities Purchase Agreement [Member] | Senior Convertible Promissory Notes [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Ownership excluding unexercised warrants percentage                 20.00%                                
Principal amount                 $ 1,500,000                                
Debt instrument term                 360 days                                
Debt instrument, interest rate percentage                 3.00%                                
Stock Purchase Agreement | I I U Inc                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Goodwill (Note 2)               5,689,586                                  
Total adjusted purchase price               4,969,200                                  
Preliminary estimate of the fair value of assets and liabilities assumed               720,386                                  
Gain on disposal of discontinued operations               $ 16,428                 $ 16,428                
Stock Purchase Agreement | Convertible Notes [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Debt instrument, maturity date               Jan. 14, 2020                                  
Convertible notes conversion to common shares | shares               1,436,424                                  
Interest rate               3.00%                                  
Stock Purchase Agreement | Craven House Capital North America LLC [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Sale of stock under agreement           3,562,569                                      
Goodwill impairment loss           1,650,000                                      
Stock Purchase Agreement | I I U Inc                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Percentage of stock purchased                           100.00%     100.00%                
Purchase price                                 $ 5,089,357                
Stock Purchase Agreement | Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Proceeds from issuance of debt funded in repurchase and cancellation of debt           $ 3,461,782   $ 3,461,782                                  
Forgave amount accrued interest               $ 100,787                                  
Subsidiaries [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Number of members | Ownership                                 2                
Minimum percentage of original principal amount on mortgage                                 1.00%                
Maximum statutory delinquent assessments rate                                 18.00%                
Maximum administrative late fees | $ / Assessment                                 25                
Percentage of maximum administrative late fees on delinquent assessment                                 5.00%                
Minimum acquisition cost that requires capitalization to fixed assets                           $ 500     $ 500                
Capitalized software costs, net of accumulated amortization                           0     0   0            
Amortization expense for capitalized software costs                           0 5,814   0 $ 17,444              
Unamortized debt issue costs                           0     0   0            
Settlement costs with associations                           18,000 $ 9,000   30,000 49,000              
Fair value of properties                                 $ 0 $ 0              
Subsidiaries [Member] | Capitalized Software [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful life                                 5 years                
Subsidiaries [Member] | HealthCare Abroad [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Age limit                                 84 years                
Subsidiaries [Member] | HealthCare Global [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Age limit                                 70 years                
Subsidiaries [Member] | HealthCare America [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Age limit                                 70 years                
Subsidiaries [Member] | HealthCare International [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Age limit                                 70 years                
Subsidiaries [Member] | HealthCare War [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Age limit                                 70 years                
Subsidiaries [Member] | Special Product [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Delinquent assessments maximum due period purchases basis                                 48 months                
Allowance for credit losses                           6,564     $ 6,564   20,016            
Subsidiaries [Member] | Original Product [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Allowance for credit losses                           $ 142,027     $ 142,027   $ 112,027            
Subsidiaries [Member] | Minimum [Member] | Furniture [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 3 years                
Subsidiaries [Member] | Minimum [Member] | Computer [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 3 years                
Subsidiaries [Member] | Minimum [Member] | Office Equipment [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 3 years                
Subsidiaries [Member] | Maximum [Member] | Furniture [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 5 years                
Subsidiaries [Member] | Maximum [Member] | Computer [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 5 years                
Subsidiaries [Member] | Maximum [Member] | Office Equipment [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Estimated useful lives                                 5 years                
Subsidiaries [Member] | Maximum [Member] | HealthCare Global [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Coverage period                                 6 months                
Subsidiaries [Member] | Maximum [Member] | HealthCare America [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Coverage period                                 90 days                
Subsidiaries [Member] | Maximum [Member] | HealthCare War [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Coverage period                                 6 months                
REO Management Holdings, LLC [Member] | Maximum [Member] | Subsidiary Limited Liability [Member]                                                  
Summary Of Significant Accounting Policies [Line Items]                                                  
Percentage of ownership in subsidiary limited liability companies                                 100.00%                
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) - shares
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Stock Options [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive stock based compensation awards 19,300 19,300
Stock Warrants [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive stock based compensation awards 14,790,059 2,879,287
Convertible Notes [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive stock based compensation awards   1,436,424
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 10, 2020
Jan. 08, 2020
Apr. 15, 2019
Jan. 16, 2019
Nov. 02, 2018
Jan. 31, 2019
Mar. 31, 2019
Sep. 30, 2020
Dec. 31, 2019
Dec. 20, 2019
Business Acquisition [Line Items]                    
Principal amount                 $ 339,797  
Net cash received from business acquisition             $ 51,327      
Goodwill impairment loss $ 1,650,000                  
I I U Inc                    
Business Acquisition [Line Items]                    
Purchase price           $ 4,969,200        
Goodwill impairment loss   $ 1,650,000           $ 0 $ 4,000,000  
Senior Convertible Promissory Notes [Member]                    
Business Acquisition [Line Items]                    
Closing share price       $ 1.42            
Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                    
Business Acquisition [Line Items]                    
Debt instrument, interest rate percentage                   0.50%
Securities Purchase Agreement [Member] | I I U Inc                    
Business Acquisition [Line Items]                    
Percentage of stock purchased       100.00%            
Purchase price       $ 5,089,357       $ 4,969,200    
Securities Purchase Agreement [Member] | Senior Convertible Promissory Notes [Member]                    
Business Acquisition [Line Items]                    
Ownership excluding unexercised warrants percentage         20.00%          
Principal amount         $ 1,500,000          
Purchase price of notes issued         $ 1,500,000          
Debt instrument term         360 days          
Debt instrument, interest rate percentage         3.00%          
Promissory Notes [Member] | I I U Inc                    
Business Acquisition [Line Items]                    
Extinguishment of principal indebtedness and accrued interest       $ 1,507,375            
Convertible Promissory Note [Member] | I I U Inc                    
Business Acquisition [Line Items]                    
Debt instrument term     12 months 360 days            
Debt instrument, interest rate percentage       3.00%            
Extinguishment of principal indebtedness and accrued interest       $ 1,500,000            
Face amount of debt instrument       $ 3,581,982            
Denominator for conversion of convertible note to restricted common shares       $ 2.41            
Debt instrument reduced amount       $ 120,200            
Stock Purchase Agreement | Craven House Capital North America LLC [Member]                    
Business Acquisition [Line Items]                    
Goodwill impairment loss   1,650,000                
Sale of stock under agreement   3,562,569                
Stock Purchase Agreement | I I U Inc                    
Business Acquisition [Line Items]                    
Percentage of stock purchased               100.00%    
Purchase price               $ 5,089,357    
Stock Purchase Agreement | Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                    
Business Acquisition [Line Items]                    
Proceeds from issuance of debt funded in repurchase and cancellation of debt   $ 3,461,782   3,461,782            
Forgave amount accrued interest       $ 100,787            
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)
Jan. 16, 2019
Dec. 31, 2019
Business Acquisition [Line Items]    
Goodwill   $ 4,039,586
IIU, Inc and Wallach and Company [Member]    
Business Acquisition [Line Items]    
Total adjusted purchase price $ 4,969,200  
Cash 51,300  
Prepaid and other current assets 5,200  
Profit on purchased policies 14,600  
Property, plant and equipment 17,100  
Accounts payable (5,100)  
Accrued expenses and other liabilities (62,686)  
Income taxes (28,500)  
Deferred revenue (9,300)  
Debt (703,000)  
Preliminary estimate of the fair value of assets and liabilities assumed (720,386)  
Goodwill $ 5,689,586  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) - Original Product [Member]
9 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
Unit
Dec. 31, 2019
USD ($)
Unit
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding $ 312,000 $ 386,000
Reserve for credit losses (142,000) (112,000)
Finance receivables, net $ 170,000 $ 274,000
Number of active units with delinquent assessments | Unit 489 598
Amount of outstanding interest and late fees on active units $ 8,682,000 $ 9,167,000
Funded During The Current Year [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 16,000 40,000
1-2 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 14,000 15,000
2-3 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 9,000 20,000
3-4 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 17,000 11,000
Greater Than 4 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding $ 256,000 $ 300,000
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Financing Receivable - Original Product - Additional Information (Detail)
3 Months Ended
Sep. 30, 2020
USD ($)
Receivables [Abstract]  
Financing Receivable, Reserved $ 30,000
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) - USD ($)
9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Special Product [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Delinquent assessments maximum due period purchases basis 48 months  
Maximum future contingent payments $ 34,000  
New Neighbor Guaranty (NNG) [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Allowance for credit losses $ 7,000 $ 20,000
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) - Special Product [Member]
9 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
Unit
Dec. 31, 2019
USD ($)
Unit
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables, net $ 96,000 $ 129,000
Delinquent assessments 205,000 374,000
Accrued interest and late fees $ 91,000 $ 235,000
Number of active units with delinquent assessments | Unit 20 31
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Due to Related Party - Additional Information (Detail)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 20, 2019
USD ($)
shares
Jan. 02, 2017
USD ($)
$ / Unit
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Related Party Transaction [Line Items]              
Due to related party (Note 5)     $ 264,412   $ 264,412    
Principal amount             $ 339,797
Subsidiaries [Member]              
Related Party Transaction [Line Items]              
Recoveries incurred     28,000 $ 53,000 124,000 $ 175,000  
Business Law Group [Member]              
Related Party Transaction [Line Items]              
Monthly payment for cases   $ 82,000          
Minimum fee paid per unit | $ / Unit   700          
Service amount paid     247,000 262,000 756,000 799,000  
Due to related party (Note 5)     1,542,000   1,542,000   1,883,000
Office sub lease income         45,000    
Receivable (Payable)from related party         (264,400)   $ 152,800
Amount written-off regained         300,000    
Business Law Group [Member] | Out of Pocket Collection Costs [Member]              
Related Party Transaction [Line Items]              
Expenses incurred by company     $ 28,000 $ 49,000 $ 95,000 $ 158,000  
Craven Holdings North America Inc [Member] | Share Exchange Agreement [Member]              
Related Party Transaction [Line Items]              
Principal amount $ 1,500,000            
Debt instrument, interest rate percentage 0.50%            
Debt instrument, due date Apr. 15, 2020            
Debt Instrument, extended maturity date Aug. 01, 2021            
Common shares pledged other than secured promissory notes | shares 640,000            
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Schedule of Debt (Detail) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Notes payable $ 339,797 $ 4,149,578
Financing agreement with FlatIron capital maturing in June 1, 2020 [Member]    
Debt Instrument [Line Items]    
Notes payable   69,540
Financing agreement with FlatIron capital maturing in June 1, 2021 [Member]    
Debt Instrument [Line Items]    
Notes payable 154,012  
Promissory note issued by a financial institution maturing in April 30, 2022 [Member]    
Debt Instrument [Line Items]    
Notes payable $ 185,785  
Convertible Senior Note [Member]    
Debt Instrument [Line Items]    
Notes payable   3,461,782
Promissory note issued by a financial institution maturing in August 26, 2023 [Member]    
Debt Instrument [Line Items]    
Notes payable   11,802
Promissory note issued by a financial institution maturing in May 30, 2025 [Member]    
Debt Instrument [Line Items]    
Notes payable   $ 606,454
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail)
9 Months Ended
Sep. 30, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Debt Instrument [Line Items]    
Principal amount   $ 339,797
Financing agreement with FlatIron capital maturing in June 1, 2021 [Member]    
Debt Instrument [Line Items]    
Down payment for note payable $ 20,746  
Debt instrument, periodic payment $ 19,251  
Debt instrument, maturity date May 01, 2021  
Debt instrument, interest rate percentage 5.95%  
Financing agreement with FlatIron capital maturing in June 1, 2020 [Member]    
Debt Instrument [Line Items]    
Down payment for note payable $ 19,170  
Debt instrument, periodic payment $ 11,590  
Debt instrument, maturity date Jun. 01, 2020  
Debt instrument, interest rate percentage 6.80%  
Convertible Senior Note [Member]    
Debt Instrument [Line Items]    
Debt instrument, maturity date Jan. 14, 2020  
Debt instrument, interest rate percentage 3.00%  
Debt instrument, issuance date Jan. 16, 2019  
Debt instrument, to be converted shares | shares 1,436,424  
Debt instrument, convertible, beneficial conversion feature $ 0  
Promissory note issued by a financial institution maturing in August 26, 2023 [Member]    
Debt Instrument [Line Items]    
Debt instrument, periodic payment $ 323  
Debt instrument, maturity date Aug. 26, 2023  
Debt instrument, interest rate percentage 9.09%  
Debt instrument, issuance date Jul. 26, 2019  
Principal amount $ 12,892  
Promissory note issued by a financial institution maturing in May 30, 2025 [Member]    
Debt Instrument [Line Items]    
Debt instrument, periodic payment $ 10,932  
Debt instrument, maturity date May 30, 2025  
Debt instrument, interest rate percentage 5.85%  
Debt instrument, issuance date May 31, 2018  
Principal amount $ 608,000  
Subsequent borrowings 141,000  
Repayments $ 51,000  
Promissory note issued by a financial institution maturing in April 30, 2022 [Member]    
Debt Instrument [Line Items]    
Debt instrument, maturity date Apr. 30, 2022  
Debt instrument, interest rate percentage 1.00%  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail)
Dec. 31, 2019
USD ($)
Debt Instruments [Abstract]  
2020 $ 57,755
2021 96,257
2022 185,785
Debt Instrument Carrying Amount $ 339,797
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Additional Information (Detail) - USD ($)
9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Notes payable $ 339,797 $ 4,149,578
Promissory note issued by a financial institution maturing in April 30, 2022 [Member]    
Debt Instrument [Line Items]    
Notes payable $ 185,785  
Debt instrument, interest rate percentage 1.00%  
Debt Instrument Maturity Period 2 years  
Promissory note issued by a financial institution maturing in April 30, 2022 [Member] | US Federal Government Coronavirus Aid, Relief, and Economic Security Act [Member]    
Debt Instrument [Line Items]    
Notes payable $ 185,785  
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern - Additional Information (Detail) - USD ($)
1 Months Ended 9 Months Ended
Jul. 18, 2020
Aug. 31, 2020
Sep. 30, 2020
Sep. 30, 2019
Mar. 31, 2020
Dec. 31, 2019
Nov. 30, 2018
Financial Support For Nonconsolidated Legal Entity [Line Items]              
Cumulative operating losses         $ 18,236,000    
Proceeds from warrants exercised $ 135,000   $ 3,081,480 $ 22,320      
Proceeds from stock subscription     $ 9,447,535        
Common stock, shares issued     15,418,799     3,134,261 2,500,000
Cash     $ 12,234,506     $ 822,909  
Going Concerns [Member]              
Financial Support For Nonconsolidated Legal Entity [Line Items]              
Proceeds from issuance of common stock, warrants exercised and related party receivable     $ 14,000,000        
Warrants Exercised   150,000 1,200,000        
Proceeds from warrants exercised   $ 100,000 $ 2,900,000        
Related party receivable     1,500,000        
Proceeds from stock subscription     $ 1,250,000        
Common stock, shares issued     520,838        
Cash     $ 12,200,000        
Going Concerns [Member] | Common Stock [Member]              
Financial Support For Nonconsolidated Legal Entity [Line Items]              
Proceeds from stock subscription     $ 8,300,000        
Common stock, shares issued     10,200,000        
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Loss Contingencies [Line Items]        
Lease expiration period     37 months  
Operating lease discount rate 6.50%   6.50%  
Operating lease beginning date     Mar. 01, 2014  
Operating lease ending date     Jul. 31, 2019  
Rent expense $ 26,000 $ 50,000 $ 76,000 $ 148,000
New Office Lease [Member]        
Loss Contingencies [Line Items]        
Operating lease beginning date     Jul. 15, 2019  
Operating lease ending date     Jul. 31, 2022  
Business Law Group [Member]        
Loss Contingencies [Line Items]        
Sublease Income     $ 4,900  
Minimum [Member]        
Loss Contingencies [Line Items]        
Operating lease remaining lease term     1 year  
Maximum [Member]        
Loss Contingencies [Line Items]        
Operating lease remaining lease term     3 years  
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Components of Lease Expense (Detail) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Lease Cost [Abstract]        
Operating lease expense $ 27,644 $ 50,274 $ 89,931 $ 147,575
Lease cost $ 27,644 $ 50,274 $ 89,931 $ 147,575
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Assets And Liabilities Lessee [Abstract]    
ROU assets $ 185,370 $ 260,260
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] us-gaap:OperatingLeaseRightOfUseAsset us-gaap:OperatingLeaseRightOfUseAsset
Current lease liabilities $ 98,846 $ 94,235
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]   us-gaap:OperatingLeaseLiability
Long-term lease liabilities $ 97,368 $ 171,648
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] us-gaap:OperatingLeaseLiability us-gaap:OperatingLeaseLiability
Total lease liabilities $ 196,214 $ 265,883
Weighted-average remaining lease term (in years) 1 year 9 months 29 days 2 years 7 months 6 days
Weighted-average discount rate 6.55% 6.55%
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating cash flow information    
Lease liability payments $ (69,669) $ (23,466)
SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION    
ROU asset obligation recognized   $ 331,477
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail)
Sep. 30, 2020
USD ($)
Commitments And Contingencies Disclosure [Abstract]  
2020 (excluding the nine months ended September 30, 2020) $ 24,566
2021 103,646
2022 68,002
Total future minimum lease payments due $ 196,214
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) - $ / shares
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Number of Options    
Number of Options, Outstanding at Beginning of the year 19,300 19,300
Number of Options, Granted
Number of Options, Exercised
Number of Options, Adjustment
Number of Options, Forfeited
Number of Options, Outstanding at End of Year 19,300 19,300
Number of Options, Exercisable at End of Year 15,134 7,634
Weighted Average Exercise Price    
Weighted Average Exercise Price, Outstanding at Beginning Balance $ 60.51 $ 60.51
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Adjustment
Weighted Average Exercise Price, Forfeited
Weighted Average Exercise Price, Outstanding at Ending Balance 54.68 60.51
Weighted Average Exercise Price, Exercisable $ 62.02 $ 113.81
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Additional Information (Detail) - USD ($)
1 Months Ended 9 Months Ended
Aug. 18, 2020
Jul. 18, 2020
Mar. 23, 2020
Apr. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Oct. 31, 2018
Oct. 16, 2018
Oct. 15, 2018
Apr. 02, 2018
Class Of Stock [Line Items]                      
Recognized compensation expense of stock options         $ 10,200 $ 10,400          
Remaining unrecognized compensation cost         8,000            
Aggregate intrinsic value of outstanding common stock options         0   $ 0        
Proceeds from warrants exercised   $ 135,000     $ 3,081,480 $ 22,320          
Number of warrants, exercised   150,000     1,377,700 9,300          
Warrants, aggregate intrinsic value outstanding   $ 0                  
Cash received for shares issued       $ 1,000,000              
Common stock, par value         $ 0.001   $ 0.001     $ 0.001  
Warrants issued to purchase of common stock   11,200,000                  
Warrants issued to purchase of common stock average exercise price per share   $ 0.90                  
Net proceeds of the offering $ 8,198,000                    
Registered Public Offering [Member]                      
Class Of Stock [Line Items]                      
Proceeds from warrants exercised   $ 135,000                  
Common stock issued 8,300,000                    
Common stock, par value $ 0.001                    
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1                    
Warrants issued to purchase of common stock   11,200,000                  
Shares Issued, Price Per Share $ 0.90                    
Over-Allotment Option [Member]                      
Class Of Stock [Line Items]                      
Common stock issued 200,000                    
Share Exchange Agreement                      
Class Of Stock [Line Items]                      
Common stock issued     520,833                
Denominator for conversion of convertible note to restricted common shares     $ 2.40                
Cash received for shares issued     $ 250,000                
Stock Warrants [Member]                      
Class Of Stock [Line Items]                      
Proceeds from warrants exercised         $ 3,081,480            
Number of warrants, exercised         1,377,700            
Warrants, aggregate intrinsic value outstanding         $ 249,000   $ 0        
Warrants issued to purchase of common stock         1,638,000     777,059     40,000
Warrants issued to purchase of common stock average exercise price per share         $ 0.67     $ 0.34 $ 12.50   $ 6.605
Stock Warrants [Member] | Registered Public Offering [Member]                      
Class Of Stock [Line Items]                      
Number of warrants, exercised   150,000                  
Pre-Funded Warrants [Member] | Registered Public Offering [Member]                      
Class Of Stock [Line Items]                      
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1                    
Warrants issued to purchase of common stock 1,700,000                    
Warrants issued to purchase of common stock average exercise price per share $ 0.01                    
Shares Issued, Price Per Share $ 0.89                    
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Summary of Stock Warrants (Detail) - $ / shares
9 Months Ended
Jul. 18, 2020
Sep. 30, 2020
Sep. 30, 2019
Equity [Abstract]      
Number of Warrants, beginning balance   3,959,287 3,843,587
Number of warrants, granted   11,200,000 125,000
Number of warrants, exercised 150,000 1,377,700 9,300
Number of Warrants, adjustment   633,472  
Number of Warrants, adjustment   375,000  
Number of Warrants, ending balance   14,790,059 3,959,287
Weighted Average Exercise Price, Outstanding at Ending Balance   $ 5.36 $ 5.44
Weighted Average Exercise Price, granted   0.90 2.64
Weighted Average Exercise Price, exercised   2.24 2.40
Weighted Average Exercise Price, adjustment   0.34  
Weighted Average Exercise Price, adjustment   0.67  
Weighted Average Exercise Price, Outstanding at Ending Balance   $ 1.79 $ 5.36
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Additional Information (Details) - USD ($)
9 Months Ended
Jan. 10, 2020
Jan. 08, 2020
Jan. 16, 2019
Sep. 30, 2020
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Goodwill impairment loss $ 1,650,000      
Stock Purchase Agreement | I I U Inc        
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Gain on disposal of discontinued operations     $ 16,428 $ 16,428
Stock Purchase Agreement | Craven House Capital North America LLC [Member]        
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Sale of stock under agreement   $ 3,562,569    
Goodwill paid   4,969,586    
Goodwill impairment loss   1,650,000    
Stock Purchase Agreement | Craven House Capital North America LLC [Member] | Senior Convertible Promissory Notes [Member]        
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Proceeds from issuance of debt funded in repurchase and cancellation of debt   $ 3,461,782 3,461,782  
Forgave amount accrued interest     $ 100,787  
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) - USD ($)
3 Months Ended 9 Months Ended
Jan. 16, 2019
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Major classes of assets          
Net gain (loss) from discontinued operations   $ 103,561 $ 16,428 $ 39,632  
I I U Inc | Stock Purchase Agreement          
Major classes of assets          
Cash         $ 246,914
Related party receivable         27,738
Prepaid expenses         2,301
Total major classes of current assets – discontinued assets         276,953
Fixed assets, net         27,245
Total major classes of assets – discontinued assets         304,198
Accounts payable and accrued expenses         144,006
Note payable – short term         100,672
Other liabilities         21,153
Income taxes payable         14,226
Total major classes of current liabilities – discontinued liabilities         280,057
Debt         517,584
Total major classes of liabilities - discontinued liabilities         $ 797,641
Revenue   221,085   501,244  
Total operating costs and expenses   101,068   428,445  
Gain (Loss) from discontinued operations   120,017   72,799  
Other expense, net   16,455   33,166  
Gain on disposal of discontinued operations $ 16,428   16,428    
Net gain (loss) from discontinued operations   103,562 16,428 39,633  
Net cash provided by operating activities   (48,205)   65,624  
Net cash (used in) provided by investing activities   (76,695) $ (246,914) (25,368)  
Net cash used in financing activities   $ (18,418)   $ (56,304)  
EXCEL 61 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 62 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 246 448 1 false 67 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.lmfunding.com/20200930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.lmfunding.com/20200930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.lmfunding.com/20200930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.lmfunding.com/20200930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.lmfunding.com/20200930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.lmfunding.com/20200930/taxonomy/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 6 false false R7.htm 100060 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 100070 - Disclosure - Goodwill and Acquisition Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoodwillAndAcquisition Goodwill and Acquisition Notes 8 false false R9.htm 100080 - Disclosure - Finance Receivables - Original Product Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesOriginalProduct Finance Receivables - Original Product Notes 9 false false R10.htm 100090 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgram Finance Receivables - Special Product (New Neighbor Guaranty program) Notes 10 false false R11.htm 100100 - Disclosure - Due to Related Party Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDueToRelatedParty Due to Related Party Notes 11 false false R12.htm 100110 - Disclosure - Debt and Other Financing Arrangements Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangements Debt and Other Financing Arrangements Notes 12 false false R13.htm 100120 - Disclosure - Going Concern Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoingConcern Going Concern Notes 13 false false R14.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100140 - Disclosure - Stockholders' Equity Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 100150 - Disclosure - Discontinued Operations Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDiscontinuedOperations Discontinued Operations Notes 16 false false R17.htm 100160 - Disclosure - Subsequent Events Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 100180 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 100190 - Disclosure - Goodwill and Acquisition (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoodwillAndAcquisitionTables Goodwill and Acquisition (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoodwillAndAcquisition 20 false false R21.htm 100200 - Disclosure - Finance Receivables - Original Product (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesOriginalProductTables Finance Receivables - Original Product (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesOriginalProduct 21 false false R22.htm 100210 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramTables Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgram 22 false false R23.htm 100220 - Disclosure - Debt and Other Financing Arrangements (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsTables Debt and Other Financing Arrangements (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangements 23 false false R24.htm 100230 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingencies 24 false false R25.htm 100240 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureStockholdersEquity 25 false false R26.htm 100250 - Disclosure - Discontinued Operations (Tables) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDiscontinuedOperations 26 false false R27.htm 100260 - Disclosure - Summary of Significant Accounting Policies - Additional information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional information (Detail) Details 27 false false R28.htm 100270 - Disclosure - Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) Notes http://www.lmfunding.com/20200930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfAntiDilutiveStockBasedCompensationAwardsAndConvertibleNotesDetail Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) Details 28 false false R29.htm 100280 - Disclosure - Goodwill and Acquisition - Additional Information (Details) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoodwillAndAcquisitionAdditionalInformationDetails Goodwill and Acquisition - Additional Information (Details) Details 29 false false R30.htm 100290 - Disclosure - Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoodwillAndAcquisitionSummaryOfConsiderationPaidAndAmountsOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) Details 30 false false R31.htm 100300 - Disclosure - Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesOriginalProductScheduleOfFinanceReceivablesForOriginalProductDetail Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) Details 31 false false R32.htm 100310 - Disclosure - Financing Receivable - Original Product - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinancingReceivableOriginalProductAdditionalInformationDetail Financing Receivable - Original Product - Additional Information (Detail) Details 32 false false R33.htm 100320 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramAdditionalInformationDetail Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) Details http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramTables 33 false false R34.htm 100330 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramScheduleOfDelinquentAssessmentsAndAccruedChargesDetail Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) Details http://www.lmfunding.com/20200930/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramTables 34 false false R35.htm 100340 - Disclosure - Due to Related Party - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDueToRelatedPartyAdditionalInformationDetail Due to Related Party - Additional Information (Detail) Details 35 false false R36.htm 100350 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsScheduleOfDebtDetail Debt and Other Financing Arrangements - Schedule of Debt (Detail) Details 36 false false R37.htm 100360 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsScheduleOfDebtParentheticalDetail Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail) Details 37 false false R38.htm 100370 - Disclosure - Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsScheduleOfPrincipalPaymentsOfDebtDetail Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail) Details 38 false false R39.htm 100380 - Disclosure - Debt and Other Financing Arrangements - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsAdditionalInformationDetail Debt and Other Financing Arrangements - Additional Information (Detail) Details 39 false false R40.htm 100390 - Disclosure - Going Concern - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureGoingConcernAdditionalInformationDetail Going Concern - Additional Information (Detail) Details 40 false false R41.htm 100400 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 41 false false R42.htm 100410 - Disclosure - Commitments and Contingencies - Components of Lease Expense (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfLeaseExpenseDetail Commitments and Contingencies - Components of Lease Expense (Detail) Details 42 false false R43.htm 100420 - Disclosure - Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesDetail Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) Details 43 false false R44.htm 100430 - Disclosure - Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfSupplementalCashFlowInformationAndNonCashActivityRelatedToOperatingLeasesDetail Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) Details 44 false false R45.htm 100440 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentDueDetail Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail) Details 45 false false R46.htm 100450 - Disclosure - Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionPlanActivityDetail Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) Details 46 false false R47.htm 100460 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Stockholders' Equity - Summary of Stock Warrants (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockWarrantsDetail Stockholders' Equity - Summary of Stock Warrants (Detail) Details 48 false false R49.htm 100480 - Disclosure - Discontinued Operations - Additional Information (Details) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetails Discontinued Operations - Additional Information (Details) Details 49 false false R50.htm 100490 - Disclosure - Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) Sheet http://www.lmfunding.com/20200930/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfMajorClassesOfAssetsAndLiabilitiesAndOperatingResultsOfIIUDetail Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) Details 50 false false All Reports Book All Reports lmfa-20200930.xml lmfa-20200930.xsd lmfa-20200930_cal.xml lmfa-20200930_def.xml lmfa-20200930_lab.xml lmfa-20200930_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 66 0001564590-20-054189-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-054189-xbrl.zip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�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end